-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ORckc2898Bi+9Ooxgo+jy4qREsgRJSQd4lPqRwEC0k+QfuJAbqeJ9ei+ktj1klCZ eIQ66RxA4Skd9fCXeNxtrA== 0001193125-05-078286.txt : 20050418 0001193125-05-078286.hdr.sgml : 20050418 20050418112227 ACCESSION NUMBER: 0001193125-05-078286 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20050518 FILED AS OF DATE: 20050418 DATE AS OF CHANGE: 20050418 EFFECTIVENESS DATE: 20050418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROTEK MEDICAL HOLDINGS, INC CENTRAL INDEX KEY: 0000929299 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 581746149 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-24866 FILM NUMBER: 05755726 BUSINESS ADDRESS: STREET 1: 13000 DEERFIELD PARKWAY STREET 2: SUITE 300 CITY: ALPHARETTA STATE: 2Q ZIP: 30004 BUSINESS PHONE: (678) 896-4400 MAIL ADDRESS: STREET 1: 13000 DEERFIELD PARKWAY STREET 2: SUITE 300 CITY: ALPHARETTA STATE: 2Q ZIP: 30004 FORMER COMPANY: FORMER CONFORMED NAME: MICROTEK MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20020813 FORMER COMPANY: FORMER CONFORMED NAME: ISOLYSER CO INC /GA/ DATE OF NAME CHANGE: 19940831 DEF 14A 1 ddef14a.htm DEFINITIVE PROXY STATEMENT Definitive Proxy Statement

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

 

Filed by the Registrant x

 

Filed by a Party other than the Registrant ¨

 

Check the appropriate box:

 

¨    Preliminary Proxy Statement    ¨ Confidential, Use of the
x    Definitive Proxy Statement         Commission Only (as permitted by
¨    Definitive Additional Materials         Rule 14a-6(e)(2)
¨    Soliciting Material Pursuant to     
     (§)240.14a-11(c) or (§)240.14a-12     

 

MICROTEK MEDICAL HOLDINGS, INC.


(Name of Registrant as Specified In Its Charter)

 

N/A


(Name of Person(s) Filing Proxy Statement if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

x   No fee required.

 

¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  1)   Title of each class of securities to which transaction applies:
  2)   Aggregate number of securities to which transaction applies:
  3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
  4)   Proposed maximum aggregate value of transaction:
  5)   Total fee paid:

 

¨   Fee paid previously with preliminary materials.

 

¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

  1)   Amount Previously Paid:
  2)   Form, Schedule or Registration Statement No.:
  3)   Filing Party:
  4)   Date Filed:


MICROTEK MEDICAL HOLDINGS, INC.

13000 Deerfield Parkway

Suite 300

Alpharetta, Georgia 30004

 

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

To Be Held May 18, 2005

 

To the Shareholders:

 

The Annual Meeting of Shareholders of Microtek Medical Holdings, Inc. (the “Company”) will be held at the Company’s offices located at 13000 Deerfield Parkway, Suite 300, Alpharetta, GA 30004, on Wednesday, May 18, 2005 at 2:00 p.m. for the following purposes, all as set forth in the attached Proxy Statement:

 

1. To elect seven directors to serve for one-year terms expiring at the annual meeting in 2006 and until their successors are elected and qualified. The Board of Directors’ nominees are named in the attached Proxy Statement.

 

2. To transact such other business as may properly come before the meeting, or any adjournment thereof.

 

Only shareholders of record on the books of the Company at the close of business on April 8, 2005, are entitled to receive notice of and to vote at the meeting.

 

Shareholders are cordially invited to attend the meeting in person. However, whether or not you expect to attend, we urge you to read the accompanying Proxy Statement and then complete, sign, date and return the enclosed proxy card in the enclosed postage-prepaid envelope. It is important that your shares be represented at the meeting, and your promptness will assist us to prepare for the meeting and to avoid the cost of a follow-up mailing. If you receive more than one proxy card because you own shares registered in different names or at different addresses, each proxy card should be completed and returned.

 

Sincerely,

LOGO

Dan R. Lee

President and Chief Executive Officer

 

Alpharetta, Georgia

April 18, 2005


MICROTEK MEDICAL HOLDINGS, INC.

13000 Deerfield Parkway

Suite 300

Alpharetta, Georgia 30004

 


 

PROXY STATEMENT

for

Annual Meeting of Shareholders To Be Held May 18, 2005

 


 

GENERAL INFORMATION

 

This Proxy Statement is furnished to shareholders of Microtek Medical Holdings, Inc., a Georgia corporation (the “Company”), in connection with the solicitation by the Board of Directors of the Company (the “Board of Directors” or “Board”) of proxies for use at the Annual Meeting of Shareholders (the “Meeting”) scheduled to be held on Wednesday, May 18, 2005, at 2:00 p.m., Atlanta time, at the Company’s offices located at 13000 Deerfield Parkway, Suite 300, Alpharetta, GA 30004, and at any and all adjournments or postponements thereof. This Proxy Statement and the accompanying form of proxy were first mailed to shareholders on or about April 18, 2005.

 

At the Meeting, shareholders of the Company will vote upon: (1) the election of seven directors, and (2) such other business as may properly come before the Meeting and any and all adjournments thereof.

 

Voting Rights and Votes Required

 

The close of business on April 8, 2005, has been fixed as the record date for the determination of shareholders entitled to receive notice of and to vote at the Meeting. As of the close of business on such date, the Company had outstanding and entitled to vote 43,290,033 shares of Common Stock, $.001 par value per share (“Common Stock”).

 

A majority of the outstanding shares of Common Stock on the record date must be represented in person or by proxy at the Meeting in order to constitute a quorum for the transaction of business. The record holder of each share of Common Stock entitled to vote at the Meeting will have one vote for each share so held. Abstentions will be treated as Common Stock present and entitled to vote for purposes of determining the presence of a quorum.

 

Directors are elected by a plurality of the votes cast. Shareholders may not cumulate their votes. The seven candidates receiving the highest number of votes will be elected. In tabulating the votes, abstentions and broker non-votes will be disregarded and have no effect on the outcome of the vote for the election of directors.

 

Voting of Proxies

 

Shares represented by all properly executed proxies will be voted at the Meeting in accordance with the instructions specified thereon. If no instructions are specified, the shares represented by any properly executed proxy will be voted FOR the election of the nominees listed below under “Election of Directors.”

 

The Board of Directors is not aware of any matter that will come before the Meeting other than as described above. However, if any such other matter is duly presented, in the absence of instructions to the contrary, such proxies will be voted in accordance with the judgment of the proxy holders with respect to such matter properly coming before the Meeting. There are no rights of appraisal or similar dissenter’s rights with respect to any matter to be acted upon pursuant to this Proxy Statement.


Revocation of Proxies

 

Any proxy given pursuant to this solicitation may be revoked by a shareholder at any time before it is exercised. Any proxy may be revoked by a writing, by a valid proxy bearing a later date delivered to the Company or by attending the Meeting and voting in person.

 

Solicitation of Proxies

 

The expenses of this solicitation will be paid by the Company. To the extent necessary to ensure sufficient representation at the Meeting, proxies may be solicited by any appropriate means by officers, directors and regular employees of the Company, who will receive no additional compensation therefor. The Company will pay persons holding shares in their names or in the names of their nominees, but not owning such stock beneficially (such as brokerage houses, banks and other fiduciaries), for the expense of forwarding soliciting material to their principals.

 

PROPOSAL 1: ELECTION OF DIRECTORS

 

Proxies will be voted with respect to the election of the following seven nominees as directors to serve until the 2006 Annual Meeting of Shareholders or until their successors are elected and qualified. The election of each nominee for director requires the affirmative vote of the holders of a plurality of the shares cast in the election of directors. The Board of Directors has no reason to believe that any of the nominees will be unavailable for service if elected, but if any are unavailable, proxies will be voted for such substitute as the Board may designate. This Board has determined that each of the incumbent directors named below, other than Messrs. Lee and McGrevin, is an independent director within the meaning of NASD Rule 4200(a)(15), and that Mr. Sarni would be an independent director if elected.

 

Name


   Age

  

Director

Since


Dan R. Lee

   57    1996

Kenneth F. Davis

   53    1996

Michael E. Glasscock, III

   71    2002

Rosdon Hendrix

   65    1994

Gene R. McGrevin

   62    1997

Marc R. Sarni

   46    —  

Ronald L. Smorada

   57    1999

 

Dan R. Lee was appointed Chairman of the Board of Directors effective July 1, 2002, and was appointed to serve as President and Chief Executive Officer of the Company in December 2000. Additionally, he continues his role as the President of Microtek Medical, Inc., a subsidiary of the Company. He became an executive officer of the Company following the conclusion of the acquisition of Microtek Medical, Inc. in 1996, and became a director of the Company in December 1996. Prior to accepting such positions with the Company, Mr. Lee had served as the Vice President and Chief Operating and Financial Officer of Microtek Medical, Inc. since 1987. Previous to that time, he was engaged in the public accounting practice, including more than five years with KPMG LLP. Mr. Lee serves on the Board of NBC Capital Corp., a bank holding company traded on the American Stock Exchange.

 

Kenneth F. Davis was elected a director of the Company in January 1996. Dr. Davis was a practicing surgeon on the staff of the Harbin Clinic and Redmond Regional Medical Center in Rome, Georgia from 1986 to 2000. Dr. Davis now serves as the Chief Executive Officer and President of the Harbin Clinic, the largest multi-specialty clinic in Georgia. In addition, Dr. Davis serves on the Board of AmSouth Bank of Georgia, Adams Product Management, Hydro Dynamics, Inc. and the Georgia Land Trust.

 

2


Michael E. Glasscock, III was appointed a director of the Company in December 2002. Dr. Glasscock, a physician, practiced otology and neurotology for 35 years and retired from the active practice of medicine in 1997. From 1997 to 1998, Dr. Glasscock served as Chairman of St. Cloud Medical, a physician practice management company, from 1998 to 2001 he served as Chairman of TrueSound, Inc., a hearing aid dispensing company, and since 2001 he has served as Chairman of Tympany, a start-up company that has developed an automated hearing test. Dr. Glasscock has published in excess of 250 scientific articles and founded the American Journal of Otology and the E.A.R. Foundation, was the past president of the American Otologic Society, and has been an active entrepreneur with several medical related companies.

 

Rosdon Hendrix was elected a director of the Company in December 1994. Until he retired in June 1992, Mr. Hendrix served for approximately 30 years in various financial positions for General Motors Corporation, including serving as Resident Comptroller from 1975 until his retirement. Since June 1992, Mr. Hendrix has engaged in consulting for and efficiency consulting studies and other consulting services with various governmental authorities and businesses. In addition, since June 1997, Mr. Hendrix has performed information technology consulting services for Lockheed Martin. On December 1, 2003, Lockheed Martin’s Commercial Division was acquired by Affiliated Computer Services, Inc. (“ACS”), and Mr. Hendrix has been retained by ACS as a consultant.

 

Gene R. McGrevin was appointed Chairman of the Board of Directors and acting President of the Company in April 1997, and currently serves as a director of the Company. Mr. McGrevin served as chairman of P.E.T.Net Pharmaceutical Services, LLC, a manufacturer and distributor of radiopharmaceuticals, from May 1997 until January 2001. Mr. McGrevin previously served as Vice Chairman and Chief Executive Officer of Syncor International Corp., a public company in the nuclear medicine industry, with which Mr. McGrevin was associated since 1989. Prior to managing Syncor, Mr. McGrevin served in executive positions with various healthcare businesses including President of the Healthcare Products Group of Kimberly-Clark Corporation, founder and President of a consulting firm specializing in the healthcare industry and an executive officer of VHA Enterprises, Inc. Mr. McGrevin is currently chairman of the executive committee of Hydro Dynamics, Inc. and serves as Chairman of the Board of Real Time Medical Data, LLC.

 

Marc R. Sarni is a nominee to become a director of the Company and is not currently affiliated with the Company. Mr. Sarni is a Principal at Cornerstone Investment LLC, a group engaged in the investment, development and property management of both residential and commercial real estate. Mr. Sarni worked as an investment banker at A.G. Edwards and Sons, Inc. for 17 years, and from 1997 until 2003 Mr. Sarni was the Managing Director responsible for establishing and managing the Healthcare Industry Group within the corporate finance department’s Emerging Growth Sector. The Healthcare Industry Group of A.G. Edwards focused primarily on emerging growth medical technology, biotechnology, specialty pharmaceutical and healthcare services companies. Prior to joining A.G. Edwards, Mr. Sarni spent three years working as a Certified Public Accountant at PriceWaterhouse (now PricewaterhouseCoopers LLP). Mr. Sarni currently serves as a member of the Board of Managers for Ascension Health Ventures, the strategic health venture-investing subsidiary of Ascension Health, the nation’s largest Catholic and not-for-profit healthcare system. Mr. Sarni graduated from the University of Missouri at Columbia with a BSBA degree in Accounting and from the University of Chicago with an M.B.A. in Finance. Mr. Sarni serves on the Boards of Hollis-Eden Pharmaceuticals, Inc. and Young Innovations, Inc.

 

Ronald L. Smorada was elected a director of the Company in May 1999. Dr. Smorada has been an active participant in the nonwovens industry. From 1995 to 1999, Dr. Smorada held senior management positions at Reemay, Fiberweb and BBA US Holdings, the latter being the parent of the former two with nonwoven sales in excess of $800 million, where he worked in the development, acquisition and integration of new and existing businesses, both domestic and international. Since 1999, Dr. Smorada has been involved with establishing new businesses which develop new technologies and markets. A major focus for Dr. Smorada has been the application and conversion of science and technical concepts into meaningful businesses.

 

3


CORPORATE GOVERNANCE

 

Information Regarding the Board of Directors and Its Committees

 

The Board of Directors maintains standing Nominating, Audit and Compensation Committees.

 

Nominating Committee.    The Board formed a Nominating Committee in 2004. The directors on the Nominating Committee currently consist of Rosdon Hendrix and Michael E. Glasscock, III, each of whom is an “independent director” as defined by the Nasdaq Stock Market. The Nominating Committee assists the Board in establishing qualification criteria for the Company’s non-employee directors, identifying and evaluating candidates for nomination to the shareholders for election to the Board of Directors, and developing and recommending to the Board corporate governance guidelines and procedures applicable to the Company. A copy of the Nominating Committee’s charter is included on the Company’s web site at www.microtekmed.com.

 

The Nominating Committee has established the following general qualifications criteria for the Company’s directors:

 

    At least a majority of the directors shall be independent;

 

    Each director must be an individual of the highest character and integrity, with an inquiring mind, vision, a willingness to ask hard questions and the ability to work well with others;

 

    Each director must be willing and able to devote sufficient time to the affairs of the Company and be diligent in fulfilling the responsibilities of a director and Board committee member; and

 

    Each director must have the capacity and desire to represent the balanced, best interests of the shareholders as a whole and not primarily a special interest group or constituency.

 

In addition, the Nominating Committee from time to time establishes and modifies specific criteria desirable to be represented on the Board including knowledge and experience in business strategy, leadership, industry experience, finance and audit, and other skills beneficial to the business objectives of the Company.

 

The Board is responsible for selecting director nominees on behalf of the Company, with the assistance of the Nominating Committee. The Nominating Committee will consider nominees for directors properly proposed by shareholders. Any shareholder who desires to propose a candidate for consideration by the Nominating Committee should submit a written proposal which includes at a minimum the nominee’s name and qualifications for Board membership. These proposals should be addressed to:

 

Corporate Secretary

Microtek Medical Holdings, Inc.

13000 Deerfield Parkway

Suite 300

Alpharetta, Georgia 30004

 

In addition, the Company permits shareholders who comply with the procedures set forth in the Company’s bylaws to nominate directors for consideration at an annual shareholders meeting. The Company’s bylaws provide that shareholders intending to nominate candidates for election as directors at an annual meeting of shareholders must give notice in writing to the Company’s secretary not less than 90 and no more than 120 days prior to the first anniversary of the date the Company mailed its proxy materials for the preceding year’s annual meeting. That notice is required to set forth (1) as to each nominee, all information relating to such person as would be required to be disclosed in solicitations of proxies for the election of directors pursuant to Regulation 14A of the Securities and Exchange Act of 1934, and the nominee’s written consent to serve as a director if elected, and (2) as to the shareholder making a nomination and the beneficial owner, if any, on whose behalf the nomination is made, the name and address of such shareholder and beneficial owner, the number of shares that are owned beneficially and of record by such shareholder and beneficial owner and whether such shareholder or beneficial owner has delivered or intends to deliver a proxy statement and form of proxy to holders of a sufficient

 

4


number of the Company’s voting shares to elect such nominee or nominees. Shareholders desiring to use the procedures of the Company’s bylaws to nominate candidates for election as directors should review Section 2.13 of the Company’s bylaws.

 

The Nominating Committee may from time to time use a variety of methods for identifying and evaluating nominees for director. In the past, the Company’s Board of Directors has assessed and in the future the Company’s Nominating Committee is expected to assess the appropriate size of the Board, expected vacancies on the Board and the availability of desirable candidates for appointment to the Board. Candidates may come to the attention of the Nominating Committee through current Board members, management, professional search firms, shareholders and other persons. The Nominating Committee met three times during 2004.

 

Audit Committee.    The Audit Committee, which consists of Rosdon Hendrix, Kenneth F. Davis and Michael E. Glasscock, III, serves as an independent and objective party to, among other things, review the Company’s financial statements and annual report, review and appraise the audit efforts of the Company’s auditors and pre-approve permissible services to be performed for the Company by its auditors, and is responsible for the appointment, compensation and oversight of the work of the independent public accountants which audit the Company’s financial statements. The primary function of the Audit Committee involves oversight functions to support the quality and integrity of the Company’s accounting and financial reporting processes generally. It should be noted, however, that the members of the Committee are not necessarily experts in the fields of auditing and accounting and do not provide special assurances on such matters. The Audit Committee met six times during 2004. In addition to these meetings, the Chair and other members of the Audit Committee met several times with management and the Company’s independent accountants. The Board of Directors has determined that Rosdon Hendrix is an “audit committee financial expert” as that term is defined by applicable rules of the Securities and Exchange Commission. The report of the Audit Committee appears below in this Proxy Statement.

 

Compensation Committee.    The Compensation Committee, consisting of Rosdon Hendrix and Kenneth F. Davis, sets the compensation of executive officers and administers the Company’s incentive plans, including the Company’s Stock Option Plan and Employee Stock Purchase Plan. The Compensation Committee’s report on executive compensation appears below in this Proxy Statement. The Compensation Committee met three times during 2004.

 

Meetings and Attendance.    The Board of Directors held five meetings during 2004. Each incumbent director attended at least 75 percent of the aggregate of the meetings of the Board of Directors and of the committees of which he was a member. The Company strongly encourages each Board member to attend the Company’s annual meeting of shareholders. All Board members attended the 2004 annual meeting of shareholders.

 

Communications to the Board

 

The Board of Directors requests that any shareholders who desire to send communications to the Board mail those communications to:

 

Vice President of Legal Affairs

Microtek Medical Holdings, Inc.

512 Lehmberg Road

Columbus, Mississippi 39702

 

All mail addressed in this manner will be delivered to the chair or chairs of the committees with responsibilities touching most directly on the matters addressed in the communication.

 

Code of Conduct

 

All employees and directors of the Company, including the Company’s Chief Executive Officer, Chief Financial Officer and principal accounting officer or controller, are required to comply with the Microtek

 

5


Medical Holdings, Inc. Code of Conduct. This Code is available on the Company’s web site at www.microtekmed.com. The Company will disclose on its web site any amendments to or waivers from provisions of the Code as required by the rules of the Securities and Exchange Commission. The Board of Directors has also established procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters. Complaints regarding these matters will be reviewed under Audit Committee direction and oversight.

 

Report of the Audit Committee

 

The following Report of the Audit Committee shall not be deemed to be “soliciting material” or to be “filed” with the Securities and Exchange Commission (the “Commission”) or subject to Regulations 14A or 14C of the Commission or to the liabilities of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, notwithstanding any general incorporation by reference of this Proxy Statement into any other document.

 

The Board of Directors maintains an Audit Committee comprised of three of the Company’s outside directors. The Board of Directors and the Audit Committee believe that the Audit Committee’s current member composition satisfies the rule of the National Association of Securities Dealers, Inc. (“NASD”) that governs audit committee composition as currently in effect, including the requirement that audit committee members all be “independent directors” as that term is defined by NASD Rule 4200(a)(15) and Rule 10A-3(b)(1) of the Exchange Act. The Board has adopted a written Charter of the Audit Committee.

 

The Audit Committee oversees the Company’s financial reporting process on behalf of the Board of Directors. Management has the primary responsibility for the financial statements and the reporting process including the systems of internal controls. The independent auditors are responsible for expressing an opinion on the conformity of the financial statements with United States generally accepted accounting principles. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed the audited financial statements in the Annual Report on Form 10-K for the year ended December 31, 2004 with management and the independent auditors, including without limitation, a discussion with the independent auditors of the matters required to be discussed with the Audit Committee under Statement on Auditing Standards No. 61.

 

In discharging its oversight responsibility as to the audit process, the Audit Committee obtained from the independent auditors the written disclosures required by the Independence Standards Board Standard No. 1 and discussed with the independent auditors their independence.

 

In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 for filing with Securities and Exchange Commission.

 

AUDIT COMMITTEE

 

Rosdon Hendrix

Kenneth F. Davis

Michael E. Glasscock, III

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Pursuant to Section 16(a) of the Securities Exchange Act of 1934 and the rules issued thereunder, the Company’s executive officers and directors and any persons holding more than ten percent of the Company’s common stock are required to file with the Securities and Exchange Commission and The Nasdaq Stock Market reports of their initial ownership of the Company’s common stock and any changes in ownership of such common stock. Specific due dates have been established and the Company is required to disclose in its Annual

 

6


Report on Form 10-K and Proxy Statement any failure to file such reports by these dates. Copies of such reports are required to be furnished to the Company. Based solely on its review of the copies of such reports furnished to the Company, or written representations that no reports were required, the Company believes that, during 2004, all of its executive officers, directors and persons owning more than 10% of its common stock complied with the Section 16(a) requirements.

 

Certain Relationships and Related Transactions

 

In May 2000, the Company and certain of its affiliates and employees organized Global Resources, Inc. (“GRI”) to provide supply-chain management and material sourcing services for products manufactured in China. The Company and J. Michael Mabry (who was an executive officer of the Company until August 2004) own 19.5% and 30%, respectively, of GRI, and Mr. Mabry currently serves on the Board of Directors of GRI. During 2001, Microtek Medical, Inc. began sourcing manufacturing of various of its products through GRI where such supply arrangements were advantageous to Microtek Medical, Inc. based on favorable pricing and other considerations. During 2004, 2003 and 2002, the Company paid a total of $6,643,308, $6,576,509 and $2,379,822, respectively, for products supplied, services rendered and expenses incurred by GRI for the benefit of the Company. The Company has implemented systems and procedures to exclude Mr. Mabry from participating in purchase decisions or other business dealings between the Company and GRI. The Audit Committee has received a report from the Company concerning the relationship between the Company and GRI and the structures and systems in place to deal with conflicts of interest posed by Mr. Mabry’s relationship with GRI and the Company. After consideration of the relevant facts and circumstances, the Audit Committee approved the structures and systems which the Company has implemented to govern its relationship with GRI.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

AND MANAGEMENT

 

The following table sets forth, as of April 1, 2005, certain information regarding the beneficial ownership of common stock by (i) each person known by the Company to be the beneficial owner of more than five percent of the outstanding shares of common stock, (ii) each director, director nominee and Named Executive Officer identified under “Executive Compensation” below, and (iii) all directors and executive officers as a group:

 

Name of Beneficial Owner


   Shares
Beneficially
Owned


   Percentage of
Common Stock
Beneficially
Owned


 

Dan R. Lee(1)

   907,501    2 %

J. Michael Mabry(2)

   532,895    1 %

Barbara J. Osborne

   967    *  

Roger G. Wilson(3)

   540,331    1 %

Kenneth F. Davis(4)

   88,243    *  

Michael E. Glasscock, III(5)

   35,000    *  

Rosdon Hendrix(6)

   155,000    *  

Gene R. McGrevin(7)

   220,000    *  

Marc R. Sarni

   —      —    

Ronald L. Smorada(8)

   47,000    *  

Dimensional Fund Advisors Inc.(9)

   2,461,810    6 %

Gruber and McBaine Capital Management, LLC(10)

   2,315,400    5 %

All directors and executive officers as a group (7 persons)(11)

   1,993,075    4 %

*   Represents less than 1% of the common stock
(1)   Includes options to acquire 826,331 shares exercisable within 60 days.
(2)   Includes options to acquire 492,761 shares exercisable within 60 days.
(3)   Includes options to acquire 476,250 shares exercisable within 60 days.

 

7


(4)   Includes options to acquire 45,000 shares exercisable within 60 days.
(5)   Includes options to acquire 35,000 shares exercisable within 60 days.
(6)   Includes options to acquire 125,000 shares exercisable within 60 days.
(7)   Includes options to acquire 185,000 shares exercisable within 60 days.
(8)   Includes options to acquire 45,000 shares exercisable within 60 days.
(9)   As reported by Dimensional Fund Advisors, Inc. in a Statement on Form 13G filed with the Securities and Exchange Commission. Dimensional Fund Advisors, Inc. address is 1299 Ocean Avenue, 11th Floor, Santa Monica, California 90401.
(10)   As reported by Gruber and McBaine Capital Management, LLC in a Statement on Form 13G filed with the Securities and Exchange Commission. Gruber and McBaine Capital Management, LLC address is 50 Osgood Place, Penthouse, San Francisco, California 94133.
(11)   Includes options to acquire 1,737,581 shares exercisable within 60 days.

 

EXECUTIVE COMPENSATION

 

Compensation Tables

 

The following table sets forth the cash and non-cash compensation paid by the Company to the Company’s chief executive officer and each of the other persons who served as an executive officer of the Company during all or a portion of 2004 (collectively, the “Named Executive Officers”).

 

SUMMARY COMPENSATION TABLE

 

Name and Principal Position


   Year

   Annual Compensation

  

Long-Term
Compensation

Awards

Options (#)


  

All Other

Compensation


 
      Salary

   Bonus

   Other Annual
Compensation


     

Dan R. Lee

Chairman, President and

Chief Executive Officer

   2004
2003
2002
   $
$
$
311,538
296,154
250,000
   $
$
$
170,000
225,000
130,000
   —  
—  
—  
   200,000
200,000
100,000
   $
$
$
24,725
24,340
18,294
(1)
(2)
(3)

J. Michael Mabry

Former Chief Operating Officer,

Executive Vice President and

Secretary

   2004
2003
2002
   $
$
$
171,635
170,096
150,000
   $
$
$
62,000
85,000
52,000
   —  
—  
—  
   75,000
150,000
75,000
   $
$
$
12,979
12,864
6,060
(4)
(5)
(6)

Barbara J. Osborne

Former Executive Vice President,

Sales and Marketing

   2004    $ 90,866      —      —      25,000    $ 4,645 (7)

Roger G. Wilson

Chief Financial Officer, Treasurer

and Secretary

   2004
2003
2002
   $
$
$
165,750
161,154
150,000
   $
$
$
54,000
75,000
50,000
   —  
—  
—  
   150,000
150,000
75,000
   $
$
$
12,919
12,704
6,258
(8)
(9)
(10)

(1)   This amount represents $12,231 in contributions to a 401(k) plan, $2,036 for a $250,000 term life insurance policy, $258 for a $100,000 term life insurance policy and a $10,200 automobile allowance. This amount does not include $1,839 in payments made to or on behalf of Mr. Lee during 2004 pursuant to the Company’s non-discriminatory relocation plan.
(2)   This amount represents $11,846 in contributions to a 401(k) plan, $2,036 for a $250,000 term life insurance policy, $258 for a $100,000 term life insurance policy, and a $10,200 automobile allowance.
(3)   This amount represents $10,000 in contributions to a 401(k) plan, $2,036 for a $250,000 term life insurance policy, $258 for a $100,000 term life insurance policy, and a $6,000 automobile allowance.
(4)   This amount represents $6,919 in contributions to a 401(k) plan, $60 for a $100,000 term life insurance policy, and a $6,000 automobile allowance.

 

8


(5)   This amount represents $6,804 in contributions to a 401(k) plan, $60 for a $100,000 term life insurance policy, and a $6,000 automobile allowance.
(6)   This amount represents $6,000 in contributions to a 401(k) plan and $60 for a $100,000 term life insurance policy.
(7)   This amount represents $1,615 in contributions to a 401(k) plan, $30 for a $100,000 term life insurance policy, and a $3,000 automobile allowance. This amount does not include $129,927 in payments made to or on behalf of Ms. Osborne in 2004 pursuant to the Company’s relocation plan.
(8)   This amount represents $6,523 in contributions to a 401(k) plan and $396 for a $100,000 term life insurance policy, and a $6,000 automobile allowance. This amount does not include $45,856 in payments made to or on behalf of Mr. Wilson during 2004 pursuant to the Company’s relocation plan.
(9)   This amount represents $6,446 in contributions to a 401(k) plan, $258 for a $100,000 term life insurance policy, and a $6,000 automobile allowance.
(10)   This amount represents $6,000 in contributions to a 401(k) plan and $258 for a $100,000 term life insurance policy.

 

Employment Arrangements

 

Messrs. Lee and Wilson are each a party to a three-year employment agreement with the Company which commenced on October 20, 2002. These employment agreements automatically renew for successive three year terms unless advance notice of non-renewal is given by either party. Pursuant to each such respective employment agreement, Mr. Lee will serve as President and Chief Executive Officer of the Company and Mr. Wilson will serve as Chief Financial Officer of the Company. Each employment agreement specifies a minimum salary and benefits payable during the term of the employment agreement, and contains restrictive covenants including covenants relating to the protection of confidential information and restricting competition against the Company. Each employment agreement is terminable by the Company or the employee with or without cause. In the event of a termination of the employment agreement by the Company without cause, or by the employee for good reason (as the terms “cause” and “good reason” are defined), the employee will generally be entitled to severance equal to the employee’s salary and annual performance bonus for the unexpired portion of the remaining term of the employment agreement and continued welfare benefits (such as health insurance) for the unexpired term of the employment agreement. In the event of any termination of the employee’s employment following a change of control (as defined) of the Company, other than a termination of employment as a result of death or disability or cause, the Company is obligated to pay the employee an amount equal to three times the largest of the employee’s annual salary and annual performance bonus over the current or the prior two years plus certain other amounts primarily involving the continuation of welfare benefits following the date of such termination of employment. In the event that any of these payments to the employee will result in excise taxes imposed under the Internal Revenue Code, then the payments to the employee will be increased by an amount (i.e., a tax gross-up payment) sufficient to pay all of the employee’s excise taxes on such payments and any income, excise or other taxes on the gross-up payment to the employee.

 

During 2004, Mr. Mabry resigned from his executive offices with the Company and the Company and Mr. Mabry mutually agreed to terminate his employment agreement with the Company without triggering any severance payments. Mr. Mabry continues to serve as a non-executive employee of the Company with reduced duties from those charged to Mr. Mabry while he was an executive officer.

 

During 2004, the Board of Directors approved the promotion of Ms. Osborne, who was then the Company’s Vice President of Sales and Marketing, to an executive level position with the Company and, in connection therewith, entered into an employment agreement with Ms. Osborne. The employment agreement sets a minimum salary of $175,000 and contains restrictive covenants including covenants relating to the protection of confidential information and restricting competition against the Company. The Company and Ms. Osborne mutually agreed to terminate Ms. Osborne’s employment with the Company in March 2005, and the Company offered to pay Ms. Osborne severance equal to approximately one year’s salary plus the cost of continued health care insurance for Ms. Osborne and her dependents until the earlier of April 2006 or the commencement of equivalent benefits from a new employer.

 

9


In connection with the completion of the aforementioned employment agreements, the Company adopted a Sale of Business Bonus Program designed to increase the value of the Company to shareholders upon and in the event of a change of control of the Company. The Sale of Business Bonus Program establishes a bonus pool determined as a percentage of appreciation in the price of the Company’s common stock from a pre-established base amount (which is currently $1.90 per share) to the price of a share of the Company’s common stock at which the event constituting a change of control (as defined) of the Company occurs. As currently adopted, the bonus pool uses the following levels of share appreciation and percentage participation in such share appreciation to fund the bonus pool:

 

Share Appreciation


   Market Capitalization
(Share Appreciation
multiplied by 42M*)


   Bonus
Percentage


    Bonus Pool

$  0.00 to $  1.90

   $ 80,598,000.00    0.00 %   $ 0.00

$  1.90 to $  5.00

   $ 130,200,000.00    3.00 %   $ 3,906,000.00

$  5.00 to $10.00

   $ 210,000,000.00    3.50 %   $ 7,350,000.00

$10.00 to $11.00

   $ 42,000,000.00    4.00 %   $ 1,680,000.00
                 

Total Bonus Pool

                $ 12,936,000.00
                 


*   The market capitalization column assumes 42 million shares outstanding for purposes of illustration.

 

The bonus pool may be allocated among employees of the Company as from time-to-time determined by the Compensation Committee of the Board of Directors, and the bonus program may be modified from time-to-time as determined by the Board of Directors.

 

Employee Benefit Plans

 

1992 Stock Option Plan.    In April 1992, the Board of Directors and shareholders of the Company adopted a Stock Option Plan (the “1992 Stock Option Plan”). The 1992 Stock Option Plan provided for the issuance of options to purchase up to 4,800,000 shares of common stock (subject to appropriate adjustments in the event of stock splits, stock dividends and similar dilutive events). Options were granted under the 1992 Stock Option Plan to employees, officers or directors of, and consultants and advisors to, the Company who, in the opinion of the Compensation Committee, were in a position to contribute materially to the Company’s continued growth and development and to its long-term financial success. The 1992 Stock Option Plan was administered by a committee appointed by the Board of Directors. The Compensation Committee was designated by the Board of Directors as the committee to administer the 1992 Stock Option Plan. The purposes of the 1992 Stock Option Plan were to ensure the retention of existing executive personnel, key employees and consultants of the Company, to attract and retain new executive personnel, key employees and consultants and to provide additional incentives by permitting such individuals to participate in the ownership of the Company. The 1992 Stock Option Plan terminated on April 27, 2002.

 

Options granted to employees were either incentive stock options (as defined in the Code) or nonqualified stock options. The exercise price of the options were determined by the Board of Directors or the committee at the time of grant, provided that the exercise price was not less than the fair market value of the Company’s common stock on the date of grant as determined in accordance with the limitations set forth in the Code. The terms of each option and the period over which it vested were determined by the committee, although no option could be exercised more than ten years after the date of grant and all options were to become exercisable upon certain events defined to constitute a change of control. To the extent that the aggregate fair market value, as of the date of grant, of shares with respect to which incentive stock options became exercisable for the first time by an optionee during the calendar year exceeded $100,000, the portion of such option in excess of the $100,000 limitation was be treated as a nonqualified stock option. In addition, if an optionee owned more than 10% of the total voting power of all classes of the Company’s stock at the time the individual was granted an incentive stock option, the purchase price per share could not be less than 110% of the fair market value on the date of grant and the term of the incentive stock option could not exceed five years from the date of grant. Upon the exercise of an

 

10


option, payment may be made by cash, check or, if provided in the option agreement, by delivery of shares of the Company’s common stock having a fair market value equal to the exercise price of the options, or any other means that the Board or the committee determines. Options are non-transferable during the life of the option holder. The 1992 Stock Option Plan also permitted the grant of alternate rights defined as the right to receive an amount of cash or shares of common stock having an aggregate fair market value equal to the appreciation in the fair market value of a stated number of shares of common stock from the grant date to the date of exercise. No alternate rights were granted under the 1992 Stock Option Plan.

 

As of April 1, 2005, options to purchase 943,456 shares of common stock were outstanding under the 1992 Stock Option Plan. The expiration of the 1992 Stock Option Plan, which occurred on April 27, 2002, does not affect options outstanding under that Plan.

 

1999 Stock Option Plan.    In March 1999, the Board approved and in May 1999 the Company’s shareholders ratified, the adoption of the Company’s 1999 Long-Term Incentive Plan (the “1999 Stock Option Plan”). As amended to date, the 1999 Stock Option Plan currently provides for the issuance of options and other stock awards to acquire shares of common stock up to a maximum of 5,345,000 shares (subject to appropriate adjustment in the event of stock splits, stock dividends and other similar dilutive events). Options and other stock awards may be granted under the 1999 Stock Option Plan to employees of the Company and certain subsidiaries and affiliated businesses, and to directors, consultants and other persons providing key services to the Company.

 

The Compensation Committee of the Board of Directors determines the terms and conditions of options granted under the 1999 Stock Option Plan, including the exercise price, which generally may not be less than the fair market value of the Company’s common stock on the date of grant. Awards under the 1999 Stock Option Plan may be settled through cash payments, the delivery of shares of common stock, or a combination thereof as the Committee shall determine. Stock options awarded under the 1999 Stock Option Plan which are intended to be incentive stock options are subject to the same restrictions described above with respect to the 1992 Stock Option Plan.

 

The 1999 Stock Option Plan may be terminated or amended by the Board of Directors at any time, except that the following actions may not be taken without shareholder approval: (a) increasing the number of shares that may be issued under the 1999 Stock Option Plan (except for certain adjustments provided for under the 1999 Stock Option Plan), or (b) amending the 1999 Stock Option Plan provisions regarding the limitations on the exercise price. In the event of a change of control (as defined generally to include the acquisition by an individual, entity or group of more than 15% of the outstanding common stock of the Company, a merger or consolidation of the Company or a sale by the Company of all or substantially all of the Company’s assets), any award granted under the 1999 Stock Option Plan shall become exercisable except to the extent (a) the award otherwise provides or (b) the exerciseability of such award will result in an “excess parachute payment” within the meaning of the Code. The 1999 Stock Option Plan is unlimited in duration and, in the event of 1999 Stock Option Plan termination, shall remain in effect as long as any awards under it are outstanding, except no incentive stock options may be granted under the 1999 Stock Option Plan on a date that is more than ten years from the date the 1999 Stock Option Plan is approved by shareholders. Each option expires on the date established by the Compensation Committee at the time of the grant, except the expiration cannot be later than the earliest of ten years from the date on which the option was granted, if the participant’s date of termination occurs for reasons other than retirement or early retirement, the one year anniversary of such date of termination, or if the participant’s date of termination occurs by reason of retirement or early retirement, the three year anniversary of such date of termination.

 

As of April 1, 2005, options to purchase 2,949,250 shares of common stock were outstanding under the 1999 Stock Option Plan and 2,015,500 shares of common stock were available for future awards under the 1999 Stock Option Plan.

 

Employee Stock Purchase Plan.    In March 1999 the Board approved and in May 1999 the Company’s shareholders ratified, the adoption of the Company’s Employee Stock Purchase Plan for employees of the

 

11


Company and its subsidiaries (the “1999 Stock Purchase Plan”). The 1999 Stock Purchase Plan was established pursuant to the provisions of Section 423 of the Code to provide a method whereby all eligible employees of the Company may acquire a proprietary interest in the Company through the purchase of common stock. Under the 1999 Stock Purchase Plan, payroll deductions are used to purchase the Company’s common stock. An aggregate of 700,000 shares of common stock of the Company were reserved for issuance under the 1999 Stock Purchase Plan. Through December 31, 2004, a total of 450,972 shares of common stock had been purchased under such plan, leaving 249,028 shares of common stock available for issuance under such plan in the future.

 

Stock Options

 

The Company granted options to its Named Executive Officers in 2004 as set forth in the following table. The Company has no stock appreciation rights (“SARs”) outstanding.

 

OPTION/SAR GRANTS IN LAST FISCAL YEAR

 

     Individual Grants

  

Potential Realizable Value
at Assumed Annual rates
of Stock Price

Appreciation for Option
Term (1)


Name


   Number of
Securities
Underlying
Options/SARs
Granted(#)


    Percent of Total
Options/SARs
Granted to
Employees in
Fiscal Year


    Exercise or
Base Price
($/Sh)


   Expiration
Date


  
             5%($)

   10%($)

Dan R. Lee

   100,000 (2)   8.9 %   $ 5.02    02/02/14    $ 315,705    $ 800,059
     100,000 (2)   8.9 %   $ 3.99    08/02/14    $ 250,929    $ 635,903

J. Michael Mabry

   75,000 (2)   6.7 %   $ 5.02    02/02/14    $ 236,779    $ 600,044

Barbara J. Osborne

   25,000 (3)   2.2 %   $ 5.06    06/14/14    $ 79,555    $ 201,608

Roger G. Wilson

   75,000 (2)   6.7 %   $ 5.02    02/02/14    $ 236,779    $ 600,044
     75,000 (2)   6.7 %   $ 3.99    08/02/14    $ 188,197    $ 476,927

(1)   These amounts represent certain assumed rates of appreciation only. Actual gains, if any, on stock option exercises are dependent on the future performance of the Common Stock and overall market conditions.
(2)   As discussed in the Compensation Committee’s report on executive compensation appearing below in this Proxy Statement, these stock options were awarded as part of a multi-component compensation plan and are fully exercisable at the date of award.
(3)   This stock option was to become exercisable in four equal annual increments beginning on the first anniversary of the date of award, and has been cancelled in connection with Ms. Osborne’s termination of employment.

 

The following table sets forth the value of options exercised during 2004 and of unexercised options held by the Company’s Named Executive Officers at December 31, 2004.

 

AGGREGATED OPTION/SAR EXERCISES IN THE LAST FISCAL YEAR

AND FISCAL YEAR-END OPTION/SAR VALUES

 

Name


   Shares Acquired
On Exercise(#)


   Value
Realized($)


  

Number of
Securities

Underlying
Unexercised

Options/SARs

At FY-End(#)

Excercisable/
Unexcercisable


  

Value of Unexercised

In-The-Money

Options/SARs

At FY-End($)

Exercisable/
Unexercisable


Dan R. Lee

   50,000    $ 188,219    663,831/62,500    $ 1,696,853/$103,750

J. Michael Mabry

   85,000    $ 150,682    405,261/12,500    $ 802,734/$ 20,750

Barbara J. Osborne

   —        —      0/25,000    $ 0/$ 0

Roger G. Wilson

   68,750    $ 246,969    370,000/31,250    $ 1,004,641/$ 51,875

 

12


Director Compensation

 

Directors who are not also employees of the Company (“Nonemployee Directors”) receive a retainer of $25,000 per year payable in a lump sum following each annual meeting of shareholders. No meeting fees are payable to the Nonemployee Directors. Nonemployee Directors are reimbursed upon request for reasonable expenses incurred in attending Board of Director or committee meetings.

 

At each regular annual meeting of shareholders, the Company grants to each Nonemployee Director a non-qualified stock option covering 5,000 shares of common stock (except that such stock option covers 25,000 shares of common stock for Nonemployee Directors upon their initial election as a director of the Company). In recognition of added responsibilities for chairing the Board’s Audit, Compensation and Nominating Committees, each such chair has been granted a non-qualified stock option covering 10,000 shares of common stock at each regular annual meeting of shareholders. Each of these stock options has an exercise price equal to the fair market value of the Company’s common stock on the date of grant. These option grants may be exercised only by the optionee until the earlier of five years after the date of grant or one year after ceasing to be a director of the Company.

 

Non-employee directors may elect to enroll themselves and their eligible dependents in the Company’s group health insurance plan provided that the enrolled director pays the premium cost incurred by the Company to maintain such insurance benefits. Mr. McGrevin is the only non-employee director who has elected to enroll in such benefit.

 

The Company’s Articles of Incorporation adopt the provisions of the Georgia Business Corporation Code (the “Corporation Code”) providing that no member of the Company’s Board of Directors shall be personally liable to the Company or its shareholders for monetary damages for any breach of his duty of care or any other duty he may have as a director, except liability for any appropriation, in violation of the director’s duties, of any business opportunity of the Company, for any acts or omissions that involve intentional misconduct or a knowing violation of law, for liability under the Corporation Code for unlawful distributions to shareholders, and for any transaction from which the director receives an improper personal benefit.

 

The Company’s Bylaws provide that each officer and director shall be indemnified for all losses and expenses (including attorneys’ fees and costs of investigation) arising from any action or other legal proceeding, whether civil, criminal, administrative or investigative, including any action by and in the right of the Company, because he is or was a director, officer, employee or agent of the Company or, at the Company’s request, of any other organization. In the case of action by or in the right of the Company, such indemnification is subject to the same exceptions, described in the preceding paragraph, that apply to the limitation of a director’s monetary liability to the Company. The Bylaws also provide for the advancement of expenses with respect to any such action. The Bylaws permit the Company to enter into agreements providing to each officer or director indemnification rights substantially similar to those set forth in the Bylaws, and such agreements have been entered into between the Company and each of the members of its Board of Directors and certain of its executive officers.

 

Report of the Compensation Committee on Executive Compensation

 

The following Report of the Compensation Committee and the performance graph in the next section shall not be deemed to be “soliciting material” or to be “filed” with the Commission or subject to Regulations 14A or 14C of the Commission or to the liabilities of Section 18 of the Exchange Act and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, notwithstanding any general incorporation by reference of this Proxy Statement into any other document.

 

Two outside directors and no inside directors comprise the Compensation Committee of the Board of Directors. Neither of the outside directors serves on the board of any other committee member’s company or organization and none of the executive officers of the Company serve on the board of any committee member’s organization. The Committee has access to outside consultants and counsel at the discretion of the Committee.

 

13


The Committee oversees all aspects of executive compensation. The Company’s compensation of executives is primarily comprised of three elements: base pay or salary, annual performance bonus, and long-term incentive compensation. The Committee seeks to provide a competitive compensation package that enables the Company to attract and retain key executives, to integrate pay programs with the business objectives of the Company, and to link individual executive compensation with the Company’s performance. The Compensation Committee’s responsibilities include: (i) participating in the determination of goals for the Company’s executive officers; (ii) participating in the selection and design of compensation packages and programs relating to such goals; (iii) monitoring the effectiveness of the compensation packages and programs; and (iv) monitoring compensation-related developments generally and considering their application to the Company’s executive officers.

 

Base Pay.    In general, the Committee attempts to fix base salaries at levels deemed appropriate by the Committee in order that compensation packages may also emphasize result-oriented factors reflected in a performance based bonus potential and the value of stock options and stock ownership. The Committee reviews salaries and pay ranges for its executives, and salaries may be increased based on the Committee’s assessment of an individual’s level of responsibility and performance and contributions to the Company’s goals. Salary adjustments are generally based on historical performance and other factors deemed relevant to the Committee. During 2004, the Company prospectively increased Mr. Lee’s salary to $350,000 per year in recognition of the Company’s performance and the increased cost of living associated with the relocation of the Company’s principal executive offices from Columbus, Mississippi to Atlanta, Georgia. For the same reasons, the Company also approved an increase in the salary of one other executive officer.

 

Annual Performance Bonus.    Based upon a review by the Committee of performance under the 2004 bonus plan approved by the Committee, the Committee approved a bonus of $170,000 to Mr. Lee for 2004 and a bonus for the Company’s Chief Financial Officer and former Chief Operating Officer. During the latter half of 2004, the Company’s Chief Operating Officer ceased to serve the Company as an executive officer due to planned reductions in duties for such employee. The former Chief Operating Officer of the Company remains an important employee of the Company in a non-executive capacity. The performance measures used by the Committee in awarding these bonuses related to specific financial targets associated with management of net working capital, earnings before interest and taxes, and return on net working capital.

 

Long-Term Incentive Compensation.    The Company’s primary method of awarding long-term compensation is its stock option plans, approved by shareholders. All officers are eligible to receive grants under the stock option plans. Grants under the plans generally extend for ten years, are priced at not less than fair market value on the date of grant, and are generally intended to provide incentive for future performance rather than reward past performance. In awarding stock options, the Compensation Committee generally considers (i) the contribution to the performance of the Company of eligible employees, (ii) stock options held by and previously awarded to eligible employees and (iii) stock ownership of eligible employees, in addition to other factors the Compensation Committee may from time to time deem relevant.

 

During 2002, the Compensation Committee approved and adopted a multi-component compensation plan for each of the Company’s executive officers. The components of the plan included a three year employment agreement described elsewhere in this Proxy Statement, a policy to increase the executive’s beneficial ownership of the Company through periodic awards of vested stock options under the Company’s Stock Option Plan approved by shareholders, the adoption of a Sale of Business Bonus Program described elsewhere in this Proxy Statement designed to increase shareholder value upon and in the event of a change in control of the Company, and the adoption of a Long-Term Growth Incentive Award Bonus Program designed to increase revenues of the Company while maintaining and increasing the profitability of the Company. Consistent with the terms of this compensation program, the Compensation Committee granted to Mr. Lee during 2004 two vested stock options, each for the purchase up to 100,000 shares at an exercise prices per share of $5.02 for one stock option and $3.99 for the other stock option. During 2004, the Compensation Committee terminated the Company’s Long-Term

Growth Incentive Award Bonus Program with the intention of adopting a revised version of that plan at a later date.

 

14


One of the factors in the Compensation Committee’s consideration of compensation matters is the anticipated tax treatment to the Company and to its executive officers of various components of compensation. However, amendments to and interpretations of the tax laws and other factors beyond the control of the Compensation Committee affect the tax treatment of compensation. For these reasons, the Compensation Committee will not necessarily and in all circumstances limit executive compensation to that deductible under Section 162(m) of the Internal Revenue Code. The Compensation Committee will consider various alternatives to preserving the deductibility of other components of compensation to the extent reasonably practicable and to the extent consistent with other compensation objectives of the Company.

 

The Compensation Committee intends to continually evaluate the Company’s compensation policies and procedures with respect to executive officers. Although the Compensation Committee believes that current compensation policies align the financial interests of executive officers with those of the Company’s shareholders and with Company performance, it will continue to examine what modifications, if any, should be implemented to further link executive compensation with both individual and Company performance.

 

COMPENSATION COMMITTEE

 

Rosdon Hendrix

Kenneth F. Davis

 

15


Stock Price Performance Graph

 

The graph below compares cumulative total returns (changes in stock price plus reinvested dividends) on a hypothetical investment of $100 in the Common Stock of the Company, the S&P 500 Index and the S&P Health Care Sector Index, for the period commencing December 31, 1999 and ending December 31, 2004.

 

LOGO

 

Copyright © 2002, Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. All rights reserved. www.researchdatagroup.com/S&P.htm

 

     Cumulative Total Return

     12/99

   12/00

   12/01

   12/02

   12/03

   12/04

Microtek Medical Holdings Inc

   100.00    33.68    85.89    80.16    168.41    136.75

S & P 500 Index

   100.00    90.89    80.09    62.39    80.29    89.02

S & P Health Care Sector Index

   100.00    137.05    120.68    97.96    112.71    114.60

 

16


RELATIONSHIP WITH INDEPENDENT PUBLIC ACCOUNTANTS

 

Independent Public Accountants

 

The Audit Committee selected KPMG LLP to audit the financial statements of the Company for the fiscal year ended December 31, 2004. The Audit Committee has not yet appointed the Company’s auditors for 2005. It is expected that a representative of KPMG LLP will be present at the Meeting to respond to any appropriate questions and to make a statement on behalf of his or her firm, if such representative so desires.

 

At a meeting held on April 10, 2003, the Audit Committee of the Board of Directors determined not to renew the engagement of Deloitte & Touche LLP (“Deloitte”) as independent auditors of the Company effective April 10, 2003. At this meeting, the Audit Committee also approved the engagement of KPMG LLP as its independent accountant for the fiscal year ending December 31, 2003 effective April 10, 2003.

 

The reports of Deloitte on the Company’s financial statements for the fiscal years ended December 31, 2002 and December 30, 2001 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.

 

During the Company’s fiscal years ended December 31, 2002 and 2001, and in the subsequent interim period through April 10, 2003, there were no disagreements with Deloitte on any matter of accounting principles.

 

There were no “reportable events” as that term is described in Item 304(a)(1)(v) of Regulation S-K for the fiscal years ended December 31, 2002 and December 31, 2001 or for the subsequent interim period through April 10, 2003.

 

Deloitte has furnished a letter addressed to the Commission stating that it agrees with the above statements. A copy of that letter was filed as an exhibit to a Current Report on Form 8-K dated April 10, 2003, filed by the Company with the Commission.

 

During the Company’s fiscal years ended December 31, 2002 and 2001, and in the subsequent interim period through April 10, 2003, neither the Company nor anyone acting on its behalf consulted KPMG LLP with respect to either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, or (ii) any matter that was either the subject of a disagreement or any other matters or reportable events as set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K.

 

Audit Fees

 

Aggregate fees for professional services rendered by the Company’s principal accountant for the audit of the Company’s 2004 and 2003 annual financial statements and review of financial statements included in Forms 10-Q or services that are normally provided in connection with statutory engagements for its financial statements for those years were $548,200 and $189,000, respectively.

 

Audit-Related Fees

 

The aggregate fees billed in 2004 and 2003 for assurance and related services by the Company’s principal accountant that are reasonably related to the performance of the audit or review of the Company’s financial statements and not included under “Audit Fees” above were $25,304 and $10,363, respectively. Audit-related fees billed in 2004 related to due diligence and other advisory services associated with the Company’s acquisition of selected fixed assets and inventories related to certain businesses of International Medical Products, B.V. and affiliates in May 2004 and to fees associated with the Company’s entering into a license agreement with Eastern Technologies, Inc. in September 2004. Audit-related fees billed in 2003 related to due diligence associated with the Company’s acquisition of substantially all of the assets of Plasco, Inc. in November 2003.

 

17


Tax Fees

 

The aggregate fees billed in 2004 for professional services rendered by the Company’s principal accountant for tax compliance, tax advice and tax planning services were $7,200. These fees related primarily to tax compliance services provided to the Company’s United Kingdom and Netherlands subsidiaries. There were no such fees paid to the Company’s principal accountant in 2003.

 

All Other Fees

 

There were no fees paid in 2004 or 2003 for services provided by the Company’s principal accountant, other than those described under the preceding three paragraphs.

 

Policy on Pre-Approval of Independent Auditor Services

 

The Audit Committee has adopted a written policy providing guidelines and procedures for the pre-approval of all audit and permissible non-audit services provided by the Company’s independent auditors. This policy contemplates that the independent auditors will provide to the Audit Committee a proposed engagement letter and an audit service fee proposal during the first quarter of each of the Company’s fiscal years with a target of approving an engagement letter and appointing an independent auditor for the audit of the Company’s financial statements as of and for the year ended during such fiscal year prior to the review by the Company’s independent auditor of the Company’s financial statements for the Company’s first quarter. For non-audit services, Company’s management is expected to submit to the Committee for approval a list of non-audit services that it recommends that the Committee engage the independent auditor to provide for the fiscal year, together with a budget estimating non-audit service spending for the fiscal year. The Committee must approve both the engagement of the auditor to provide the non-audit services and the budget for such services prior to commencing the engagement. To ensure prompt handling of unexpected matters, the Audit Committee has delegated to its Chair the authority to amend or modify the list of approved permissible non-audit services and fees.

 

18


SHAREHOLDER PROPOSALS FOR THE 2006 ANNUAL MEETING

OF SHAREHOLDERS

 

Shareholder proposals to be presented at the 2006 Annual Meeting of Shareholders of the Company must be received at the Company’s executive offices at 13000 Deerfield Parkway, Suite 300, Alpharetta, Georgia 30004, addressed to the attention of the Secretary, by December 19, 2005, in order to be included in the proxy statement and form of proxy relating to such meeting. Appropriate proposals of shareholders intended to be presented at the Company’s 2005 annual meeting without inclusion in the Company’s proxy statement must be received by the Company, at the above address and attention, by January 18, 2006 in order to be considered timely and must comply with Section 2.13 of the Company’s Amended and Restated Bylaws. If the date of the next annual meeting is advanced or delayed by more than 30 calendar days from the date of the annual meeting to which this Proxy Statement relates, the Company shall, in a timely manner, inform its shareholders of the change, and the date by which proposals of shareholders must be received.

 

ANNUAL REPORT

 

The Company’s 2004 Annual Report is concurrently being mailed to shareholders. The Annual Report contains consolidated financial statements of the Company and the report thereon of KPMG LLP, independent public accountants.

 

By Order of the Board of Directors

 

LOGO

Roger G. Wilson

Secretary

 

April 18, 2005

 

19


 

PROXY SOLICITED FOR ANNUAL MEETING OF SHAREHOLDERS OF

MICROTEK MEDICAL HOLDINGS, INC.

To be held May 18, 2005

The undersigned hereby appoints Dan R. Lee and Roger G. Wilson, and each of them, with full power of substitution, proxies to represent and vote, as indicated below, all of the shares of Common Stock of Microtek Medical Holdings, Inc. that the undersigned would be entitled to vote at the Annual Meeting of Shareholders to be held May 18, 2005, and at any adjournment, upon the matters described in the accompanying Notice of Annual Meeting of Shareholders and Proxy Statement, receipt of which is acknowledged, and upon any other business that may properly come before the meeting or any adjournment. Said proxies are directed to vote on the matters described in the Notice of Annual Meeting of Shareholders and Proxy Statement as follows, and otherwise in their discretion upon such other business as may properly come before the meeting or any adjournment thereof.

The Board of Directors recommends a vote FOR proposal 1.

Proposal 1—Election of Directors:

¨     FOR the election as directors of all nominees listed below (except as marked to the contrary below)

  

¨     WITHHOLD AUTHORITY to vote for all nominees listed below

Dan R. Lee

Kenneth F. Davis

Michael E. Glasscock, III

    

Rosdon Hendrix

Gene R. McGrevin

Marc R. Sarni

Ronald L. Smorada

  

Dan R. Lee

Kenneth F. Davis

Michael E. Glasscock, III

  Rosdon Hendrix
Gene R. McGrevin
Marc R. Sarni
Ronald L. Smorada

(Instruction: To withhold authority to vote for any of the above listed nominees, please strike through that individual’s name)

(Continued and to be signed on reverse side)

 

 


(Continued from reverse side)

 

THIS PROXY WILL BE VOTED AS DIRECTED, BUT IF NO DIRECTION IS INDICATED, THE PROXY WILL BE VOTED “FOR” EACH OF THE PROPOSALS SET FORTH ABOVE.

 

Dated:                                                          

2005

 

                                                                                    

 

                                                                                    

Signature of Shareholder

 

Please sign exactly as your name or names appear hereon. Where more than one owner is shown, each should sign. Persons signing in a fiduciary or representative capacity shall give full title. If this proxy is submitted by a corporation, please sign in full corporate name by authorized person.

 

Please mark, sign, date and return this proxy card promptly, using the enclosed envelope.

 

 

GRAPHIC 2 g96795g43r13.jpg GRAPHIC begin 644 g96795g43r13.jpg M_]C_X``02D9)1@`!`@$`8`!@``#_[0FR4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0`` M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`& M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4` M```!`"T````&```````!.$))30/X``````!P``#_____________________ M________`^@`````_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0` M````.$))300:``````!M````!@``````````````-@```2`````&`&<`-``S M`'(`,0`S`````0`````````````````````````!``````````````$@```` M-@`````````````````````````````````````````````X0DE-!!$````` M``$!`#A"24T$%```````!`````(X0DE-!`P`````!Q4````!````<````!4` M``%0```;D```!OD`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4` M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P, M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X. M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`S_P``1"``5`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$` M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@) M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D M%5+!8C,T)E\K.$P]-U MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$` M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D M8N%R@I)#4Q5C+RLX3#TW7C\T:4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1 M`Q$`/P#T3KG5;>EXC;:,.[J&1=8VC'QZ`-;'AWI^M:[V8V/[?TN39[*EEMZQ M]>&M%MOU>I>UQ'Z&K.9ZK03[I]6IF/8]C?\`AF)K/K-UCJ69DXGU9Z?7DU8E MCL>[J>7;Z6.V]D>K5736RS)R6USM]2O9[_\`@]C[,OZR_6'ZZ]%Z#DOZC@X= MC[V&FK,P+G`5V6_HJOU3,K]:U_NWM])UB2GH^A_6?IW6B:Z6VXV2&"X8N2T, ML=2X[*\RC8ZVG)Q+'?0R<:VZE:ZX/KHZ=TKZG]"R.FV-R>I8;L1O0[:PX/R+ M'>FR^IK6D6_9\_'-OVFC?L_ZYZ2O_6W_`!D=%^K5CL/:[-ZDT`G%K.UK-T.; MZ][@YM>ZL[MK&76)*>M27/N^O/U:HPQDYV8S#L;31=?C/EUM?VEN^JEU-;76 M/N;_`(6NMF^IGZ6W96M?+ZC@X6!9U')N;7AU,]5]\RW9$AS=F[U-_P#@_3_G M/\&DI)E96-AX[\G*M9114-UEMA#6M'\ISES/1_KY5UGZQMZ/B8-S<9V,[*;E MV^PN9+15:,:-[,:]KFOIMMV66>K5^A7#]:Q^N?6G/P.L]6R7=(Z'U3)^R8++ M!`;0`GOS;*OT;K?YRS]+_1&8R]$Z#TS`Z+U&_I^+BY%EEU+,J_K% MY-KLAY_(_04U?\9^KI39^L_^,;`Q[6=-Z)G8;LFVMUEO4;'^IC4, M:'._[3^J[*RW[?T&-5O_`$GI^HM+ZB977,OI=^3U:VV]EMY=@W9%3:+7T;:_ MTKL:GVTTV7>J_'9]/T_^#])87U2Z9B=$Q.M]/=TS'SNO="C)]>NO<;W7U'+P MV4%[/4HV27&Y/^,SI[3CU8/3L[,S+;6LMP?0?7@^M7CY->9A9%KV5BK)Q;6.#GD,8UWMLU5>J_>ZNO%MP/5WG[7]A9UB[&_[5^MZ_V=_I^OZWI_ MHE"VKZZ-H_REE=;M;W^Q8_3*G?\`LMF9-R\5224^P_XN&_4L9C_1?<_JA>\] M/_:;&LO;1KO9A;++<2W]8^V^I;B^E=_2/T7IK5ZK_P"-9]MZE^T_L'VV#]NW M_P`Y,>_T-OO^U?Z3[%^M>I_PJ\)224^\]#_\:_?3^R?V=ZWH/]/=M]7TH?Z_ MJ_:?TWJ>EZOK>O\`I_L_\Y^@6KG_`/,__F_7]L^Q_L'C&YOI;_6_1?SOI^G_ M`,(CXWV;[-5]DV?9MC?0]*/3]./T7I;/9Z>SZ&Q?+222GZJ7.]*_YG?\Z.I_ M8/3_`.<&GVW=NWQM;_,>K^CV?]R/LWY_\_\`X-?.Z22GW[ZF,K9UGZQ#)MMN MZU]HJ_:#[*V55[-K_P!G_9*Z[LK]!]G^AZMOJ_Z1=8OE5))3]5)+Y5224__9 M`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\` MM9S=-T^IZ\A'&)MA0T?_LGM:,>D&I:*98:-9DMD3 M%7?;%_7M^UAHE]8WJ<^.E/O/>L/9Q/<[[B_1*1<>W9UMOG:"IQS;IY$-.:2U MCO\`B6QGBDF/O9O'4`YBX_UY,PG#14L[\9G&6T--8:SAL)%>E/W".M]WM$-I MOR':*O73?:*'A(.QW^,!E[7J&/L2\*^0Y:JT:*/MC6(+SKC*6FUA6%MC"\N% M%L,IRYP+>NOMB4';-,KVQ=776J[$H-MC1YBKW2DST79ZO8(LI&%CGP\[#%&1 ML@*ZG/\`"VG%8_/YQG^<9QP/9['6]TPC1\#+".&@F#ZY@8QX"2VRX&4TE;L5Z!$@HT2,H94&XRTI*2E3"7'<$%8;4H.B[P'`!D2&F8BQ1$58*_*QL[`3L:#,PDW#'"R<1,Q$F*T;&RL5)!.OA2,;(A/H>8 M?96MIYI:5H5E.<9X&D'D<\B&@/&-UBMG9KL!*/*C8YYNO4&A0[XJ;AMC8TB* M63`4&H#E+2VHXYL%X@LI>,L1T<,06[^4,Y2H.;!'PWDT^T=VPMNRME7^%U'U MATN\8?/W6WR!$+U:Z@4*67@A,+`!&&Q8UNV5.1P+:B77'DRTOD=#IY84:PSD M4/.^36X>'7IYH%WHIXQZ]6^V^^;48`-V+\AE]B@;V4'%QDE\YS7_`%SD)`-= M5KDA83AV63I^GC,C?H5.`8D91TTET4+Z7UNNEFR.COBFTI0]OC34+LK;$U9> MPUGI,\.L*1UVG:+,.NM4PR.?0T=$RP=-A8XJ4"*0@H&7++'=0A;64)">#@.` MX#@.`X'_T;_'`CJ\D'BVZD^5'5E4U7VKKMJ+%H%F`8.M*&W4);)98?:#='4FJ-?Z*UA0=-ZJK,73=<:Q MJ<)2J76(80<&.AJ_7P&8^/%9'%:99]S++/K=<].%//*4XO.5J5G(9$X'E[O< MZWKFEV_85RDVX6H42KS]SM4P\V\\U$UNKQ)W2WE#T/KG:H=$>C=K];MNU:J5_6>[NO=.OMFL M<,WJ*$VMKZ(K\_88&MM!11$9B76=DUP`A,LF484.T(&*7H_O_P#4F[(5TTBS MVCM5X?=X[(?C"`/>%R=5I29=)+=:9@"#A0]?]AX>IPOR<$C?$K%X&%4A>67V M6:EI>I420BA9+6FG!I+]/,;5L#9R2'S5.R?NLPT2VVTJ977ST]@_,-M.3Z2]&YU6ANF67I\>YW2[7:)U-_FBHPB2?WNQMX7.P/0 MC6MM$@0V''TUI\E3D@A;>3V2CW`XP0(O-N;]Z.]'=49Z[^.X.-[,]I[E69*L M[W\D]LJ,^`/")MT:Y"VC572/5]Y#231(T<0EX#_(Y$<#;S$OD*CE"M.C.LA; MQ^J]X-M@]/P)GR`=OZ253-^;&JK]3T-J:R@/"6S4.MISVW;-=KI'%*PY`;!V M(PTT(-'+::.A81+Z"58>DWQ`PNC\!P'`<".3RL^.NB>4;I9LGJAOM+>)G6MS@0]L]D0.K6CH$^0%V+K/>,!M+2M>US5&5,HDZH#99DZW:YJ0XR M/^Q$EPT&^G'X_`6/4G*@B(C;%Y7O.=O.B:33;MR]V=P5&JVR;IM7LUOKD7!T M>IBJ"*MUD*E;5*T_75+!,*R"*_)2!0BC2U@`X==?6&PH)2],?50\XNTHF.UK ML:'H/7;6(]B>E50FU^R-.]Y__`&]['U@@:8K8UIUTKQ6V9D$X89]U^).MP3\9J:*G&"FDB/`FV M,8P4IS"'VFDH=4V$.]K^[?TG#E%LT?I[VFL4)A/Y;D+7+:EILHI?J5CTKAXB MVWL1M/H_&?S@Y6?SG./Q_'YR&RNA?N->*?:[+];BSFT8D[/L#6T# M19%MW"U9=RE`60^X/5G5_=?K/N/JYN*+'DZ%N.ER=6D'70V M328"3<2DNMW"';>6UAJP4VQBBR@#B5MJ;+$;5A2?Q^>!4=^GWV9O%3([Q>+' M9TX+.E]6=A2U_P!7%1F73XT>.X*KNK635FF:87: M*JJ1:;C;77T!/RU>F(R:`BIN&EA@I,0I+)8S*W@C!R6\+'(9<6&R/`'PV4\57AX[8>7#9=GJ M/7\>KU6@ZV_0O;R'1I\5GUH>C?C5G:UN*Q/27:KM'7'FI&&V_LR#`AZI0IIE>5,2VIM3C M&S<74Y8;TH6S)24A.S`I",N"%BX5[>`L41\C'RP0\E%'!R<>8WAX0^/)9,"* M:SG.,.CE#+<8?;SG&<>I*LX_C@?9P'`?+KYI.K_`(B]7`S6S_D;*WM> M(\DG4/76JRHD=;+@VTLD7-GLLL0.>S1-;AR(JAR)AX8IUQY*F@A#'FW6VPYL M_D/^PMY*?)Q4K%HG85LJ>OM!7V8@U'Z`TI1Q(R+LQ$--A2U6CIVU3&+)L^S? M%G`QB,!8EFHXHUIIQ0>5M,^V%B;Z5V^>J]>)[2=73*.14.Z]G('V23>YX[WL M[*TQ2LQ\!C7E;")8%_M>4U?:)TF1/CT>X7+MRZBE+<:C,MA!?2NMRJNN:=;= MA7J>C:K2*)69ZY7&SS)"1(BN56KQ14W89Z5*7_0-&P\0"\0^YG^$--JSG_IP M(R/&1YE.G7EE(WT)U97LX(SKY8H")M`6U*I#T\VRP%L786JIL&E!QEJLQ)U- MGG:L:A.#TQLL&MM"3011V0+#!F$QA#+,IX&W?`ULWKW'Z MJ=8[%K6H=A>PNI--VO<4XQ7-75O85W@ZW.7F5?E(J$]NOQ<@6T::&-*S@;!) M>$8$%62W[SK>%8SP-D^`X#@?_]/^7]AWR[=JNW';:0\)GCAB;QDLFV#ZDW5+ M44A<9=]Y;!DXQURSZ?B9!+XJJWING1I*T6@XA\-H]P0Y)BVH41QT\-]_'?\` M3YZ5::I%*'QD:HA68&B>/_I]$ALLI8669UZU?8I\YIMQU MUK$Q:K+6IBSS:F5OK]"C#'U(QG\)SC'\<#6[LW]?WQ$]J8TT>Y]*=1ZZGBAW MVV;KUZ@QM`6<4U\@PMF(^2][\(2ZEQ"$)P',5\POC MMUB3 M!N5G8E7.=]LZPT^\I@W7G"GTY-&E?D,%J<7[118;H^57R@:'\6O5 M^Z;KV?9*Z7LLR!FP=#:<(DF\6;;6R?UI7]NQ(T,(^F::IHDMAE4[+H;^/&!9 MSG*\ON#M.A4P^EWH#;]LVSW@[^WL>054KG#BZ6C+8>D85O8.R[+<0=L;0+CP MQ@VT+_M9$?$**=1\<9+LVEIE+JFWL#!)SYX/LOTKQU34[U4ZBQM5W#W$'%<# MOL_/9+.UKUS=D(X8N.1-A!_'1?ME.B')>:AFBV@HO/I7)+<5C,<\'-][;=X> MV?>S8CFTNV>]KYNNW);P/%YL\BT/6JN%A*4YC:31X0>+I5(BW%XRXX-$QX;+ MQ"W'G$K><<<4%UGZ@O9&"ZL=&?(AN+LQ.P^G.HU%VYK2>B]TW:9,C*S*;*+H M\L%?Z+7P'\."SEL`@0*HM(D8V[*FO2P@^&GE*&0D)H^L?VI/%QV!$[*S-QNT MYUQKF@B,2%8D-Q8BQ)?>U,?=*#!F=85*#+D[')6@H\+.%5Y+#TBR,0.\O\>H MA`P:E]8?N`]3.P/>MCKI:M0RFC>LURD'JKK+M'L>^QX)#EL2]EJ%-V?0TP.( MG7M+N+JOCL&YGRU1+N&7#L)9(?7'!;WC).-FXV/F8:0!EX>7!$DXF6C"QSXV M3C3QVRP9"/.$<=%-!-%=0XTZVM3;C:L*3G.,XSP/`[EW'K+KYJN^;LW+<8?7 M^K=95N0MEWN,\^IB,@X.,;];Y#OMH<()(><4ED<=E#A!1#B&64+=6A&0Y._D M3[H=L/L@^26A:LZ[T2Q&4@>6.UYU5TRXZM`U1IY#PY5TW!L\\?#\;#24ZQ&8 MEK#(JQ\>(B`A@\*?^'AX@+RE`\`FF^LOAG[1="]/1-=NG8KL#U]LHNQMV2<' M'"S>V-[1D019*`-DLP@)^$U[5K^(.S7H]XOV8IA62GLNENEOOA!/]/+R']:- M!5+L7T-WY<:OI+<-SW1C;NNI79!HE,!OSKU1K&OK'K),]/D@QXETJ4A3V20X M@C+)AN),KXZ75#O(;"[7WJZ]V3METS[0=9:?>%:WL^^-';'U9!W3*25B0DA< MZS(0K"IAL+"C7JZ?DOXLFVQC+SD>^\EO^O*>!%!]<#I7WP\?_22[=:.\`=5C M/[:WC:9_14/7[O&7HF$UY9HB"-G0,R$"\_$`5TV^-R,H`,I7ST$21BB$MH4P MVD+!G`Q`TVJAFEFO1%-IL*TQ&Q0?NN?&!&;1E2U84M07._JI>"L^QSM, M\I7;6G."U:!(;G>F^MK$(RK-JFD(=;'["6"(+9=RW7X%U>54Y+N$.DR+>)A" M4,CQKY08$\L!]-\8OVH.OW9#4HH=0B+];-`;SVG%1@K41%,,[HD['I7L*Z$B M.95E)&PJB+,2D@^IMQ;\M,E.K2YZ\I4%_KO=UL+[B=,^SG5N/LR:;*;XTM?= M:Q%I=^6H.#FK)!%APY\HT#G!9,*U)J:^-&I-LN41U]C-_:IOD'`3#I\&;5[W_`&9=JLZS\HC+S60R MQ2_01A!3*5XPV@,C6[>?VC/)W$$:GFAN_>PZ9:V\)FHFIZ45UOUE/1Q*$P:H MZY62BT'3U`.K9>6LX="E3%1[KK;CZV\N(<G["W09BG=FNM]?G*YL M]89G[J'ZM=A(A.X*9&!+;F7Z_=XR,F("$O<'..Q#>'8B&.M`4@I*&"&%^O#: M@SZ!YO?M&].@RHO?NE=K6F/BQ<-XDNR/1V>C1A&R$D2#1B;E0:GK']PK`[#V M$ND'%IPAI>,_RVKTA%9VFW=Y%.M-I]*0F)JW3K[?_CLJ\;3]'6K= M=PUM!_'>@XBB[8TKV2K,"A@@0G$5`4';)EJL$+%X-+SET(2':!?SA]2D+;RX MI0?E7GB^T9H`X^.W)U:N4\2&4D)_.W.@E\KHS)!#8KHR!CM=0^N`2TOLAN+9 M6AQU#R'W%)RI.&LM!(WX0/L>>03OIY,*CT[[4:FU-&4Z^TW;[A#&K=97*D3N ML+71JJ9?XZ7MC]MO=L-9K.!*P3`_'?;2^J1F`\K=RI/X4'__U,7>1W47=3P0 M>9K;GEQT5UFK/8OK9OT[8-PE)M^ESF[8;`F=R0MIL%=;/D=-7XFRBG& M1]G6G(4C&R!#2DO8=D`D!,YUJ^X'XI=M52),WR5N#JC>%CB)L==M>NK1MFJ! M2#V2/E8K5RT]"VB7L,.'AI'_`"#8&&*<]W'I%_A7I#>MG[(_A(?::>1WVH:4 M/-H=1A[7.]1W<)<3A:<.L/ZL;?84J"MU3:G&HYF3DM?PT:\A$ALEZT_%U-6 MI^$VE4*_'WT$55YK_P`*;H59J4I49FU#8FPH9R"1'0IK0N`VTX"&R@)\.DOU MRO)!Y;-F0?=+RE[RN%)UGL6/K5M8L]FN4/L[?FWJ#*`L3M<$H(,?*3-1U50R MXF2PF.49Z$QS+F/BPJVJ-5B$N MJ;&%;4M\L^0.)<>/F9Z9/>=,D)`MQXP\U]U]]Q;KBE9"A'Y'/J+=Z-Z=YNP^ M].MFY^NT]J;L-N6_;G')W)=-@U.\4N8VG:#[M:8*S`P6L[TQ,QL)89\ID&0$ M+++-"90X0.R^K*%![#:GTJ)2J],;(?JGLP5MGOA'%1%AAX:6#C-;]?)Z'#09 MFR:VA\&!6&U#V:09)0J,L$E(B1[Y8;31(<>P2\2,$9'4?ZL?E[[-V>J:T[/C M/=3NO>M3CG&9/:>QH78^8(*QR'["T#:4U50;?:8YV>FCTI(+403`1KZ_RZX6 MZ\E+3@2:A_2(LF.Q+2)#NU!KZF8F"#'B@Z*>WV)7`)QEX6NM`OH=UJW,/9_` MSDUDA;+7_DXBW/\`Q>!-;NSZFGB8V5UZJ^E]=4:_:+O%->^9&=A:E<#;+M.R M%O(7B2;V2U/\`Z<0G0+J1I_J5 M6]H[*W%!:AA38>,O&U9,>2LQ(QTL=+IB0FA&6A8.HU]1^0H6+;RZB,BV6!DN M.8:PO(:E><;QQ[(\I/0FU=8-3;:'U/?&[Y3-F02YQZ28H6P"J4F7PSKS9+L. M+(2C-3D")9$DR\P,4H69BP'\LN(:4G(:U^`'PAP'B3T;-V+:>*7_N_K1V8JVSMD=8=H;)F'+#MD6BPM:MM!O=F,-')FKGBJ36(LZO M72R)^0N1*&DGO:CNOXQ)'6'4FI/;$O%4WEKG:5RUM%N,8ME]UM582\1\M#4D0E33,M9HN MS6"(F,!8=;(+#C"&AL/%*8&?"O?X/_JA6V1LU?[.^5:DCP=0B?AS.O.H1DHR M5.VN1RCWQ9??Z(OWA86KAI<;=:K#)N9`TE.6Y9(P[3H)P=`26EJ9K.F2$U-2 M%;H6OZ%6R)"3DY`B-K52I]2K4:I\DLLE]0<1!5^"B`\J4I66AQAVO_:A/\!R MB^W&Z3?/+]A:@":)'.*UK;=S:NTIJB3=8>00C0^F#G)>Z[2)92*DP:-D8N.L M=N;9>:22*"2V.[C#K:L<#K.;^Y_;?&_5?JOC.?L/V?S/^)^O^)Z_>]W_M^W^?5_3^>!5( M[TM?44?/GF>R9'0(.VO'6=JQ%]9$RZKT+9'/>182+(GI8P5-JM3!^7%*Q*-. M$Y/PO\I4][F,A!_==)?22TIMSV1AT8;=7G'I5A*D!+/UT__'5^T5_C3_ZY/E_, M<_/^Q?[3]7[WM@^KT_[;?_"_#]/M^G\?\?U>[Z?ZO>X'IO,_K#Z^.V>E^F*U MO/LEJ;JUIAC:L#*::V1T7IU9O8A,\-19UD:MG5[K_JW:\:_29&BDONC./"!, M-.CC*8*PG"AR`LA=5A-.`=8.N`/7639F^OH6AM0":*F1VW&AY?3@VO:\SK&3 M8:>CXAYID^DH!=2E8@JDI7C&6F\_T)#//`K=9**6C853)I/GM-_MOW&(IY M1]QV1M;7.P=6;%&UJN0!:D8;4U0V/KRA#`5!H]`BYC]0N5/4ZIG)Q6&,C--A /;MX#@.`X#@.`X#@.!__9 ` end GRAPHIC 3 g96795g46z80.jpg GRAPHIC begin 644 g96795g46z80.jpg M_]C_X``02D9)1@`!`@$`8`!@``#_[0D,4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0`` M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`& M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4` M```!`"T````&```````!.$))30/X``````!P``#_____________________ M________`^@`````_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0` M````.$))300:``````!M````!@``````````````*P```-@````&`&<`-``V M`'H`.``P`````0`````````````````````````!``````````````#8```` M*P`````````````````````````````````````````````X0DE-!!$````` M``$!`#A"24T$%```````!`````(X0DE-!`P`````!G`````!````<````!8` M``%0```)E\K.$P]-U MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$` M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D M8N%R@I)#4Q5C+RLX3#TW7C\T:4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1 M`Q$`/P#T>SJ+K,BS$P*QDWTD"]Y=LJJ)`>*[;MMFZ_TW>IZ%3+'_`,UZ_H5W MTV*7V+*M'ZUEO.LEE`]%G^=^ER?_`&80/J_B9.%@V8N2PBRO)R'>J2TBUMMM MF4W);LM4#7TV_T'776NM:8HHR[7_ISMI;7]I]-_P#Q7J)OJX76 M?;WI>1:T].K>206-8UEN31O]U6+E6^['J_FO3_6ZOZ6N>Z/TNZOI72NI M=0?;U7!ZI9]IS\6S8*ZKC75TL%.7>Q[:J\AYN;;CO=E>G7E?9MN/^N8_J8=[[?T7K?S M22GIDEQ.+]<^K-IZ33?1ZMMPN?U'*;5;8TMHNLPSA856*S]:ZFZRO]+Z;/0K M_I/H?9K?T'1].Z[1E7'#RV?L_J8+O\GW/8;BP2ZNZKTW/KR*WT^][\9]U5-O MJX_J>I38DI/U7JF+TK#=F96XM!:RNJII?998\^G3CX]3?=;==8[8QO\`Z+4N MG9>3ET.LR<.S`>U[FBFYU;G%H^C9NQK+J_?_`%UB_6:WJ5/5NE9%&)9D8F-Z M[WV-#WL9?97]GQ;+,?#KRLVUK*7YC/;1Z/Z>O].KV!U+K%_3KE6N=H?E=/RNG?:JLK'Z%CUVOI]EEV5?EN+#]JZJW#9<]GVO[1EWT MXW^$R??E>ED_9L2M*>CLS'D=6ZR.I.SG8F3@UW/HKOR74FXXV&TOOKQZJ*J\AU^=U)V[[=94VVCI[,G M!HL_6<=4FCTJ_7S,CJ22GT5)<93];>O]1NS\KIN'^I]-MKQAA/I>_(ON+W5Y-#\B MFWT,"S'VL?[J\FFJN^NS)L_T6_\`MQU;V-S.FYN*VQVUKS6R]L_\)^S;<[T6 M_P#"7>G6DI__T/54E\JI)*?JIFS&M;ZM;\C*OP[?M7ZQ75E4^G5BKY[224_2WU;K=7TEK;+6WWF[)=E/K#F ML&0[(O?FU4^J&V>C1E.NIJ>[^4.[>P1YC;4^/DH<'AZ=E"1M;4)`?U&:<:`L./]!!'C`P#"$/T;VS>Z7K$BN0RW6"BF,1A67**Q")65L3+1)\*,&&`:;3DLCU M]C34L&G#\,B409T*#D8O`<^`BR'!>=2IK+CBLSC=G<%Z;LH3TJN/1:14K3K4 M<G&=N*T<;@5HY5<-,O#%=C=4,EKQYLM(C:G2<5_+P2 M$AQCYS^!Q?25#8Y$C7FD$E!X%MW`PE"W\5+S MZ*NNI[F(KZ4*X3.SJKL*)V`5#)B@#@:V+2@R*NSJ!AD"4&?(TBK)1XM;ZHI&KB7?,:-OO8N1MHP.;-7B=_":C:6=LP9()4)'9BF]C-*8F`5D_)\&C"KU^I#"MU@=,?3,4F$IW4@ M+C-%"+UDNL@=!%!.X$Q^`X%%=`NAER?_`$%[_3MG7I1L.I&@6HNIDA(0J31$ MK9?;UC6ELND$N+PI.2J79@:CCB#,A"`24M2``@X$8(0PLKVVW(I'3"OV^:VX M\.2U^E[TEAE/T]!V[\KNN_;,=3TR*/U=2EOV=[(DL2UMHFNG"3F4IK= M"GL@@@EV.CB&4+'F6.A00E/$O=UQA?E(0C\!93P'`#\)FN.Q.*-*M\?WI>=GS\$KH:TF,_D%L2ZNZO@$&E M5IRPX2B565)(E%&E@?)_)3QC-&?()DYMYKBM'D0LB4J1YSG/GSP,H63Z6*DR!, M44$6"0F#4'9+3D'&EAC/JXK';&H=$->H7O%:[Y<>T1<34R"U93)%29S>VIUE MSTY2A#`G1]3EAS(G"NFAV3LJA>,9_P!D]$,19IA/J%P)^C``P`BS`A&`81`& M`8<"`,`L9"((@BQG`@BQGQG&?TSC@4UZ,5S%XKVB]N[[6,3B\,K)"Q]?-0J6 MJ&1]HCL?,MF#4W9MDS+`4#*6G08=&^"WC$P*!A*`,032RQ^?2'@3'9=3]6M= M=B]I.PHAK+A5H7;5\(0[`3QS>U!<5*AM$L;J,J4#:Q^$C0LS&$Z4#NJ\B`C25BA46!8&ZUP'`?- M]B^YFSYR<8HN4797**//&P2[9-\L"F4<[>-^]FI/&1.K#3> M&Q:^KVV&IR&*%5UK=6J#"U5EQC\=9V$L)X!`=,*5A0S.!F2CNU/KLV4GM5U9 M1.W5.V99%V163S2L8+''U09*9/'H:?(R),IPR*T*5>SKFK$0=#1H7`"5<-*@ M/4`)$06(S`0F['^[MOT!VDCNK31J58FP4E-UHDFVDW?V2TJOJI"PT_$':6() M2=!T=E+6_-L3",ML)<'->RMAY2XMN+]Q03@%JS6ZRM*X+OVNGK76 M6N$TJ=IM]5+K.7-T8+AS"X(PF+6N5&B6J4">0,KK@QM.3ICE/O<"O4F$?D9? MS#O]/-S-=]]*4;]B-7)LLL*H7B22J+-$K6Q&80D3FY0]W.9G<)23(M5WTSB\&`,4D+1E9P(D1_@)A=FEW;_VM]G\5UPTO MV.G$,TYZY7B+WGN%;E*NRUF2['75F4N;74^M+'.FU4H;)32!BV)/9DJQDDQM MD(6M:D3Y-]"=<4%UFV6RD)U#UYM#86>DJG)IKV.FK6F*-8\?D=A31Q.*:('6 M403^I0:OF5C3%>B9FM.64:,U:M+Q@&<>>!3"\;;BZ9=%*R.O"%MM^=F6[MW/ M-FFZJ5],$;',+UVNV:LE(]3"(QI\3LLSPRU[2;-(&^*)'H:%8WDML?;$)8QF MJ$WS#R7?#M7"$,0U5TXO9V<*\KF__MWYNM"H4K%+K"DVOE'JX88#5JLRV@MM M=I?.-H=C9A%X*W&-821J4.'`P[!"'[!@`R'II-];452:IZUMB1F2*2F^+TI!C2&++XO*;V@U_5+TY*L\H@L MX86\[>[@:_:*4+,-D]FIT3`*IA8FU,X.N&]Q>G5S>'M<4VL<=CL?9TRQV?7Y MX7'8`2G(*%\08&<;DL@HTT`0RSHRYQ]6H2I"TJ_*Q,(PH83#X#@5T=NDYGE>]96\#Y5U?3BT;&==>)_ M7T(A=*+)B%V6X)(S@I"A.,,&44`9H`R M]H/316OVC.H-%F,QS*?5NLU)P1Z:'!"8@7%/[%7$>02?+NWJ22#R'98_%JC5 MH#2P#^R89\PX%YQP*9D?5%M#:NOUM]ZE6:W-+&X&ZE73-+ M2_*;&UV'#,KFD4NKP%A$)I:TMP,(41;,8K0"4Y4*332PR5$^N#;N9;?:6[5; MCSC0:KJ]Z[TMV2.%MFG%36/7BVRU5E5W^WZHRPE=E2I3'*O@L5CC&FNPOM>ZP^EY^ MUNH5*5K&56K9*MG*OUT4TFDD+?(&R+M-91)\KZD[,<:2JLIECC6D?E<=0(%A MA4<<'S8ME M,P)U;6@SQ)*G:7Y M*Y1E0E5+46%9"]1A7X`%YC"](Y(Q,LB;R79.@?FEN>D*=^87V*OI"-T1DKDQ M+U%Y0W,\EC;L42>$*E`XI$JY&=@11Y)1H!@"%+?;)TZ-W9#B(V*CN1\(MFF) M1`IS3-3WA]NR-*#W6"J7M8[QJQ]?V@Y/2=O3E$(_BE] MR-0&.5&D/9Q-JA?*#?8=T=TS64S>W_W!;A`WDDD8.,P7\\AZC4;5&O=,*<34 M;5TEM"40U%,)W,D*RVYXYV-*42RP92Y2YW:B)$[%EK3KWX[+VUPT)"ES`K.+.>AXQ\S0S]8NKFWVB^XJK9CK M>URI6]M>K@UYI+7FZ]0SK)9M<)1`E>MJN=D4K85+31Z8WFOOQEMB5CN+6NJ=J2CEYM MT:D;=%;5VW)++&VBA]A67^T$01OGK-[DMMMTZ3[*W!SZ\M?[LK^,RREJSI&Q& M6>;#(]3:Q7&N;S&+Y99RB9FV)W5M:QR23.YJ-.I:&Z)-N`MQI?M-RI^N$1%G M4'W722#377%XJKKB>9!--FH7=5E=E5HSFUY;L;>J&G[6:[&KTV=Y"&12U*2( M$=0(R6-L(9F="UEF(DY*(P\Y>,,`]P/71VQ;$[71^I]B&ZZ.R=-:-%M\>U4E M]1UL2D8Y0BAIBD#VHN*^6YZDUMM(NM6J51REN/)7%I/2K3@,//*#.S;UL;'PC!+C6G<3V-E2(G]3!7 M(1IU>4/79P6;CU+8D_:IL1X$YI@PA']5Q2G>H/@LTL[P>$/F)$]TE-6M%V:: M+])MW->WN;-S=(YHS-D]U&V*@,,<5R,ERDQT8.=+CJ"P11Q`H..`WI#V52L& MD^&#@_;Q](/_T]_C@.`X#@.`X&O+:ZVJ=MNWBVM0-_Y8C;:,I"KZ$L/2S4Z> MN>8G3>XC M0H4R31CSD)U\!P'` GRAPHIC 4 g96795g51a87.jpg GRAPHIC begin 644 g96795g51a87.jpg M_]C_X``02D9)1@`!`@$`8`!@``#_[1&84&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0`` M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`& M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4` M```!`"T````&```````!.$))30/X``````!P``#_____________________ M________`^@`````_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0` M````.$))300:``````!M````!@`````````````!R@```B@````&`&<`-0`Q M`&$`.``W`````0`````````````````````````!``````````````(H```! MR@`````````````````````````````````````````````X0DE-!!$````` M``$!`#A"24T$%```````!`````(X0DE-!`P`````#OP````!````<````%T` M``%0``!Z$```#N``&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4` M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P, M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X. M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`S_P``1"`!=`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$` M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@) M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D M%5+!8C,T)E\K.$P]-U MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$` M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D M8N%R@I)#4Q5C+RLX3#TW7C\T:4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1 M`Q$`/P#U#)H;DXUN.\N:RYCJW.82UP#AL)8]ON8_7VO6);]4.GRRX6WM=0QK M6-I].N0UOI.KV5U,9Z=M6^KT/YBGU[_LWH>O8MVRVJINZU[6-XEQ`'CW4MS2 M)!$'4)*>2;T:L4-8W!SVUBGT[*C922YTVY/J$'>S?7DGU-]=E?Z7(_14>AZJ M7_-['(=4[%S7L<&F7.H'T6L:YM=S6?:JG7>ELMS.FX&H6M+6^]P M`!^E`8YK>WTE`])Z8;67&IOJ5NK>U\F=U(=70YVONV,LIC[_TGJ5+_J_39BMQW8V: M:MSGNJH./4&N#/0<^MK*L6O9D4CW5M]/_B?TUZZ&OI/3*HVU`P&!H[])^\DIS'](QLS(.1D8%U;LTM?>TMH< M&F^G[/:'N>QUK/LS<6OU/2?^EMO_`$GK8_Z-#'2["ZUKZUHK;](_N,:K. MYOB$E/+XG2:J;7N;@Y8+W-=6^S[.XU.96W!:^B6NV[*[/6]SG_T?_K-EUGU0 MZ8VRNTV7N=6272\`/+CNL]8,8W=ZGT-OT/\`1K;W-\0D"#P924__T/2^H_9_ MLQ^TXQS*YUJ%8M['7TW*+*,:Q[WNQFN)+=7,;,;&0T[O=[4SLCJ%UV1114*# M06>G?<"ZNP.:2_8UCJG;JW?UV?V_4](M8R=UGN9,B?:>=K-WYZ2EOLF)_P!Q M6?YC$OLF)_W%9_F,1(R?WV?YI_\`)IG&]K2XO9`_D./X!Z2F'V3$_P"XK/\` M,8E]DQ/^XK/\QB'5;U1V1D-MIKKQF%@QKFDN?8"V;G64>ST=EGLK_36^I_P: M-OMF/48#IRQPYX^D])3'[)B?]Q6?YC$OLF)_W%9_F,1(R?WV?YI_\FE&3^^S M_-/_`)-)2/[)B?\`<5G^8Q+[)B?]Q6?YC$2,G]]G^:?_`":#>YK3+6?G.^G[76?S=7_;G^"L24TJ,PQHX%C0X'P>Q^U[$9K+V-#6FMK6B&M#"``.P]ZA M9C66N:]SFA[)VO:'-<)Y]V__`*#O8DI7V3$_[BL_S&)Z*JJ[GBJIM4M;(:`) MU?\`N*O59UIN?]FLKJ?ABG>,^8<;=VW[,[$W?Z+]([(]3T_^"5JL6"Y^\@G: MV-H([O\`%SDE/__1[W)P^EUNS;LRVVIESV^HY[G,;+6/>'5/;M_P=KZOI?X+ MT?\``UJY2W&]T.<6^V"'.U&QFT^T[?HH;,RXW=0KQZK;KL=S"RNT>G4[_^6DIELQ_WG?YS_\`R26S M'(@EQ'@7/_O0F8=[+\BYM]\9#FN%3GLVUFP_SMCOYOV)*04],Z;1F9.;3O9D9GI^N[U+"UWI-].K]&7>F MS:T_F-10&-'NW/U@ECG_`.=L+O\`R:I8=G7VYV?;FL_5'^@<*E@K?Z?M_98_U&?\`!T>JK=>1F.^AZ-IDB"Y]1&TP[V.9@ MTUYMG5+[,C`IJI%=19D,>'/M>TOAEWLJ?LQ?4?Z._?\`SGJ*Z[)#2&QN<3`: MT[C(&[M]'^VDIJUUY?VNUUMU?V,L9Z%;1;ZC;-?6-MQMVV5_1]/]&S_TJ<,9 MWL/R+^?^W$FY&TR+0YSG9/VG=ZONK+:O0^A_A%8I#!<_8 M2?:V9)/=_P"^AUT9+,I]YNLLK>P,&.[T]C2'.?ZK',8VS?M?Z?\`81F%QO=( MCV-[SW>DI__2[^EIMS>JUT9&33;-32^R'55NV;M^"RS>S:YCF^NS_2_I/\(K MU3'%S_TSN6Z@-@^QFNK7?23YWH_9+?7I.35'NH#/4+A^Z*OSU"IU+2\>DX`; M8'IG0;&0W0?FI*2^F_\`TS_N9_Y!`MHMI>YS7P*PW82\G5 MC:_9[MRC5CW/<+K[7"S\Q@VQ7(AWYNU]G[UO_;:!C8./CYV5F!^18,G;MQWM M)JIVC;9]CK%;?1^U._2Y7N_2VJWZE/\`HW?]MN_\BDIEZ;_],_[F?^04;,<6 MM++'E[#RUP80?^@EZE/^C=_VV[_R*7J4_P"C=_VV[_R*2D0Z>/7ML=DW65VM M:T8[RTU-VAS7.8ST]WZ7?^E]1]E:,VDM:&MMI3_HW?\`;;O_`"*2F7IO_P!,_P"YG_D$U;2V]\O+_:WF/%_[H:F]2G_1 MN_[;=_Y%*HL-S]K2T;6\M+>[_P!X!)3_`/_3]3?OV.V1O@[=W$]MT(`KS02X M/J;N@N&QSH=`:[W>HSVZ?N*RA;K7/>&EH#2!J"3P'?O-_>24TJ,_*NO%(#F% MS2X.?C6-8(.TM=;ZNS>K6W._TE7_`&V[_P!+(D7_`+S/\T_^32B_]YG^:?\` MR:2FE3FY5U_HMEI,PY^-8UFGT@;/6VJSMSO])5_VV[_TL@Y.?9C64UNKML-U MHJ#JJ'O:TD;O4N"3M]G%A_P MOT_^#5=_V_USZGV,#29W;X24Z:2S8O(9#L-I_P`*""?SO\'[F?X+_P`$46#+ M#7>H["+I.PM:X"/;MW^YW\M)23/?:VW$VC+(.4`?LXK+0"RULY>__M$WZ7^E M];T$/)]3U70S,<2``UC@&N/I9.FX?S6[]_V?K/V129Z^WW_9`[W<;B.&^E_Z M,]11'VS8)&$'SK&Z(\DE,6.LJS]YKS7`EM8:YP?2-[0XOVM+O93MV/M_G/5_ MST<]2R&U!YP;]YD>F`"=PC;[IV^F[_2/V(7ZY[],+6/3U=IJ)#_WO9N3'[;. MGV&!/.[4_F_U/^FDIT,6Y]]+;;*G4.=/Z-_TA!CW0BK,(RH$'"F!ND.Y]^Z/ M=_Q7_@B57VCU6^M]C]*7;MF[=$?H]N[V_P!=)3II++'VL&''"=`/N`K'6;O#WH>J?=3)[(E]6Z[22M%UR7>?"70MJ>)R0!)8CLK:5>3"U29>F0L$` M+1MA*HE2C)<7WE.%(=S;:FB&Z50V_H-=V6'5UP3Y: MMH:.NN>RIS5RIO._]7J7.%((Y!%3`]O92`1:U"-S4-QZ!S18"%4-$J.3%J)[ M7%3RUYZ;:FH^_8N?;O:+=JS;:<:OKBYGFJ:)I2'S3Z"CT&0$)3UV"@ISV]T2 M("F2-KFD.!("TQCHZ"5*EHSI]U>OMB;VI0D, MT;N:Y*"Z_2#[7Y>*N9Y`W-3><$P@+0G4,EB')G$"0!"4UT9RE:9(F"J.S MQ\$U,1V\JI=R9MM,]4J=WA6SR6NJW,TT;E&X=-!D#DK5@P[4G/[8H\;>U&.B M@19SC)9N)*5D!8\>$"AQ\G^49G$A>T77VC7NFPV-%*>[Y!BF$DD:AZ:^Z^G4 MJ2@7/3FI4,Y\JI^0S!M$3E0K-&A;"J-^9+HB"A*;6W32;A&MHK'3U(@@*A+^OTUN51W2 M'?(D,%DVO/=/(1/8)'=/+"L=QXTE?O0CW,@]KB-AWKNTU&H$`<;BS2:\T+B^6 M\H;'@@95VJQZC0LQ?2U@OSPO52AGBJB8%,66;#FH5GN"-N6-/T4 ML3("S%F/RB8>D M?N15ZYT[K'4)>YK5;BN4PZ8B4+5RDY6K/$&U9Z6$1RE0,PXT02P8#C(LYZ,8 MQC_#'-1PY]N9:6ZIUZ4=^-W@6];YM=8MEI-9-/[/.J&I*-ATM,86LQ<5()E% MD+VI)R4Z)&U2I:Z^-<70`0'!/Y1$UEHQT"=>ZTD-.25;WA6R6V,%N@JS'E+&&BJW><+( M\HK`$6AIK*XK#6R!S$@+R=*SWHHP.518\$$DYR4'&<#'&IB?$13^@/IM7%75 M/JY2$*I-]F,GJ4B"MLBKZ06`X&NDQ=XQ.S%$[;5K\L/;F@\:LTJ2?(`Q,282 M7U2Q!ZP<\TY3R\)527/I[;3S;5K[F7UWK4+'8&T=F8;;(UL?X^5K+`H7*'0I M\BC;)'B1)YI)A2;!RIP.&F:$RG`6[Q8)*862S#3,NM3XB'O[98?!)92C3``. M`Y_64FJU!#PNRUT`YF3:"/,3*90N"M[;0I"W`6MQ-&'>"9`E2@;P^"0S)G68*%@T8AYSPZU':I9YWHVKA6A/=V=VW3LUE227JIK7C-9;^85`W%UK../=D+$\G\)&$ MX3FP3/%%.1$^$!D\6,%X%C(L9PP3[5-U3*N_HD=P[A;?UUHAKK(75$NU[UVN M39^TBV=>X)25+^C@;C+8[&'$MI.\<&]GQ^+H4#7U@A)"KF9.3,]3(A%I.M1% MRLHAVP<=I/\`C>V3:![ZH'8T)U]=:CG[BE7&A=RIK5SNR1K#NN6$&`-*>)5& M"6U[.R'(>C+I\F,8Z,<>$JN[S]F,_==-?=ZL]I)=V=CVGO!R:_1O:"M8])YT MXL95O)W0PY(QJ"`UVG;69DRD3X&8N\XB?$\]!A9QIN`)CIX:S[<8>X;NU'>] M7_0W5M[V5/?%=TNM5,Z^7K90,9LH<"%*A:;%'&4&G#,5FR9PA@FXYP&ISXX- M889E1C!^3,8TYSS-/.Y46MG]\;O`M\Y/MO8EFD:\ZB6:.G:=IB%2HIA:B#B9 M%.XP@=#0&(75.A4":H,>X.IQ)0%JYQ=@`"K\4283YG+Z7/5KNC856,(UB`(,"R,6,9Z`\GB&H_MV2#WB&W M,TV9[L'NLJ_ADL MMD)0E)H1!"((@=#Q!$5V[,ADTJDX5?\`Q?L!D;\'Z=F$`"]]#PX8^F0CV:I< M@877H4?^L`B)-$#.#NOTA%G'^&<\:/\`-M6[VUZ>6_O6NY6;V]VJ3)'`O%B5.#!:Y,2:`E6#`#!8Z#`BQT"SC_`*YY?,,Q_7LP[NGWU[<. M^9[X-M7O#JM;FV82(+>WJW!6I1(`XMYU+P%$E..&0E#@O'5Q@`0_L_)_AQYD MG^O5O(WJV20ZB:AW_L4K-3@65K7CNOC!2KP/@%T\>,DQNO6LT)^!%C*=)N\M MZ<>,A'^P9G]D7^&:S$7,0\E7PLH?7&(=YGJ^"S(6>^N[DN1 MI9`?))C(*R6K5SJ>;@Y\>V6*+2\%%X"(8I6CZ>MC(!CS#?:IB:\)D[_CNZZ? MUGI*<;GUG8=^%VS;VT0%2)X_'4+(V*FQ(E=TH`(2Q+ M#<)TV.IGKY_:Y9.LW-.?WF?=^U-H-W6MBS^D+`O9PD5PS#6@,G/L"R12,M"% ML6/KF4&.^(,S$H:PJ5#^=@_&3#?"`"7C/1U>G+P1-]DG3A8_Z<][/W76Q@GI MU3U+N_KS7-&V"F5.2TQJ/L@%?1>NTRLXH]1]'-V/&WB"K,FY#@9HDJL6.][UN&<]OAE7:PU)8NM=/HB'-R!&S)8@@;["7E_9@ M!/PE4#3M\'=EQG0'H"*4%&AS_P"#H;)Q'6/+0IIE*^Z?74DA4;PW7O`RWQF1 MR`+@AJ)^7&PT,9"H*Q'#"1GLCL9](&)NOD__`#LXZW1\F.3#4QVO$13W_P"E M;!5L;U*UT0TB[3)]I]=4,(D]9O%AJ_'9PXPF:,B681U7*5'BR/(GDUM?2\G! MR4#)8OV,XZ0]/-.<\S;R,]Y1W7-&:G;6]UW2]76;LBHB&X6PBFL+9-E5M9=G ME/&RK(U[B@1Q%:CC[40SN?T79[EG)IY*L'A0DBZG0`01R?#?6;CLM3WD-.R' M0"J].^[-TKM^XH:A[Q/;-\3S2T)I/#WR=-83\T#5(XHAE#.BC;BUPUW52UM5 MK4Z;`#CP(CR!G93JCB1ITG7-S/A@W>'=TM$>ZOUL2;VZ(W?>E?7'K_(J]S/W M=_FR-T(L=AE\O8X0R:FU'<7=[S7OAF^3W=$;\MZE].+7!"VJR,IJJ83+*!K_`%VH:TT5):,N M&`)(@^#ZV-\D;GM'?8*9!(P:QOO>"NE!":#SG8H@BJ2X*B1$-_T08,AO/'B MA51Q)8Q)B\8>4`S,])P1X!/ENHKU\TWJ=]9(W$C??N&OH%^6DM,@V]4>-_1# MH>6W/;<=.STH&.6%$%`"8;/IJ+J?:,,O[PR3:FD]^'NBT M;TV/L)#Z,2UU4!L3#0SRM(?0V891^MIC6F5)/$W1*4P'QQ0]FGY"2#.5>"<] M;Y=4:([SD=E$>7(W/H)/%U?!)4W1GHS\O'E9FN ML338WITF5Q7_`)'V]-:HGR0+8G"='*P9&-O=G92N++)9H%HBW)EIQ._H[X%IR].V6IN[MIW6M[9EQ69 M;T"S%/Z:F85HT?AO%DJG!BDP7A`!"/K&"ST](L]+S)^O7[:.=3H_W6LGTKE, MZVRW1V)K/;1&*Q<1V&02039Y+&8@)Z*W-31U-7KXVN)CLX9`$X!KVB*R#.+>8Y*4,C>FQAC=J-$-G!JQ,JRH="GQ"Q&(EROP@_''-M.5 MYQ@I4GR-X(C\K\2VG;V4QWK4L[RZJI_0,OLTK7JN5T=;&.9L]>4:N%535LB0 MU5U;@((S2![(!:;5%FF!)G)R4R?*9&-T!".^+V]W6J:^MLFYXT M8UCHM(-<*AJPN58,J\Y"`1JE,@F[%#IR\II*UF/."#%IC\02D`UIO$TB8PQ4 MI589)]8BHS*!HIK'WHG=.[%;'+=':#A6W^I6Q4S66&R0Q?,H_#I-6T1[^[>6JFBFVN]J=4[-J35D\F=UCX&H0K4V>RHY;AT4I(,N:L)3"74\:).$I/TEB)R4!$)V[9FIPK MYWGG=U[1]Y+W@.ML6>V625IHS2L%D*UUO&,SNMRY4&QY*F5/KHHB$//?%TR3 MN)SG'(RU%J%3/X!/A.J4@,R')>!IRO68ZQ.T%1SN>]E=#^\;U&V7U->+=VHK M@Y[--Q;).$ZHIVL-NIJVSG2%.,KM!U M6.+64C<)FX1$I:F?&TTU,M`@4&9$'`BLB*%@"$[3=5*EE>=UUNA7FI'?.:W, M>OV6A!L+:T2?=2(^UV=4&(I+H>PW"^+LELQ1EB@\QLIH&D:S@@?RFDXQ,`HC M/^>3DD*N5GM%]9M9!]H/O?\`6:GN[RE^L;0U64T4GJ[#*;V@T2D\S@J2/R"3 M-#0^I':0`>Q/@8W)U!R"1^*F#;WD0TZEE0F$DN)!R@H+*7UF9M'6KG=\;2[% M=Y)$MX=C-,*9T*J.NJXFD055)6\@BJM_NIWF4/L&"KUTH!7:_P`"8K5ME@'E MN;DL(:S53:@2I"R5`1F*"Q,Q$5$VQR@:*[X?NAE5O:^ZMZY0+=?6F83=WG50 MRQTF[!%GB(.;HB1-PL2)H73&,/"8U0W-Z(+FAP7E`:K3#.1+B_"GX$S"S/7M MF9J62UCW3NX+=I?WE]F764QS[?CO`8XI$96L9?XH@9(E_P"U2N3"C8)6O>FR M"EN;XY.>1FEEK1-;; M5.FH1"R(J"7P]N-D;(Z1]OC=I52MFY3^&%J``#_WJ0\;IEO$).H(";U%Q@LJ MP1VKM.FWWNJ:.M'6WN_-;:1NF+^9EH0",R9OEL8^FH[(OHE8X6%+WQ&3]-1- MV?8\O\,UNA!O63*S@A\)U19P,(@XL,SF9EJ1E.IO>0=VWO%LCLMH!34*VHU] MV^?#9O9-..LMAIZ,3:<,8%.)GAT MB>L3[6]2=!U8GHRBJ6I)(Z&O:6G:EKFK$ST>6(DYW3U]#F:)$NAQ(C3Q%&KR MVC!H@Y&/()Z2['WQWG_=J[%5?5Q,LJ&@9-'7"WID. M65ZS"BB1HL]#)P'"89)*&F5/_B*`LQ26%L1+1!'TX!CPF>KF>6HF(ZS'ER>_ M6U(VOVEB6I2[4RITUMR^E+T466],JV:P&%HTJ1N;&\YI&K4SR8PTE;%A+3:DT9;E@# MH\Q"N'&2MB.<2AI;$6R3ZL<7-@C!RI6004A6&G&E!`$@T6<%B9T5U_R4*J+N M3=CMP-C]P=L-Y9C>>H?HALD<8F MR/M2%'D]*/I:S##"Q@\!D"FO:(B(C+JZ5[KO>W6V@^]KTAB55NU@4-=T9$\Z MES]TLVF4"F7REJ?V]H):75B'.6U='9%+X*M2"7+G)"TMV#XR+&,E^'3EB5R3 MVB9ZSY6U=^ZB4/?WI,ICEV'S!0TQPRA'XP(6.*PGM^5WAM7[M>N+:IW1+6*I[SC#C#+4K6LF^ M"RN,NC[%9*I:1Q9>X,K024]PF02F,KFXU@1I#$>4ZXT1:090#@DGA,)+L,SS M--+#_JKWF/=I;N;.7_H-2D*VLUYW`D9\WF%9/,O:XS((1,5;J^2$W/( MX3-=RJQF575;KJVV*ZS2HM>D$B:UI)$C30Y#*I5!FHX*P#<00F:SSEX6TA4) M4L&L7F^!$S$3%1PUU,5+=^I`=&'[NJVW3*NGZ$.*63UPU[%H[6@12,BKI=*7 M222`.`JYVWDG`5`%OK?M:Z5H]USL="H?W%E M6UC'4EJMVCFP<5GNQLP;I1$(ZUQAM46?5U@S-\9T4S?8V^R=D0+4+QA$2WI% M+D5<)>(EK0@!.`Y@QHXHW'F'><(FT6/I81.>N(H(25$ MY2]$N,P4IP<2`HU7!':+[7Q*08IKIWGG>$=X/J3L[N'KK#=0:;TX<,2=F9D< MXCDOD,SDY3B@D2I&VIVE^D#N;]./34UEFF*R4"!$W)SL$'*%>1!$RE]8B8B4 M3L&O/?(:@=X?O?LKJWI57MQ0S9.R)8:PNMA7)4+0C51`Z;+I*R/3,V7UGK$3*1=U*:[XOO)=::.U_NS4Z&T4<_;9Y= M+P=:^MZIES#%:*C4>@2"'2M>D573+7.4''R*<2IP4MS=XTK!F*HLX2]<\GPS M,D3UB9FT,[:?\?VZ:+:*/NW0:VKYV.O^EK=@CM&H1<5DUNSMD7A\;"M?4[O$ M7B0J8&UMIK+*&%H)$WA6@`>C.,R`'6)"$2ECO$W$\-HW?<%2/I,( M\(5C(\)9ZS$3EW'?%:F[`;4=V^AH2AH#Y]VR3)J;<#(IYU0J,=5'%"\A?SOI MV92..QK/B&<_^'"S(C?_`.'@?$\'68CM<\,;[S_0^YMGN[CI:"T_',J-KM<5 M=$3ZLF=/(XFQ+PS"),[7$9BR)Y<_/+?%$@4+4YJG``S%P4RA6TI\`&+.0=*3 MK,1,WPR;NUM$[+U0[KZ54A.8[A/LE;[#=TWM%G%(F)Z4*;-L)I27:&N8]4M].K6^0Q^,.13\[)FU*VO+5))>WK MBE3`0D4B$6Y*L!,.$'(@Y#D`:Q-7CAJS[U+3W8S9#<7NC;4I>N_/.!:P[+JK M!O)^\[8+'?,B(&6EK1(P._T7*Y.Q/,EZ6:OW<[Q=G3N"K_M.IX/KFDA,D^%Z MS$1VMFG?%]WW:^Z4`HZR]:Y,W1?:74JQS;/IDY[6$-[4[F+%$<&M'8BN.^_[TZ#0[4B]=8JLT[IX MR3QEYO>W2YS'9*3)O-E?A4F+8(NTS^4O"Q"4N3Y<$[:DP>2H7I4N#W5*GSUA MLRU'KUS$VVK]YEIU.;'[IRP]+]5H4;,).TP77:NZKAA\BC$=.61NH[4J);X` MZ0S%XCD;3&MD(A9YXA*%9'ALD=0O`C1@+$GAF)_*Y8Y8$SNG3*$#FH\,L$28G M$85TF8>")CVN>+:>G+_C2/8=&L`17?>*[9I+4Y,_)UV-FD$#2(KYQ',.RZ!( M\FD%,A0S7!NI:7)X\*3%04V1"PIKWSQADNR&G7>NV/2/T9C6XFC5)TC0JQNDILGL2%VG"Y1(&ER2,* M]3&4J5F9KXG+@H*=7\I.F-$%M.P669D0A%XQD>&69CK6)RC[OL],+_W&1Z6- MU'5@FL]OK#8Y',[30+9-`(^C:X((IH(<%BM+/9)'R'],<00<`Q(D"K/,!TXR M5G`L=*3K,1=HF[VSNR9'8+GIE8>B&J-=E3BE=@$,UGQE2%TU2$C#"D"B/OA1 MN'![?:V:GU0F=XX7E(#*DU0E/'UBO!@,.'E*]9YN4)7CK]WL-"=\%MAO1IKJ M'!KTA-R5;7]4L+G/[9JJ-LRQF25QKV"2.*9B7W+`YBA>C`Q9_9Y69B/$JXZ-Z>[&4[WJ/>1;( M6-7?F[2]^?0OHFF?G;!7?SK\4>$2I1_[.L4G#()$+_UDA1]/1T8Z<]& M.3RLS'K$>5<-K]6>\/U>[TV;=Y1I#3T5VAC=[58Q5O:E6NTLC\/?&`AGC->Q M4U"E&]OC$<:A6*:I875,X(LKSBS_`!I.H2@(P`X;S:Q,3U]9N6W_W M@G>![B0",U7O4W/#%$$30-UF9D);&RL&!L2>- M.7C)YABHY44D"$O`Q,Q41'#O.[[[I]PAO=;6?1.T.JU0H-H90T[`-L?72ICI MFPY:WJ):PK$5=.*.Q6%PDB5`>@.Y[UEU+74&X`NRF>\%3VLXPA9:=%B3(*9,B]I.*F6M,E26>IBRIO!* M;"\`)!E:%YRJ&<,*3*;`#A/"W'M,WX3%W[OTLA+BM"%EM$E>6ZPWX\AE4)$*)]8&5T8F<*\N1(?%CG)2B M(4C4@`4,8LY#@5.7[2G:W7Z$[`PG5F4V,A:+XL."OEF1.!GLTF-$N@D;+?S7 MF2KI*E9#X>P(4I<6<VI:#4VBQAW=8[4<:A2^R"VMF!^TK4K&Q*01G(`"%X0TH`UGK.4UZ^;,4 MSM%$W>84U*E#\DC,D7PN9L;W'9+"9K`YJTED&.T0G,%FC0PRV*2%O`I!D1"Q M&5X0`@F%9,*$$>1,3#\JCVBH>]9I=]>558"64S/7"9`@%TL7T))V-1!Y6:)U M`2WJ#Y&R-"-X2GC8U@2UK<8L0F"3&8"=G(<\%3%([J3?G4F]DU2+:FMU/,4= MZSJR:UJA8DAMAMZ683.HHJ[S>P6M,H>8DVDMR=CBS$J5@6K1)D"X)>`)#CS! ME@$)B81FL[T[2U#*G!A-L&7G1EHGX*L=[K0TY;KCKDU6&8XE,WFLX;!H82HJ M1,J+>3P)#%`G;Q$H\70,\.,"R%9ZRR*P>\GU#K&:V77TIF-G'26G7`MJL_S. MUCVCLF/0MP,C;9+_`!9ZFE`1>!4NL8^\;U.D=9YM9BEMB/D?23I=6,C8HSK]L#,[)@M M@-B`YR<(K8M40JL)%9$`7)D1.1^%=VM(D,P('@SA^%+ZZSUFZ8POV9G+&F#19)#ECC2"0,Y\AU,S&;$FCG);>BD2JF#+['GV%>O,6CKQ&JS8URK."$2F1+6LIP4""4F$<8 M+`R28!KO72=Z>H^>^HI-]"YA MIJDISCJ[&6[Z1^D_`I3#_%_`8\)P5-7X1?,N\%U"@+QL?'Y/;Y25XU(0P!QV M#1-T'LF1#@">T#6]/!R\&1R'.Q$L7/"ET(*&E8Q.:E$:+(%19`P#P$5.'"8N M\*U=?VNP'TMYN-A8JNK6:6[.GV=ZI[75LR,D`KUJ$]RUW`[V%2<8;G9@P[*PP9WN6L8$QR]:4U=*KQ9N4J5(DP1&A+R6$0L+/68<^8=X%J?": MV0VHYV4M<(Z]VK+Z.BK3'(#8LCGLVMN!R5ZB$L@T(K5HBBJ>RQS9Y!'U9)AR M%N.0^#*\/@_*<0#1+*EG>OVV=);+D3X%:/DA22*J'A&Q6E`+&@DVJ>R:YYLP)E`;'88S*&5(^M:8Q0B5&)O%5)91F`&9&2<`L3%,)BG>!:@3K6Z>;=1 M"YFZ0Z[UDND#;.;%;8M/3RF%=%CT"=[(,C/FKB9KLI_I5,87E*W'A5)U!9Y& M3"1A,R*FZK*W;:X(W=N0.K>=XP@K_W*A8V)2BA9"#.>N,`1+/6 M8>%/\`YO!4I-V#V:IC5N-Q.5W7(WR/M,[GC;6,/*C5 M=V3:#](IV[L4DDS='6N*55$9K*5"E2QQ%Q/P9A'X`.$V0B'@8RPC$1,\(EB_ M>'Z?R^#W78+7;"M$R:Z1XR6W8TRNL[;@E@U]%P-Y[H"0.]3S>!QZTCV=6B2F MB3*$K.H*5#*&63D9@4QUKB5D-[G>$"@T7LJ45\:SR5J M)WHU6/!YY7EA50M- M(*4MR*9U?+8TU6$WJW\D\'T66!M-$ZF"\$D\,<$1814W3L:)WBH/82>N54Q% M39,1M%NAJ6QRZZN>FK5I"8/5>*W`II*G479[3B,5-E46`ZGEIC5;?E2`@TPO M!O4P:5D8F)A.-QW#7-`5A-+FMR1>:5;5XS&R"823Z(?7[Z':"3B2#%?T/&6Q MY?G#JFJ`8\&E2GFYZ>G`>C&>@G.&&Q#:.A9W?UM:MQ:Q&]RORC6:*2*SJW,: MI$V.C`Q39F9W^/.Z-P=F="Q2AO.:Y"@&I-:%:\+<8M()5Y(.-++$6IJ_"'I/ MWBVI4;KJH[,)G\@E[7?KS(V"DHO7]7VE-K1M)TASLL99<7$*F8([.:1D:G)Y7 M^,^(M#>LZK/%$"8Q4I\4:VM,M>:LU!]&HZC ME,EA5AG>:YD<#,UGF_)H@XINJG;C1*_%_")L'%&%&#%3=>422[O'M2X78$OJ MYQE5JOZO;36JCCV9U#&*P8F4XR&L:7E\;+4O$.DJ):$G"L1I8 M#NH8$!H#``6>LK&+[SJYFI=7L)(Y*;$*C;H0;8KK*)Q'Y/!U3+$B&_+H&S@&16:\H.I+?/7N^;!0U5%SK3B%A/<.4 MV%$HO0=":@*<)1`C+2A451S!J0?2J49V4)IQ@"5`#>IX/K"")B8 M97L;N;K;J8*-%WW8AT,/EK?)GEF2-L(L.?+L1V&%MALNECP@KF)RU9&8;&`/ M*7*]Y0Z55Y`:WLV77>A;(A;C<_O<`4$PNR7=\>H]%' M'+3*)2IAS+#7&8L$1C:_]A>[.2!&VH\9P,T\`,X%D5,^'<6[W@^FE%+H`@M" M^HFP&V=$&NQ(>I0(I)+&M37#VH`D9[*>WJ',<@9X?6[FK,P41('@]`SFF=(0 MJ)+*$"<)B=,:66%1@TP0"0C,"2F.5AM/05RVG=%)5O8S?([5UZ=FMDM^ M%9:9&S.L27/):DQN$$;^S-2*1-YWBHPB6-1JY&49T`,-",00Y+4\H!5=Z!I4 M0AK=P0V//)23;=8EW-`B8#KCLS8[@[5B;(7"*`EZ]I@5/21TC+?F0M9R7('4 ME$H",()Z=ME,P&_P6VH?ZOLZQPU!"G*$UM;5@R=TM+Z M*DST;`%=;06"2*RV&5)&R'N)JA&XM"0Y-X#`3<`$:2$P5-U67%%WC&IB6#26 MS'Z6V;!Z_ALDK^*2F769K1L[5K&Q.MH.R]BAJAQ6V+3L7+(CRIX;A)EKOG_U M2SFG)L."E+XVE\,L]93^BOVI'*[W37%LEP'2Y&*O6ZTW^)-C+(G$B/0AX=C& M5FEQ0\HFU8X$NBQ,`2DE.-/C)N!6+\)BX0X#@.`X'__TO?Q MP'`#I4T%R"22$A!@DLK/B:90<,OJ$!426HQ$RU5.=5WC?-6 M:-:A31*M)VATC=M^:):).U%.1S.&U]:JJ@MC:H3>,/KFS,JE1%GE$TQ0M(XF M$ISEI91_7`4=DT@LMQ$S/B7(>XI<&^=D1/;1DA87M.@M9068N&WTRHR`:ZM.G9M7S9HGM96BU-T?8!NLK(<8HC8HK"ZN>V4;UYQJ M3T[8(AM":4?@W.`A>"(F.U^'4LM'6S5UX[J;KU2VO,QV%U,V:AZ6SCDD5Z M/:7[";`K7BH:DL/NLVW7.$7T[Q%ZDL4J2[8]?-CV&\L4S1)&Y>7$#9C&7YJ7 M)#G("1`ZCCPDHSLC*`'A9S<1ML<[JNU)I:-N;OKI%-D]RQPI[H)PA&PYVKD= MUD>KT;ET*EC0Y2A2D:V)H>K"CS`XQK+*SNS@:J")(W_]ID*88,C,S%4U52EG MNND;8W+LFCHM)C9-O=N%MQW>CLO;6Y5E/&)_.I37SMKI="X@&"2S$4%:)-/\ MFN!V<$ED")"(>0@"'A8\7X2?KC2;C!IYJA3-<)W>)-4'[R;OC:V@#NW%?P]KH24=WU)JU>BG*R+$2R0;2ZN+T8[5]*($.J92N$9)54M.*7 ML@41XCS#!J>DK(F)N_"4*WHW:F?W?WJ1U%;./FMIRN_FEM:(VU4]65@,[U)A MZH4L0B?$+_8#4DW:?L^P7.WJIECTC32-37_`*1G9YP]IAN` MTJ10H;C4^ M,JIR.31#-K:9V60D-KR;&49$C;V-N=3$A8'8I&/J9ZJ7'6).(B/+7<[DKV'_ M`(_.F)R]TD,"/C'>3-L=P\R&!H679Z).;E+D\:<&-_(<%<41)QKPIU+ MCM.D;:20;O*"=R(I')"]/FE>I6J]S*$T:;CU+S** MN6;/[*5OL-!F=0'J$&*U],V"XN`B!"S@1C>1D>.KT=+RL?UK:@LCK&?1JB^\ M?L*>-+XSVCLCJ1I9M%9RM.S*%2]KG%V[DVM9JIB*1";U))[A5T*=FIERDP08 M$DEH+#DKJ=`>%QB/EL5FVRM:VGK+O;`XMWCMR[A25_T*VU)8ZFFVNE?5HWD+ M4]1/RPC8)0[62ZV4ZRR<26(LC"A6R9M(4QE$ MB*5#,=#7096.L7TA,:*KVF4`TN[)-=;"U9VUNB/OA&OE:[+][?6LNG6(W('I M'1LRNK8YQ.@UE2%O:$:QP:8M+&:+N#&>\^+C2I`+2\'#`6>`>"SFXCE9?9;< MU%L%5NS8-)Z81+I)L$EH[2ND]S!LKG$R[LL>ZG&9-LC:V-W/@C=+%]8:UUZI M=GOSGPO6MR=T5&!1I<@`%I$<`WK#$4`N M)F)^7HGU*WCU7Q*3DHI08<+PO6"`0`C$&L3"A50:T7);.VG>4R.$[=[`ZT,Y6T\218CE8 M1VH%K%*3@:U4@8*3GJ;,K&:.1BWH,\3SXJH+2X"FQCJ>$ZXLS;5Q48M2#N[Y MU&]+/<\V.V=;'^)4K:_=O0FCXC=KA&9&YQ2G9]7=QV-.Y?7<_5-B!P%`$MBM M$C;W%O6+"R$Z]2VG$X%@1`\\$YN(V^K]L&,6#<=I;\0YED\?U(7[L=TRW)K. M5PN8-B"XU.N-KR9_M^[6",*F8B4N\1A$<>T;$2ZE-QA;I]&'82B-P3GI$<5Y MJ5PMSM_-3+<(TML^NK252:#4%WB5(R6W7U-7-J(PPQAD-";7I&AT5-SG!T3L MYI52EI/!G*$A5DH00X,P#PA?6)$3GZ5ZW%G+)N$Z[Y[+Z^1V6/U(P'NEKCU[ M=+870.8PQ#:-J3>PF>PV.(0Q#+XRQ/4Q1UW'8NN&J5DEC*2*WL)!>?\`-'DP ML8J)VR5WU\L^3;5;B[,T(T*`;/ZK,^C-B4ZD4%+4:*WHJ/6A4AN77AT/*`'Q MYGMB,H<(R@ASTI']*W'=[M^Q24Q/7-?77>-5B MIFL@CD@<"=<[2MK>286/%Y%832T-CNKAR*9PAC6Q\;OX(*,LT[`%1Y1'@Q"$ MYN(Y<_%FYNV/]X(ALY7.MYJ,6U+J.XK]AJ>UCC>L-L2QK;KKE'T[8-72B,PA MVDMR,.LJE@2OK;UP.27*UL7%)B,IQB,/%56UB-:]I&%GVE)D39MH#?O72JM8 MM@IS:.P4QUH:4UO:BL$)'!W[S7,NFMJYC3A.O2B2UK3%D6+;3I`<]-D;3:G=-;/3&OCE,FC]A:\(Y9#52-L="53XP2?,>>V-:0T+4 M:5X3C7-:PLWP!ZU2TPL298EGC`B&)I.$4I$W29`D,)\$,1H^%N M*B)X5UT4L:-:Q)>[^V]V(C\BB&ODLTYV(I!#:CNP/+JPT=;#WMK*K33DSQ&V MHG(^$$V+!TPD13P,DLH9J'Q<9G@!F"+$YN(;B:+W7U^F4FLVYFNJ05O5]NWW M2^O%2[*D0"5@D.Y%C.T?\WFAQ7,K95Z&6M\#@SUD4;9Y,^JU3*:40>,*E$F+ MQ@9)CC*[U6756EU%V";6DB-D(*LM.:TK._#,,D8!L=EUXJ3HI='<%R5G9S'4 MIL/5E=1>BPI;5@!X&F4'`SUN5GA2VL$2POO6MMW`:14!`HT\U&3)UHR#0I#U M">Q-D1J""5.08)-.(`>#(PA%D0<##G.,=..3RU^L-*X-7;N>.YYV3LA!MCL3 M&8QEKWP=`:Q-47J0RO5Z-NV,O=,?'O"N=7KK/&W38:02]3DMXPHR8O'XL845 MX(('AJX]HPD`BZ8G2^ZV\J6;[YW!I?F2KM0G!G8(+0RZQBELM]$S52&M"2 M14G$RH=;JS&^QELSP!-^:O26>U0(YS30E\C59M3"./I"<.HU[^6M\)XJ+.,) M.O#<1J'?4AV6T3;K+F$>CT,L)3#K*C,\K2,,,JC2>K93&%4C90.U%LFP&JTCOO8?8_4EFB,%V$,A]V5*AC#97CG(Y=Z+VEPK^7V( MYL4^8TG7-GS*J7UK<[,6UWMQ;3ZQL$BK]HCQJ.)6E?-'O40=R6;P16'X:3. M,!P8660$LQ<5&T`:QN:+22C[NKG/#,?VG^4(L]1V+`K.WDWXH^+NSG=.M7>,7,9,8.W)%)+AL3J2_45J\LMNJD MA8?!_2[XS_18I)$AY`IP5(&O))10QJS`Y+C$3I!/=_;!U/J3)=&YGL/(7.MH MT\=TLV0E`YK(7.7T)DKSM+(WSZ#/312-OJU$M^B4)I_0>66'J!_QZ+7=6TS]%P3YQ$:Z:-1;0KAPOTRIYE7$G.0& MVC*8X>O`0],2HT],>0>:GP(W!A@^/A>%UW2HM?JSL?&P;'67WH$GGZ*,5%": M-G=#Q.MUTKG-N$R.+Q&O6XB"471R)P9I2M).6.ZY0-6>TM[2:H(,),P`!Q*S M&*=IW15?2K2R:6YHWL.U%.&Q+NPP.]F;8$A3('IJV'K4F&QR`$Q1'*)(84JA:,Q?)VER`8@+,6#:DY!G6-1X4D&&%&%EC&86,(2U.'7->V^N+W2\ M'V(9K7CSM2]D/T2B\*GS:2[K6I[D4YF"6OXRR@3)FTQU0N*V:+"VTTI2G)$C M5=8"G!74'D(J>*R@QR[TO0)DL21U6_;*Q".S.(SQ[K&3IY(S3:.L#%.XY(3X MH]1URFSW%T$(3*D$A3#2B,$X^`$,/2$>0]`N+*G2S]VWW4VN<".L^Y)8&(04 MAQ;&DU]"R2.1APO>!C+;2`M\39WUV,"I&#/0,)&2P_XB%C'"[REJ M"4.D?V-;%[9"XZ^RR4.(J_MM&@9V"-'%)WU:I5KX"E3C&VJ#PEF$%B&HZ_2' M`,YQG&%KZSI=F9VM7U>R"MHK,I*E8Y!;TL50:N&T]*XGFRB5HHT^3!4SI342 M-2G2'%1N-KE61J1D%9`GR'`\CR$(B*30OO:^[VL1[B\>A6PR60.LT>6B/Q@I M%6EQA2N[L^N!#4U)B'-17A#64!6O4@+\*:<`D'3TC&$.,YP6ITME>NQ-+ZT1 M!'.KPGC=!(ZYOS?%F0Q0B>'MXDI1*7Y60D.-`C;D:E1X M$DPSJ=0`Q8$1,\/PH;9&D-G(LYS*C+!:YZR,3\KBTB"F2/#(^1>3("B%"N/2 MR*29M995%7LE.J*-RE<428_)1@1X#D(L9R)B8Y=&?MSK2EOPC5P^YX07?ZDH M`RJO$Y#\X$R$/7ZP@XR68F$JQ.Y*TG-AVO5$4E:1XL&CE< M,0VK&B4CF2JAZNPHN3,X:2M5*T*=N6B?(PH`K+RD.48+`+JF9`/I#PBL$V[S M#1ZNV*!R677PV-K-9QUCIX(J30VR7HR0F5'-55=6-XNB8H:YKTH(M-$9B`X: M@HD!A@>L5DPO.!Y+4Z2?7NY>M-ITO86P\)M!$XTS57G1FP)RXQV81E#&@0N, MM\QDQJIOE,>97M22UQMU(4B&G2G`,P9U"\C-"(&!4\,B(V@H156=27&ELIF5 M5G>TCK>(U/+4J9X4H)C);<=4C%7K,D)(;3%Z!;('E:6EZJPE-A(?G(%.2<@' MU14L?V/W(UNU')BJG8>R2JZ3S8J2'QH\^*S>2$KR8B!E,D1QQL.C4A`V%-@) M"CR(2O)&!X-Z0=;J&=41$SPCVK.\=TMNHYF(K2[D,D,D,]A-8,610RR&0MVG M5C,$\E,+8$!\BAS22I-?6"L7U2`\(LI2@(,X-,`(TC!@J5F_2K7_`*5O0?YR MI?2IZ/?2KYG^+.'CGH_\Y/-'SE\<\3^BO%?./_M?!>,>,=?]KP?4_:X17#:# M<[3:C3U=/;&6LU,SO.X0]*G2OVIFGLRE8J\<2CV)XD+VS5++@#!JW'8A'%S/84=,`M@+?$ M%*QMBL93LA4:2K1%4JH-GK,:EV+<$3922Y!A:YM]BJW&%NEBM_P!!.#:D5HO% MET)9E+B4>>820807^R/(A`"(5.57JM[T[0"YY7%H37FR\.=)).7%,S0Q$\,\ MUAB:5O*[)@4#-'G:;1>.L[N[N!A>0)TI"@9YYG0`L`AB#C*RITY=G=YWHS3E MBR^IK%O5*PV%`G!(U2^.D0"U7\UB<5S2WOB1&J<(U!7AI&<6E,]H$3FM:#'!$D?FYJK6K=TWF4F`XO\`"X:L!`V0183LR6SI(>GBM7Q@*?)I0U'G%/WM MN1B`7G)G4.%D(19Q@.2Q%S$//?2597IW?$R#7%XUO"ZVB6X6C=IU)(Y!%[G- MMG-D[>T?$+$N%7:DX7.-8UN"(R2UXY/I.G(;2#WK*D]"47E:>866(V-S4\3Q M*!,0Z::F:B]WU#&)M='O5S>A[[KBVF,1'AU9%(;;M,BUYEMILQYJHXP::';" MQ9H7R9/@)@@)I&U.`"R"@*^N(Z?BTZ+7#\,O22=B@+"VN[[GJ#:6N]N> M[,=+WW"]XR.KMK9<@9XO[OM=U%]!O6=9;S48?_IN'.:Y3U8"25/T7X<(U`>J2+/1C*/L[1F?Q;'>]`75JRRG3>1S6\Y MIJ7+X_:\_5U#MFGCD#DM-5+.'&LW:.JXW>B2QR114J/6E$GIQ0-YAYR'`5B< M0O&R,!SUDIU\X=3W85LN=H6QN\!RD]#7X?&I=2:)5NGKM$G*'0K9!P.@+NF$ MS/J`$GFL*63JG69K0HEJF/.JUORC=$98AX.*'CB#MX:,[/VC4UIMO+MR'&3T MY(5BGFT/6UU(&`MV?=H-*E4$E2E/YSQ8#BZ;) MU>;&)`>E;'%!YPL`5)Y"D1:=63XVFZ<%G`Z^!X2SUY290.HUW1[9EQVYVU5LI8_>?=[*?0>UWNVI&F4Z5E25%Z"X%#J)\""H\8Z1]&0!Y-K-5UPUQ4)8)E-Y[N5ZE&W5=:O." M>MN]@8'2\K/A,8>XW('4>_\`CQQG!&'J3QAE;7.4*$0UA6"E8LIP)QE@`(.< MYP:G-X;`]F+T=-I=?Z+U$I"_J>WYGNS6PC@TV+((8X,U,P-UH[7I'%[RN2`2 M%]B`+;3P@YX:%$=8#E?B;@,\F3!QE,/KX+&2(J;G"H0K`==<*A'JGL6VQ.D_ M="[VW2F]6-K(F^91`(+JI?=_DW3'OHJPW>.0A1*(Y5[V3)FUP4WGB*P/HR/!0LX_PSRL5,3%J'[',,TE&FO7#KJ^J%U#W^[Q=5MK8,+I"67.\4E9-16%:CRCBKV7P+NXM2U5;+XR:C&H"46$'BW&EQ^4 M^*8SO,T6I!Y)WI#9LK:,+G]P*M,=)I'7UE0NNLU%$4M+I-M75"[D+*U622BEEVVIB`>\[UXV^<'"( M/)S15-95W`H5)DJU`N:%I\NPX1JPY8XKV]H:B%)!J7*8!8LK`FB,#DH(1DF* M\-=O>Y?Q-[R#_P#XV4W_`%=7IQ*]?'V_!XB M3,S.%"2-U8]:_7FVV)KPZJ#!B5854O.9*D-9##1GC41Y\3EB&#Q3`.-',=I5 MTC>R6N5M=QO2&EE>SZ'6KN+-*^KBOZIHV&*T\EM"/7-BQTSFP2-0WH,'*8(5 M!"2#'9:\*QI"&]&G,R(SI&$LQX6I]K\+%L-^HJ/O\`WD]"Z?.2[9&$ MN"B(6C6,'DSI-#@ZU4DB439J')[$C*IK:5)Z424*4L"@H!B<7^;G.( M"W,J1*V(HTR-*0#(" D?0G8'"$J&XQI5-V,!\04HS$^<8R7T("1I1%9(3"0^##X'( M`A\%U<=7HZ.!Q$L8C2%R.>44>8T;PI&H,4.J5I0)W(\Q6/)BHPY<4G`J-&I, M%D1F1#SD><].>G/`[S@=9EE9A(%+6)I;!-BP:@Q6W90)G*.-1J!%&$"/2& M&`$-.<(@T8,B!G`L@%G'3T9SP,;(K^!ICB5*:$Q%.H3FEGD'D1MF*.(.*'@P MHXDTM$$99I8PXR$6,XSC..G'!<[=\ZM+4^MRQG>VQO>6EP)$F7M;JC3.#`0-30A3-K:B M)ZPA^!2(491*5,5UQYSU0!#CISG/_7@?@;'F`]6N7GL;.0XR'HZ,<#G<#B$H$*94M6IT20A:X MB($X*R4Q)2I>)*3A.E$M4``$U4),1C`"\CR+J`QT8Z,?)P.F5PR'KRDQ"Z*1 MM:0C$J$D)5L36H*2B7'B5+1)BSDHP$"6*A9,-R'&/"&9R(73GY>!^[9%XTRC M`8SQUB:3"_&/!F-C2@0#!XWA,%7U!)4Y0@^,A1DX,Z/_`!X*!T]/5#T!].,: MCCN,XQVC[(YF*2B"%!CBU(%HSR4I@S4Q)PU)!HC2DYI@A%A%TX`(6#-$'H'@6.J+./ M\,YX'/$UM@RT!(VY"(EJ-)/:RA)$XBVTY,08F3G("\EY"C-(3&B+`(O`!UCY&(U)P(BY)'F.0EMJTIR;BWQI0.P$#B1G`B%Z(*].H"E6DBQT@-+Z MHPY_PSP.SPB1X6#<<)$V'`Q,6B&OP05A8-&4:8>4D&JZGAQ)BSSAC"7D74P, M>2?&!*"$)@B0#R+ MK!*%D&,X#G..!\+H\P.AQRAS8V=Q/4H0M:@]!V"QE9G`2D:]I;%PUJ(#:L&L0)5(E;<6<8H+0*1'%#R> MB+4&B&$H72#`Q9%C'3G.>!R%"!"K/1J52)(I4MYHST"A0F)./0G&%B),.1FF M`$8F-,)'D`A`R'.0YSC/R<#KFF,1I@,..8H\QLIJ@`2SS6EI0-QAY81=8)9P MT:!PUT(A;HK.7N<0B[BN4B")0M7,#4K5GB"`)81'*5"0P MXT02P8#C(LYZ,8QC_IP6[=N9VAH"8%I:VYL"<%.$X+G.>!R^`X#@.`X#@.`X#@.`X#@.`X#@.`X'_UO?Q MP'`G%,TI9M-%KYD>Y+;'1VD^WRQ9E,W<4:A$ MD;4+@96"$QNC:%/AXZV34_C2E2L3E)IMJH_'Y0737>/[07])T6OU6^[:ZW8N MMVVHZDM^2UG>\`J]56E/4Y2]EOSJX:Z3*9M5ZQ*5.4IN]LCR;#D\EI#"DZAT M3!6)P!($)B(SX;/M<]D2;GU0JS9:21=XCI\QKQJE4JB$29)-8KFRR`/2W2=E MCK/$&5YE,L3M\@2J"DN4B$U0>G`$SP>.G/14F,TA]=WG.IK9,I?`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`(528F.5AN$. M!__1]_'`'VA(V#.FKM, MENSZ23U*DN1:2]5NBJ9=#A($],%TV@AN8.V)2"DZ.))E1"I*4M+4!6@PHX+^ M,+M5!5$*HNK8!3E<-IK3!:UBK-#HPA4*SW!86U,B,M&0(7[X0X#@.`X#@.`X#@ M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@ M.`X#@.`X#@.`X#@.`X#@.`X%`])?XI=Y+_O\7_T=:=V'B/;%YH`B&5G)>< M]8/0+&,\DM=8N:EY"*;_`.03WH4Q=-U:F,4-+W) MVML<2"U*>+%GIQFHU0PX&`01@SGIQG&<\TY'`6X+C&V)X^E_HAZ?T65.%+.TNGF^O\64J`EDG^)*.H(7@3 M.J&`"V#H0,&3V<*[ZA#6JQV^@$EA"LJ&8@RI]ZYI?T*GEF7KZ`/=O"$##XL% M1D[I`+'5Z<9X*2R0>2I))4ICBE"=046>0>08`TD\DT&#"CB32\B`848`6!!$ M'.<9QGIQP*$ZV_SJ]Y!_K+5_^G&-<+/$+]\(\:;_@V/NEIU@2>\HXY[LZ]MWR% MWQ3<41M>SD"9RP#'XW<%"-(B6.V$#:#(0J'N"B(=!E%".''1"R(7#.)XQ*\% M,7K3^P\)26+2=AQFR($LX*&:;/9$P3F2+O3295GU[@VPQVX/> M"ID-_15"ZHY;K<%\=#*/2K"'LT_7Z.G-YJ9MS8A`6<*!"()`@X-/\.(/A.D' M3U<1<5&%Y/1WL_\`F5AO9[1^U#E2XT>CO9_\RL-[/:/VH<%QH]'>S_YE8;V> MT?M0X+C1Z.]G_P`RL-[/:/VH<%QH]'>S_P"96&]GM'[4."XT>CO9_P#,K#>S MVC]J'!<:/1WL_P#F5AO9[1^U#@N-'H[V?_,K#>SVC]J'!<:/1WL_^96&]GM' M[4."XT>CO9_\RL-[/:/VH<%QH]'>S_YE8;V>T?M0X+C1Z.]G_P`RL-[/:/VH M<%QH]'>S_P"96&]GM'[4."XT>CO9_P#,K#>SVC]J'!<:/1WL_P#F5AO9[1^U M#@N-'H[V?_,K#>SVC]J'!<:/1WL_^96&]GM'[4."XT>CO9_\RL-[/:/VH<%Q MH]'>S_YE8;V>T?M0X+C1Z.]G_P`RL-[/:/VH<%QH]'>S_P"96&]GM'[4."XT M>CO9_P#,K#>SVC]J'!<:/1WL_P#F5AO9[1^U#@N-'H[V?_,K#>SVC]J'!<:/ M1WL_^96&]GM'[4."XT>CO9_\RL-[/:/VH<%QH]'>S_YE8;V>T?M0X+C1Z.]G M_P`RL-[/:/VH<%QH]'>S_P"96&]GM'[4."XT>CO9_P#,K#>SVC]J'!<:/1WL M_P#F5AO9[1^U#@N-'H[V?_,K#>SVC]J'!<:/1WL_^96&]GM'[4."XT>CO9_\ MRL-[/:/VH<%QH]'>S_YE8;V>T?M0X+C1Z.]G_P`RL-[/:/VH<%QH]'>S_P"9 M6&]GM'[4."XT>CO9_P#,K#>SVC]J'!<:/1WL_P#F5AO9[1^U#@N-'H[V?_,K M#>SVC]J'!<:/1WL_^96&]GM'[4."XT>CO9_\RL-[/:/VH<%QIU3Y%]AXRR/$ MDD6U-?LD?CS6X/CZ\NE"-R)L:&=I2'+W-S<5A]I`(2(4").,TXT8L`++!D6< MXQC@QI034NK]E=GYA_<"F=QLC"?)(\_UYJFRR:B23SXWK:L?2W%/9P8T?8"( MJ(3?84]`G=5G[2M6".)VE,)0''AR,19F(Q38AZ.]G_S*PWL]H_:ARI<:/1WL M_P#F5AO9[1^U#@N-*@6#W<<]EMJ$7W"=G2J%OG!J43U:]&TFU0QXL!&CR8-. MSV_&CY^[0"XF@`QXZH9(T.2@@(^.M#ZX-V[DWA\6JCQ MLSS>VVI37AQL.E$K;CP02<7A&BI]Z1*(<0Y,QX9Q5(W*)8SG.1.Q/5R'@Q/$ M+^1=EOB;QYGET+VYJ^7Q20H271@D\7I)C?X\^-BD/63N+.]--L*VUS0J`_*` MXDT98\?X9SRIC3OO1WL_^96&]GM'[4."XT>CO9_\RL-[/:/VH<%QH]'>S_YE M8;V>T?M0X+C1Z.]G_P`RL-[/:/VH<%QH]'>S_P"96&]GM'[4."XT>CO9_P#, MK#>SVC]J'!<:/1WL_P#F5AO9[1^U#@N-'H[V?_,K#>SVC]J'!<:/1WL_^96& M]GM'[4."XT>CO9_\RL-[/:/VH<%QI7GN^D$C;)CWB:&6R%)*I$GWW/IL=Y63@?_]7W M\C5H M/&CE`JDBZ&,VKO5(6X]22#,"4K`NE7ZR!7I/&!O\,6Q]RQG(AJ0KO\`YO);V^X=OH7!92Q5)O'78]2[3?%I3)%I MHY/H9/J[;SQGP)1)56WP8@96U`\NIAN!$QV4I&%]!D>"BBE><8-&*TV(!$$8 M0C`((P##@01!S@01!%CI"((L=.!!%C/3C./\>$?7`DO\4N M\E_W^+_Z.M.N3;4_K]+^0?ZRU?_IQC M7"SQ"_?"'`H1/XK')O#9(B$W2&)RUE;I%''Q`,8#!(W9D=TRMM<$ MV3"PBZAI8P]8.,]'3C&>!KQ]T^_=4,"=="[$3/59(QC5J=*MA)$_/57DHP@$ M[O3(H[+7HE/DTM2]55)4BM=!+NB7A$Q@@.46?"Z/"'`U$+E!$B5%J^JK:T)^`$#+6(^59J][R&X[O98&PU-K.TM-VV;;> MS438:]NBR'&"H(C7&M)+":^2RQ5\<@LX>FB7O*V:Q]KRS$-YJ=`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`C#33%:H!998`Y$,PP8DF`@``.,YSG.<8QC'!4M<-);.T+LUM!(MOK M$M2.ME44WYSU)I;#G@Q46!R)7X`VVSM0>@,;>N2X69DG+!%#1#P:3$TZ@_J` MR[C#B+,3$4V1>^/K!ZZ(;\Y6>1\J5)[X^L'KHAOSE9Y'P5)[X^L'KHAOSE9Y M'P5)[X^L'KHAOSE9Y'P5)[X^L'KHAOSE9Y'P5)[X^L'KHAOSE9Y'P5)[X^L' MKHAOSE9Y'P5)[X^L'KHAOSE9Y'P5)[X^L'KHAOSE9Y'P5*';NL?N^=CX:9`; MOD=56)&/&27!$F>LN);DQ.R8P!J1]BDC;24,DA\C1&%!$0XM2M&N(SCI+-#R M+$3'"EF-DYSIWC)]7[#LV]VO2``AFU59\H2LVW%?MA`"Q#+K>X5Z)MB%ZMZ4 MD)N26>7`;'TS."RPORC/07DM7XJ5MH9WL?=^RR,$R)TV0A%7KBDB13((/2%[>/IL=Y63@?_0]W-KRIP@M6V5-V@E$I=8;`)C*FQ. MXEGG-Y[A'HZXNZ(E>4F4(U)J(U2C"$T)9I0Q`SG`1AST"P'F-@O>O]\,KTUC MO>-/^NFD$\U1R-Y=)9'H"NMZ'7(DBT8L9YK&0N90)-8LL8FT":1,9PL&E)G< M8$H@GB3=3!G@YEZC;=B]_TS5=X0K"L,2MNOXE8D>)<"PE.*5KES M&B>TJ%Q*`(8"G%`!9X%0$(A!"<6+&,YQCIY6)QA$$LTYJ6Q["O\`E]H(,6#& M=AX%KQ!);73X1DF/I2=<)C9D[A[LE6-ZE*Z&+E,DL8*@>,C!@DQL(R#.>L/' M"WPJXT]UC#:T4))5KO;LJI*TV2YKJM&,STF.,UA$-4?O=M3LLPK97&)PJ<43 MHT(F]N0F(%WAR5I:YN3GGY4`P:2;*7VWPOW0]-137FFJSI"$&NJJ+U?#F6(- M;@_*\.#\\!:D@"E;\_K@EDEK'Z0+\FK5IH"RRQJCS,@``.?;>(8(XWG#>,HG"OVMT38R(@8'077;B,#// M#@,EKKS$SP_GL:=5Q?T[VJIB*Z[QB3.]WM=F1AWC"!FRI:E[$ZQF0(ERAX>W M,174B[,P#39,<%RK`$Z(D(Q&_)C.,QUF8K/#^H;*=FF*FZ8BEN[,Q234E],N M:=BD\?;FI]NH$"=U87HY,;)'VGF"5)$D6,2,V3!O9Q2=M2Y4$EJC2#!X!S3C M6EDL*TV3BTWAR@JCDXE9:48\%JA)BQE%F'X3#ZI^"BC#P!%G(>@(A8QGHSG& M.$,%I MD+$[7/^82B?\`\9:P_P#.['S+K/$OZ\_-O.*M_=0,G=7P;NT=EV^SY M:TS^N'.YYXWDPBKVJ-6?<4SL.0+E"E_3-Q"(88M)A-?67+4BB0]1,ZN\9C;>V.[@B+R66 M,EO5.9!HTX!XR8`C(`C$(6,BS6)FYF5A.$.`X%!-;?YU>\@_UEJ__3C&N%GB M%^^$.`X#@.`X#@.`X#@.!^1YY*8DY2I.*3ITY1AYYYY@"B2"2@9,-..-,R$! M918`Y$(0LXQC&.G/`J,;9SYMU1`)9I=#%RDDH!RL>!F"STF"%GI%G/_`%SP M.SX$2S"AZ9G]A5_;,RK.'2&SZK-5&5Y/W!E2#E\2"M"9A6E:'\``.1+H`S`.J7QPQN)S>_(O75CRF_*RB M*V00Q<^KHLPZV2&3V2ZV)#T*$EP;#4$;FD3@"QGFZL9AB3+2%6X$F'D]&2,]]UHKKN$69*WDZH&*P%J5G8&R]41],RO$E69P\,#NAE MAV&=4,M`(O*@XH@1I01E=`\BDQA$$80C`((P##@01!S@01!%CI"((L=.!!%C M/3C./\>$?7`GE)S>4W1BKHJNZ!'"KBE8F M4GCS&7DP81EICE?_`,ZL.SD3/^RY?"'`1$FY*R,K.:1@7A"R5)B,X)8LXP$8BAXQG.0BZ`XOTLU>(!=/I-O^C!^#ZCCXXF\0'X4 MX*+B\(H%@L/0+Y1YP''R_)P.PX%!-;?YU>\@_UEJ__3C&N%GB%^^$ M.`X#@.`X#@.`X#@0O,]?1>.55!G"8N7TDYA.5K7J M0+<&-\;B$3C3*C4N+BXNJ]$06D2F8*R[9P[0Q9$$ M,2B%$D-D4:JXBI@C&Y9():XJD[.=+9=,G5Q;`>*JE+@4G;49IR6;Z1+@BSA7HE@`Q.'6,]LE;35$NP/)J&PZ^Z548E(2 MC1!&2I&06O(R#`"U`2\C`,MORCS??Z6XYLKD\IJ=YH!R9D2BOV)HALK8K8VM,\JIS&WJL)E/VUYAPT"KY#AB3*P'DG%& M)@"+STBM,Y17C33E49M^MMI0)RI(B,.%0/PO^282,`^@81!P2IX\M>.O/?9]W3L[2%S$SPD$QA M,KA;)/G3KB`G;HL]/[8D299;/^5DX#@.`X#@.` MX#@.`X#@.`X#@.`X#@.!0/27^*7>2_[_`!?_`$=:=E&6H0N;,W.!RE. MI"+&4IQ03O\``'$KUYAH/1=VEH&?W"`[UQ!XBIMT.H*_8WW@0F&$6"&\T\.4 MS#,/\XQJ\F":$L]*\TWW5%D6!;?=U:B3^ MT53BXSA[I]E3O#N\*A+G=_(852^.,DD=%QF,'KG&2,#0E7GGFY$<<:H$,P0Q MB$+-ACMS*CUXP&!5-9_>\2>PV?82:UC9E`Z.OLB;(O*)4_2N;/;_`&9M&R+J MKK][D9CLAC<&7&N#4T.#4C\$U,S"XG"$6248(>9MK_%3.)0'7%CF-9SR_6*F MD6E5@6W?,[M'6VNZ[G:[4G7*VE>OU<1*CF,^./4%86J3R9\C<6EZQ4ZIHZVM MBB7+"1MJ=.I"2)6,^.6\O1AGN9'H%KBRR)>MBUND4I%$Q"NWH\]2QW8@!2!S M&"+!C14IALA\%*;;DH M!(]$2W6[$C<%VM-BN#6ZG&:_1TQL,9&@C;!L5Q\I&W9"4>`]3S5W%]>VM'9.M+XT>5,'FKN+Z]M:.R=:7QH\&#S5W%]>VM'9.M+X MT>#!YJ[B^O;6CLG6E\:/!@\U=Q?7MK1V3K2^-'@P>:NXOKVUH[)UI?&CP8/- M7<7U[:T=DZTOC1X,'FKN+Z]M:.R=:7QH\&#S5W%]>VM'9.M+XT>#"OR!7OY: M4IO.K,S"`T_$XTS$Q2,;`&ZM/+>JE&)\4.+2#\.,13.JCHC:VFZYB]:L6R=/RANC"123YRV3K_=U@3N0KW% MQ6/#N]RB72/=M6Z.SHZN[B>>/Y2TR?!F"$Q)"8LD@L3,3X2/YJ[B^O;6CLG6 ME\:/!@\U=Q?7MK1V3K2^-'@P>:NXOKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X, M'FKN+Z]M:.R=:7QH\&#S5W%]>VM'9.M+XT>#!YJ[B^O;6CLG6E\:/!@\U=Q? M7MK1V3K2^-'@P>:NXOKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X,'FKN+Z]M:.R M=:7QH\&#S5W%]>VM'9.M+XT>##6_WIVDVWVUFCMGU*PV%2$N?V(+5/H+`Z[H MJ=U0^25^B:HP\^,M+ M?2[NUM];$VNIR,LVN=S5FOC5H1)_?Y]9U4SR(PRND42DZ!T=)!)')[210M(7KSB\)TV<'##G$=)F*E_0`B<86I;G-.VN)&"1&9)R5D(\Z#^'<^:NXOKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X,'FKN+Z]M:.R=:7QH\& M#S5W%]>VM'9.M+XT>#!YJ[B^O;6CLG6E\:/!@\U=Q?7MK1V3K2^-'@P>:NXO MKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X,'FKN+Z]M:.R=:7QH\&#S5W%]>VM'9 M.M+XT>#!YJ[B^O;6CLG6E\:/!A1;;B5[J/,EK[2ZMK]I'TJ[+MDE!+Y+`==I M[%9506NC:G^BK)O!;F1C1%(498S1;I9.5JS`%>$4 M*#^:NXOKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X,'FK MN+Z]M:.R=:7QH\&#S5W%]>VM'9.M+XT>#!YJ[B^O;6CLG6E\:/!@\U=Q?7MK M1V3K2^-'@P>:NXOKVUH[)UI?&CP8/-7<7U[:T=DZTOC1X,'FKN+Z]M:.R=:7 MQH\&#S5W%]>VM'9.M+XT>#!YJ[B^O;6CLG6E\:/!@\U=Q?7MK1V3K2^-'@P> M:NXOKVUH[)UI?&CP8=2_)-J(JQO$FE&R&J4;C<>;%ST_R!^U?L9G8V-F;$QB MQR=GAV<-UTZ!L;&]&2,T\\XP!118,B$+`<9SP?PI=1_>#Q+9&QC*DI/O%-'I MU8V!+0HHJEU9N9I7OPF_Q@2T,3-D.WK0BF(DY"0P_.&HU9_VP,G8Z2?V^19B MN87G\U=Q?7MK1V3K2^-'E3!YJ[B^O;6CLG6E\:/!@\U=Q?7MK1V3K2^-'@P> M:NXOKVUH[)UI?&CP85Y[OI-*T'AYBD8I.+S/%1_TOA<8O+(`V"8LO6$)9 MYG3@\2L;SUND?TAU\];DIKWG66]*(Q.-0**QJ#PQD;HS$(7N2."=JAQ3DC4@594+OEPBZ322CQ>#*,"/5E&,]QJ=>K/O^,%%VO3B< MB8(X?%+%FKI5$:M=T:&PIT>TS3G$6:)^KB"PA22P.;PT84(BE)QI11)IN!7E=KG&HK4DSK'6=8W:EK92_"F*&64S`*[)`QS0] MV9W9T?LPF01EU@SP&4`90(G8H]#@Q6A/.P6:G49+4E%O>7)DDTMVL2:/CX:O ME6PGT^K8H;;MG0=;7D+,A;@:!@9AV>Z5Y*98SFK8DYO"Y2N<4C&J7K69"0,1 M2=7@(0Y&,L^;K;JQVL20U"UV/!E]K1-L;7N35HDE3(?/6%E>$Y2IJ>'6)%K1 M/R%I<4YX!$J3"`D&8%CJBSGA$A63DM.A:&9`$8#'60R!T4$(&U&7GPJU>I)(+Z1F!QP1%X5A MTBIF>M"&=[0;"-)3=L_M$K:9/-F$1QBP-,5DSDJ"ZBUV95!H2@EI*W8%XSGD MPHLOZ0E#@XJ19&#)&0EG4<+X\("03;BGG60[(W;=D9G%IPN+3BK;&GC]/8Y*8_+),C9G1JCC'* M%[@V1![$2Z"$WJ&H"+)"H!.!=L5.']"N-77/974$ELE)J]><:F+ M*H7I6>BY\X4?';+EPT0$`R3V=T;+CDE6H$+EXZ,)!CC(D8NLF-P8`O'@\F:< MJSR_R36K=3=4,8G<6U=F4ELE\4H"GJCEUF4['9)#$RDIQ,6JGN:"F3M73A]' M#1DEY`UN2\1HU8.ITA`:(L?RR:;S&WF69UHRP:F$TXALF6FEV1-E]EL40/K! MO`I:RBU2>+'M+RMG2PY,K4F^`2'I@!\4R')W28#/"/\`?.>ZA7+F+!J2(AHX MN/!6&6^=;1H9D;)ADB,PPHJ?)KM00:UEFXP68XG25./&<](4H\8X7%,%Q?P^)&FVU/IJ,)XD]ZZM6P@QMX9F[ MR.+V7(*:(+$2OPZFQB.MDPC4W5C)/$E$G+5.A�`-",9>1@$`8_AE4]:[Z7 MS>NCZTFM41FM43CD^V6J95Q*Y?/)&V$K4"@AOKR2M%FQ".0U0K1DJ4YZAR:' MSJ^'`:66')75,&/Y:J.^QUZW1O73O8=DHJQV%]@A\4AKH?KQ&Z=>#[:F942F M,>D,J(:;71V:<6YE'M[88K+8B(GXROPG\3`H&([JCDKUF(F+>&?NXJ"V#MC> M37J-4U%9DFFD*NZO))(Y"A9G4DFK&J)S!K=9!+)BL\6"7'V^/H4!HS`*L@&H M-"%*6`P\XLH<=9F(B7]4_FG`X#@.!0/27^*7>2_[_%_]'6G7)MJ?U^E_.5DX M'__5]_'`UJ]UANO/=\=>II<%BQ2(0][C5\6/5*1LA07D+4>S0Q-&ST#BHP^N MCLK^DU0GHS!W5,"5T`#U0!^7I+,5+95PAP'`<"@FMO\`.KWD'^LM7_Z<8UPL M\0OWPAP'`XH%@8%<7A<8H5C`3X)ULEZ?`GL5X[FMB,AK#UP@/FZ MP@HPL668>!1KB/F6T'E98:?8U>IILAK53.X:GL9S;%+TVP`^4,A4V<&=$'`U MCLABIBX+ZK;$@!8R:>60(HO&>D0L<"/HE=Y-AN-RL4*KFTRGBHERR/D+K)KZ M85-"K&E24V1H1-]W*%:K7H^+<92N<$6$;'M$(92G],>$`#9K#ZR:'^3.$8*-3F",;AH$ M*T[!P<+"R_!F#%_#N)=KM"[00TYBX'.8V$^TRN8I*U/!,SEE>MTEGS(2T"!- MIE"ZR?(C"I0K$YM/CA#>O0JFE"<>9XNF+QG&,"V9613E66_%9K"K,@,8F4:L M:*'0B;-[PU)S3)#%31*#0,RUP*"2YA3HE2D:A((LX!B-5G!Y`BSL!'@G#5QK M1W$/=[:L74SWS`X5.I+-HFZ`?8&FL:<'2B.0)\(-,-0/4?:"6UJRL=&K(\91 MGNIKD-*:6`\K(5``G8E-3VF<-R/*RDO\4N\E M_P!_B_\`HZTZY-M3^OTOYRLG`__6]_'`\CO=B;:W]W?E&6+1UA=U_P!Y-8+R M[;#6E9**1UWK%-%,<.9)3B/H6\HI0]HVA4B?PZ M3$3GVAZQHP]&2.-1Z0G-#M'S7YC:7HU@?THD+ZR&.B!.N&T/2(6:D-AH/=>O5=['D#%!H9/(0U3)41-5K>TG0\2LO!3LRR- MP-4`:B5OWC M->_7M37XGPCZ\X*G1[QFO?KVIK\3X1]><%3H]XS7OU[4U^)\(^O."ITH[WD7 M>(Q[532ZYK[H&P*!L6VX'Z._-.&R"5H95S(J^4LFW M.PVG]WR1=/,3A(U,N(`VUQ"RV=Q;'2#,D<9I=+)6Z/#A"G1J`O3OBXW#@)P' MX4L*?!9(`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`3DRJR8(H3G!P+`L!-).>AEF!P(.,]&<9^7'!4Z1,\R7 M6=WNB)7@5M>B9'V+QE=$5D*9-E6E+4WL[_="JW;*U8]&<:'E^J!_J>Y1RRP)1%P$ MO*ER89C6:EI`)@,U:4TXF,=:[&64V\3 MO;!I.>:@U%^& M-)-)/*,,"*IG212+/U"33!=82:P];D\__7M37XGPCZ\ MX*G1[QFO?KVIK\3X1]><%3H]XS7OU[4U^)\(^O."IT>\9KWZ]J:_$^$?7G!4 MZ/>,U[]>U-?B?"/KS@J='O&:]^O:FOQ/A'UYP5.CWC->_7M37XGPCZ\X*G1[ MQFO?KVIK\3X1]><%3H]XS7OU[4U^)\(^O."IT>\9KWZ]J:_$^$?7G!4Z/>,U M[]>U-?B?"/KS@J='O&:]^O:FOQ/A'UYP5.CWC->_7M37XGPCZ\X*G1[QFO?K MVIK\3X1]><%3H]XS7OU[4U^)\(^O."IT>\9KWZ]J:_$^$?7G!4Z/>,U[]>U- M?B?"/KS@J='O&:]^O:FOQ/A'UYP5.E4M"7YBE$\[QE^C3TTR%C<=^7(QO>6- MQ1NS2N++U`T^3F&(W%`]JGEUG[XQF[,U/KW79`FAI0B55R_ZWR^U)[! MIRW'K%1Z:1'#EEBIU)S>I3E)QEM6"AC&!2/P9;X0&'NY+9)F^-CDNV#-?FTZL#H1)*JAM0+:U;Z)46>:I;FM*Q5^U.:=:*5GJ?I\D:@_!Z4 M?B(8M^*POE0=#Q.@J#K+7UH4*Y5&*WA#-#%,4-'DL@)QPLC'@.,=86>G/R\$S-1E?/T"YVH[WD6CWOC:77-KA5:6LX!/;&] M'?T#+I`Q^(-#3YHVO!9VZ>-JXXRN#R5X^S1A0F+\"2/K&G!P/H!D0L18FIMY M.I/_`,8'="NV!SGB*R*&MD^&I\27-9199-R9-/$[*86O61:/"DD/:6`Q[>49 M!A*4M8J3)SCQA`,T&!=;$IOWAZF=+-2^[F=&"&[1ZDU0EBS/,&9U(`SHI-8J M*.(%)ARAJE,2FE*O$N<*_9YM$9"D/2+B3FG"]K<`R`7\)1IJG;LC#9-D=\*=6[@7)T3>.M'BMZ%=Z15K5I9+V) MV36$W/EAW,W!`J49;@I5#6(G!!?C'A"#1>#SFI>K01FV]AHGDPZR^ZF6.C:F MZ?&W+7.W];[AR`.1A*`:C9+,4:Z2ER`(>>G(24`C@EYZV0?(+`9_"_\`TG5' M;5"(J.>=@+-IF149"XVM-121IMJD_HR;L?4?D<;)7*8G%6^7."UI6N:\KP*M M'XTG&G%E1U\$!$9BIFZB6-5]M?WFI4@>/&!)!QLN85@@EB=4`)@ MAIE<1=5*"3(U`/`CP(!J0`L"+&'..D`L88/R^5KTT!K18G(5I(7!E21424I2 MJDT<8#TZE.>`)I!Y!Y2,19Q)Q8L""(."YV^`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`__]#W\<#01_QR_P"1^U_]Y-[_`/\`80/D MAKMRW[\K)P'`<"@FMO\`.KWD'^LM7_Z<8UPL\0OWPAP'``THTL0@C`+&<9Y67?\!P'`B^PJ0I:W"?%[7J&K[.3^"&1X M"PH!%)H3X$P`0&$^"DC2Y`\$8`&,"#T=&<8QC/\`AP6PFTM6J:MN%0J`/;1* MH?&ZU*3%5PGI>S+*H11!"V]G"P-">-*Z6ED$.1MS(TE@(1H1Y,0$%EA`$CJ8 MZO"W,(38-*9Q!']I>:ZWMW3:FQ`[,ZIPA5@S2L;VBKVSMZ@HQ>PK%MRU1,K" M2@>4P!$FJTS^2L+":(8#,&!+&6+^(=MMW-]HJ>9)1=E7V#J^Q4I6];KY78T< MOB$6?]-IQ1/+^^R20LME0&=@2HT2Z.!2I2&PZ++C@K$^30*#/#838$5./+RY M]S3WP]EVGWE]O1V^G%&FBV]TI+71UK,>%0&&KK&B$>4-M:QJ,A5D'8/1/T/: MDT8R$62#EZTAO-$+)F!`,D3EOMUQCP]2-A[]453LT?H;@/ M!,3'*<.$.`X#@.`X$<6O;]6T5"7&R+DG\5K*`M"AN2.DPFCRC88^@4NZXAM; M"%3FO,*3$FKW!2625@0L9&8/`\^[N]]=6QC9MT=7!&U M-3:BM*+J%C@Y.*DM(A0I""U^1G*5:HX!98`XSD0Q8QCBU]9TO9PAP'`ZL M,>Z$-*,!C48B_+:%RLG`3]&-[=`989*=;U10,)E4YI!F`UPI M]&"CD@2.KU$(A.=W:0&L+&TLIK^_JA+GU[,:T"="-W>EHL8$L=G(1&3E)N?E,.&( M7_7E8=YP'`<"@FMO\ZO>0?ZRU?\`Z<8UPL\0OWPAP'`O_`,F]Z^D-4V[$VZ=5W+2 MD1$EB;P-6%J>B&YR1O"-.O`B4I#CTY3DWDF^#R/J"$7C`L9QTXX.%+X]W2/= MNQ-_8Y3&=0ZH8I'&GALD$?>VM*]I')F>V9:2XM3JW*R7D)J57A-'&-*\2),4B?W=*U(4KJ])$_C'BZ9U40`LSSOU1UYOM*$.!%N6OVQSM7TD.ZHP!&#,`OBNFF.$&&@ M$(8?_;080=7`JYS>3C6#P ML8RW=R:+"5T`QV>T-2=B6"$@.K!_VZDTK.#,BKX8K6N_.E=O.I,=@ M&T-*.\L4'`3%P=?/&.,V#A29GJ@2FU_*E+)-"%.<]'^6-`$>.G'R?+CI$Q,> M%NN$:-?^1@>25W5-T%FG%%C4S>E2$P##``&H.#:494B)("+.,FFA3IS#,A#T MYP``A?X8SG$GAOI_9_/3HG+KB[Z;RQ@;S'O%JUYEG`[&*2FH;KB7-'T>!R-1 MEG*RV\2OJ8.$4`9F"^G(<9%T8YEUGB7]/3TK=Y3'`^"D&G&LM@Y_\7TC5>YL ML:19P(GH`3]!V;JY&PX&$\H63!_26'0IJZ!3O67?"O$X!"\=7.NG5Q3=L;"2S0A.5KW.F&6T4!:0A,/!XC M`&#QDOI"'I.",H(KY@QWI.B";I\Y+W*KOJ""$WTOUO;U,>+"R:(@85?I8@$- M\3$0>'`#L&]3P(A@P9ULLJ-4@`,M(Q7K6#DX M!R-*);X(]N32E4EI0"&82:6`TL(1=<..KGH%3I9%E?V*1H\.,>>FE^;\C M\'A>RN*-T1Y,R44?@O"I"<>1U_`'@'T=;IZ@PY_PSCA';WZMHJ$N- MD7)/XK64!:%#84F)-7N"DLDK`A8R,P>`X^7 M/!$7PUG[)]\!J1%JM7)-;-CJ"N#8.>/D;K"F8$T:C\FFYZ1 M;D#1`(>>NRYNR@T901IDN4Y8_&#R0BEM1UGS&%\=6]>(_J_2\:JIG>'&6O!" MAVE-BV*_9R.46I:LR<3Y%8UF2E0,U2<<]S&4KE"K(!&FA2$9*2EB\"07C%29 MN5AN$.`X#@.`X#@.!T[;(&%X72!L:7EK5;&SR9*TO M:8@TPYK<5,62?@!@T:T@[&,EF@%D.XX#@5(L#?C22K50FV>;9:]L#V$ MXM,&,CMF%N$N.4'8QX$A+$&EX7R=6<=D00A"4D&(0AA#C&1"#C):G3*XWM%6 MEA4Y)[OJ-OL.W8K&U"U"0TPRN)G;9"SI,4:6[%>#6D#^ MC1YP;C"GI).P`5X0)G:?<"69$;6'=O6@B;C0DY;W78B^Z"IDI3X0(\,L` MDU_S)J*(.!CIP>UA.R4+`L%Y'UBPBHVGF<)-L)54T)#7+[15+W0XG,Y]D&3" M,S6_8+&4"AG<X!2)3DY1WA$81#+Z@Q_"#DNJV MUTD5D'VGWC5Q#;RSD:E1'*&I?7VEF96:F%D1R8;I)X1=%@)VQ:'H",HE]+.P M$0LA.P+P8BQ<:31>.HE$[(O+,\7.PR^7`8&P34W1U/;=NQ.##3FJCU:@YW@, M*G,==+/J34.M=>]5+.LF M.'0LR\62D(VYS9FBS\,:";$IY`VB8I@K=I'%%R]KPJ-=,C(+<#3,=(NCDI8[ M9RU!:;_\=*]M--EZCV1@FZ\05.U:2E,Y.3'BFGY$GE<37%&M,RAZQ0&QSL$I MI/&%RI'X7)9GBXS0G!#D98>*:GO$Q5/5]RN9P'`<"@>DO\4N\E_W^+_Z.M.N M3;4_K]+^BV(T&,C;C`&309#&:(UR)&$PI8>'`@)LA%+RUZ_C;?%RLJ)]YK*'Z' M:&;-/L8D#S$GT%>Y:F^5,;JO8%,:,D;ZS1PU_<)"U+&]UC<99T[J-0\.24XM M2W-):E24+!A0>%CF&AZH9=%AW$EIC92X84SZ:H=A[N6NK_3NS5HN&IJ&;G:D M4;):LK>)7Y))JT3,XY(>KFLB<6A8YE)$LQR'*-&(0B!$QN>,1EOGT8D]R2W0 M+7&5/RHZ1VT\TI%%Z5UM52Z-ZZ2DFI`8BS_.EZ)N6/67:01/"1:M492B5'J3 MA&&`P,8\8K$\RK5KVLVGQN#W@HFV/:_F/0I;K=YQE+IE8I360=C7Z.X:\,B@ MB"'*U11C=U1*,GE$Y`?TA!@0>@68N*A>3Q[<;[,:T??NTO9URICY/'MQOLQK M1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^ M[2]G7!CY/'MQOLQK1]^[2]G7!CY8_*V+:"=1B00N9UUJE*8C+&9RCLFC;]++ M*X(CQE&E&!$$8!9QG'!CY:^*>F^X&CLZJ_3*S M,T_)*JL,UY:=3+JGD^LAV9, M%``\]Q29`=&L3<^6R?Q[<;[,:T??NTO9URLX^3Q[<;[,:T??NTO9UP8^3Q[< M;[,:T??NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[, M:T??NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[,:T? M?NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[,:T??NTO9UP8^3Q[<;[,:T??NT MO9UP8^3Q[<;[,:T??NTO9UP8^6#2VOK\GRAM5SNE=+YJJ9E*-:T*9:NF/MZMM.>*J6&(5*!=CPQ)A60C*-_;#G`OEX,?*CN^T=DT=;6N]KF4,L) MLD*9KJVK,:X;6;>UW;%E2-8N>76+557U?ULA8V"Q)?(G9T4A))7MJH."AB$J M.*1$C&7%C4*:$ZP;H4S'VS?W?BW8%9\'UYK6T)NDUEV,E@;9057>769%=V+5D:;6.G M;Z?MQK":11VI7@4(A#9!9UF2'FP=%5;U)VX#(S#;61P,8T+<-0W_`$J<%`$Q M5@\HO(XW,17/#VL47M/LU>:.8Y!3<2I^05X!J.F\2OQBORK'1D3O13LW&^S&M' MW[M+V=<&/D\>W&^S&M'W[M+V=<&/E$LMI"T9^(T4[UNT.FHC\]8X4M1R&1B. M%XP)7UC$14OJ#"7TEY9@R!9&Q%"4$%'&!RBR$XTH.3<#QUL9 M4>T&=)M^FCH-@F[-LQ%0G$(U$4Z7TWVNVA.P:%02%>FN?4>P5[DD+4XR(10U M8)?U6? M'MQOLQK1]^[2]G7-N&/D\>W&^S&M'W[M+V=<&/D\>W&^S&M'W[M+V=<&/D\> MW&^S&M'W[M+V=<&/D\>W&^S&M'W[M+V=<&/D\>W&^S&M'W[M+V=<&/D\>W&^ MS&M'W[M+V=<&/E#MM;)6A0R5`LNBAI4R!I:V9;X8:Y/UCB\"%D`B(G MR\NO=#=Z+LH'O%)BC?YK!C$^^-I*W2;MUD&OB6'!L]4@DY=<-K`Z-1+NY1`A M0Y.R5B1@(2*`'%%-Z0SJ$E!,*D2WVZQ7T]5,_P!1=V;/F\CE4LV7FB%@?'$" MI#6%;;*32FH/%V\HO!(&9BS.UUPR=_+9!KC6\2Q\ME#-%Z<19KD<+. M$PR`"ZP0]7J%EA`)F)9[7U06_4I`4M5:]Z,UDF`2!,!/7P)/#"`)R_"8+3A* MCE2-I820>&'T`QCJXZV?D^7/*EQ\I/\`'MQOLQK1]^[2]G7!CY/'MQOLQK1] M^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2 M]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7 M!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY/'MQOLQK1]^[2]G7!CY M5Y[OH)CG":/))4+?=S^F$\46N3C'RCO="U`P3AM6NZ!KWCZ;'>5DX'_T_==M^7Y`O3VRDW6#8$27RU@`I9&\J(*8TG;AIG1S?$34:O&J-)6X. M$/"GP2C/",3!7=?EQDF%%P6'%PU.:$]/$@1 MED#&2#@*\KP'$L(4.&HHT*[.3L""5C.#<]?_`,7R\#+PA"`(0`"$``!P$(0X MP$(0AQT!"$..C`0AQCHQC'^'`H-K;_.KWD'^LM7_`.G&-<+/$+]\(3_FHUR8HT/3D/1D1-952U8O2QX?8"_2G:YW*7WW#612_5%;9I)#:R[: MTLU"(3%3]G*QX`A/<$++.)2SMB(+QA*K&6Y)<#;U@,DEF/,<-A7"'`7I7DIK9&\(E"HT./!@,+$6B#7;5J;&V#[UNWSJQV!L^X)G))! M(VR&*%]5:HPA\(`2LK:ER%Y1`E\B1H3'B%6'%6*:Q)V,:UZ9U;#'*.21`Y,ZX;ME-(')L&]>T.Z!$ZM3JB5- MSFV.*4AN(&F6H%Z)2`U,L1+$QHBS2C`B`8`60BQG&6)TH9[32K7US3@4"R(0!Q8)@@B$'! M@?DR$MSYRG!VSLQ45&L),:2LVX5RL#A@F1*I6^QO7-9.6!2Z.AQC@W#C\1E$ M(;98S-9Z,DM*),VMSD-.8,1Z+)F,!&)G4(*3=Y%5,-4$-&TU97IIF^#.*0C7 MWU7QI]3J'(1@23B6O86KEUB44>F"<+'4,5OZ$TPL819*#UNK@5K+8?PAP'`< M#HY'&(U,&D]AEL>8Y2QJAD&*6:1M*![:5!B8X"A,8>W.:=4C-&G/+",&1`SD M`PXSCHSCIX$>IM?*$1J"%:2D*A2JTIQ2E*J35K#"%"900,)I)Y!Q3*$PDXDP M.!!$'.!!%C&<9Z>%N=I>X0X#@.!B;K.8HT(9BO/>25WF`TGO4O;&`E7*)&S( M2&U4[A"9%8TG=I,J<%K>C,&D1D)#5:W(>HG*-'G`+'[1KK;EB+Y59+D(6?EZ#G088Y2QJAD& M*6:1M*![:5!B8X"A,8>W.:=4C-&G/+",&1`SD`PXSCHSCIX1'R37ZAD"I,N0 MTE42):B4$JT:Q)6T-3*DBI,8$Y.I3*"64!Q"@@X&!`&'.!!%C&<9QG'!<[2[ MP'`(O;0I4(U&.J9 M@8"Q-,+U'V8?K=2RRHKMC[?7&V='#0,]VUTB4*#F-W3+YJK7+DZ-3)* M>M!,C&J;5/@\&MRL*AL5]"E((1@F/,<+F\(OY0\[&;"R=NMS<.QX\C8YM/T*52EA%;10I2-R3 M4O0,?<1G*(95C&K-QDXT0OI21KB\N+F8,X8"B!,^(X7;X0X#@.`X#@?!A99Q M9A)Q8#2C0"+-*,"$99A8PY",LP`L9",`PYSC.,XSC.,\"L-]:C57L&],Y(S>GH&4+ M'1C!8FF+U'3>V=53YL3/^VB*_P"BL_29+@Q7'3<:;;V9DX&E:"/89;>J=TK^ M&2#P3QXKX[EVAIJH],$W.%.#1A$$7&LNBL'>5FI.9RAAOF@-D:S@;,\C1LM\ MME:GW#3$@8S,!"AD3B]4FNL"5UXF/.P,)P9*S-):7&`",-Z!_(*OB5BZ?ORD M-@X^=*J-MNNKQN>0E#Z4JL!*@&0" MP(&,ASC`F)CE+?"'`<"L5];B:_ZWNS'%;*E[F=84K;QN#0"P(X/4'D)8B98G4FP>PEP6$VD@TYG- M.T5DEP-YYO(7FY]LMC7JLEKRI41RAJHE"+7F`-T<.SG&([+)34J-C MNB?]H3M1NM5!ZT,3E':&J6$5W_`.#5G_\`DA\X6.8?SK$4>U$8>ZPBEB9T,W-;MKQ.;F!#OHD;K*CN MKF'PF[Y$ECJEGF>+"=8(XJ62*)"&$U.DC*)5E]0&EA/PH`-0//AUS[!()HW.IZ=(>YH92[!.7$ MJ!E%#.+/P/(`YST8TY3S+N+\NV%ZXT[/[NL++F*)UZQB>'%(R(PN#X[J3E29 ML98^Q(3#DQ*I\D;XO3($99AI)0E*D&##"P=881$7-*/-'>59DC%#D,5UAM:6 MW)/9O,XG$JFBT\HF0-LD:*Z@K'8NV!7?2]?WS#W`Y)`+&AK+-FD^2`3,SBTH'A&4H,;)( MG$J/3-+XR*1C1KR/#F!3K"3"^N+J].:S6:4TUQG<')W.[Q=2=,HH4F6S#602 M-0;(F@LA6$C76-DGB3&C68+/"2<'(!Y#G/5%CHS\O"S$U&%\_2-7OV\AGWH9 M/+N"IT>D:O?MY#/O0R>7<%3H](U>_;R&?>AD\NX*G1Z1J]^WD,^]#)Y=P5.C MTC5[]O(9]Z&3R[@J='I&KW[>0S[T,GEW!4Z/2-7OV\AGWH9/+N"IT>D:O?MY M#/O0R>7<%3H](U>_;R&?>AD\NX*G2E&V]:M-B'1.^]?+2KB#[G<#ZPD[E M)&<$;L>++!A5R?7ZWBTKHE.>:LL+P&,!$,>3H^\8(=4?5.),`=%C4QA*NLVY M50[*5@FG2%W;H#*&EX=(3:%73!_9TLMJRT(P86DF$#?NE00G<#69D:O?MY#/O0R>7<%3H](U> M_;R&?>AD\NX*G1Z1J]^WD,^]#)Y=P5.CTC5[]O(9]Z&3R[@J='I&KW[>0S[T M,GEW!4Z/2-7OV\AGWH9/+N"IT>D:O?MY#/O0R>7<%3I3C:'>./U:XQBFZ(#" M[IVFLXK)L%KL( MT:<1&^'*U=I6K*&,E5BSRZHS=FS=J#"JN"_I,[QU$]OI0%(E;;`H0T@=%9%= MT]$1"P6SQM`;A(1U0S[T,GEW!4Z/2-7OV\AGW MH9/+N"IT>D:O?MY#/O0R>7<%3H](U>_;R&?>AD\NX*G1Z1J]^WD,^]#)Y=P5 M.CTC5[]O(9]Z&3R[@J='I&KW[>0S[T,GEW!4Z/2-7OV\AGWH9/+N"IT>D:O? MMY#/O0R>7<%3H](U>_;R&?>AD\NX*G1Z1J]^WD,^]#)Y=P5.F`"2:_DBGZMD M=:VB#]:#?EOG4PA#W&X=.)#X-(YHV]Q7S&.J6Z1'/+(!Y5#;U@E&5"$X\9A` MP#%G.1EKZL-EN+5&"3>T*A[QUEEE!.&:+IG\KSSU>>?NPN]^VGOCDY+J3!)ZK1O&U^\%M[+K20$C.A15LLFOM%`5D"ZY)R>I* M!6083R22+IZI)'G.,]`QCY6+GQ#87BPJYP8([$XA.#1@++&;B2L6#!EE" M,$46(?CO6$`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``:H1)Y M$SK&)7T]$6W*7A)"XZW1M(YJD))ZDE*K6IFT!AH`#R7@P M0NKT!Z,8K*--PM>$VUNM=KT`I=T+"*PF1O(0NKLS8D;(E>8](&>6L.)#'\JV M\3[&U#VPIRG)&!0G,4H1FE@-+&((PEB:FVO:(]W5?E:ZVP78)3-) MJL]',:K.8L>LZ.!S:FJ[JUT:$C(SR1!+\2M<_P!3L,C7+^N%,N/1A2"3`R$M M8"4OM%5X;%=>]=8W1^M58ZWNJI/93+!H*UQ1_B:BUVO,<6+2VU*:T#(0@6+!Y--P4$.##,Y$+I%GIX)F:C*]?NYZ]^H MFFOPPA'U'P7.SW<]>_4337X80CZCX+G9[N>O?J)IK\,(1]1\%SL]W/7OU$TU M^&$(^H^"YV>[GKWZB::_#"$?4?!<[/=SU[]1--?AA"/J/@N=GNYZ]^HFFOPP MA'U'P7.SW<]>_4337X80CZCX+G9[N>O?J)IK\,(1]1\%SL]W/7OU$TU^&$(^ MH^"YVH!M7I:PU[-F3<762@ZZETYA#2G8;NUT2P*'"8]D:71J#EK@CC+*>V$- MC=L)`@'&K(DYX$5E?CPK.KR8G5%9(BQ/B96NI6-::["U;#+EJ6JZ1E4`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`N5ULIB4M1$A<6\H9A9 M"XHM0`.2S<#+$(&1M`0L3`%DH\HTDS&.J,`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``'&1BSG/RYSR+/CZ;$N5DX'__U_>?.9DP MUU"IA8,I4C11B"Q:03*1K"RA'F)&&,-*M[=U)9`/VSAD-Z$P6`8^46<=&.!Y MWV?ORMG%=:Q[;IQ[LV9!T*D\R\W$%SQZ\H9*+'2,N)2IA@I&LJ=K9AOH#@OJ M`XO*8X*5!D_(4X'(?6+/-E_#?K''MEZ.6EU;WUJ;'MI4@6M3PWHW5L6%X&$M M6WN"8M6C4EA,"`P(#TQP1XP(.!8QGY<8SRL.PX#@.!036W^=7O(/]9:O_P!. M,:X6>(7[X0X#@.`X#@.`X#@.`X&K"XV)]T#M66[:5HT.CUJK:3P)_P!TJCCR M!4Z+:WDYP$Z8S<"M6%"E4*C"DB,@(+%:TO5\<;"0O)10U:13X>-1G'ELWC\@ M89:PLTIBSRUR.-2-K0/D?D#&O2NK,]LSJE*6MCLTN:(T]&X-S@C/`:2<4,19 MI8L"#G.,XSRLNXX#@.`X&N^]=E+,LBR';4O28YD%]K/42, MNZ3"H"MS1C4)44_OE[;S,BC<1*-,`2;T+GGP#>5DM26(\SPL?K;K36FK5>9@ M-=%/+BH=GEQET_L&9.7G#95L6$^F8/DEBV9+#"$ZF2R]_4XP(T[("R""@@3I MBB$Q11(!,VL#PAP'`DO\4N\E_P!_B_\`HZTZY-M3^OTOYRLG`__0]WUH M^/>C.Q/HN#)+/<_,67?1U:KW)(S(;#7?0#AXI!EKNO1N"%J22Q1U4!BDY.>2 M0!1D8RQA#D.0\!#W-]<:W@ZUWT'D/>.:+]X@;-4S8'0"-/%BV/"#7H$V*;#V MT]P50R)/[ZB.CF?#9+=Q+#A*"0HC&TW&,GFY=<^:F'OOJ-3/5E4UBKM5*F16 M@JKV%J;(1H@)RT:2>GQMM-F"5(!&:>D`F(D(E`"\%#&7@&,=460]&>:!JD95"KNT+210QV-' MCN]KNFJ=!7#V:([*#2RXIFXF=6MGXW/C.&S6ZU9(LR-@<#,IVZ'/:C+:?DI" MK1#*G#7]OMM@Y63@.!K,MF^+0VEL"6:KZ720V*M$54?06RNYSITX0P MX=:@HX1Q9K/.=CU:$>0K%.!F-D&+,":K\*Y9)1`C55F5TZ+H>K]<*Z:ZOJ2- ME1Z--ZA6Z+SSE"ATD4KD[J,)\@FTWDK@8>\S";R=:'QAQ=5YQRQ6=GI&/HP$ M(:DS:8.$.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.` MX#@.`X#@.`X#@.!0/27^*7>2_P"_Q?\`T=:=Y-2`!'I1+']'%YD[M2V6QH" M9R5*0M*LTQ0I$+)`>OG`:S/,JU:]R/:8O<'O!36VFZ`5O1\MUNS(V]=LM8K> MUM1Q>OT=+;"V1W(U/'&#A19JH7D\ZMQ?43K1 MVL;2^"[E3!YU;B^HG6CM8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ)UH[6-I? M!=P8/.K<7U$ZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&#SJW%]1.M':QM+X+N#!Y MU;B^HG6CM8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ)UH[6-I?!=P8/.K<7U$ MZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&&*SE!LK9L-D]>V#K)JC,(1,V1PCDJB[ M_M)9CBS/K&ZIQI'!M<$9^E@BSDZ@@S.,_P"&0YZ,AS@6,9P/Y4.HJVMR=.YG M76DMSP:GIDT3,`$I<$RL(HLU.8;&_.K<7U$ZT=K&TO@NY4PULR.^]V=]S9A46LD1J M*O*4A\Q40R\=FHGL7/09I)9HS&6;:RU"TB%(6(9I MIQQINF)JMQ=6XOJ)UH[6-I?!=P8/.K<7 MU$ZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&#SJW%]1.M':QM+X+N#!YU;B^HG6CM M8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ)UH[6-I?!=P8/.K<7U$ZT=K&TO@N MX,'G5N+ZB=:.UC:7P7<&#SJW%]1.M':QM+X+N#!YU;B^HG6CM8VE\%W!@\ZM MQ?43K1VL;2^"[@P>=6XOJ)UH[6-I?!=P8/.K<7U$ZT=K&TO@NX,'G5N+ZB=: M.UC:7P7<&#SJW%]1.M':QM+X+N#!YU;B^HG6CM8VE\%W!@\ZMQ?43K1VL;2^ M"[@P>=6XOJ)UH[6-I?!=P8/.K<7U$ZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&#S MJW%]1.M':QM+X+N#!YU;B^HG6CM8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ) MUH[6-I?!=P8/.K<7U$ZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&#SJW%]1.M':QM M+X+N#!YU;B^HG6CM8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ)UH[6-I?!=P8 M/.K<7U$ZT=K&TO@NX,'G5N+ZB=:.UC:7P7<&#SJW%]1.M':QM+X+N#!YU;B^ MHG6CM8VE\%W!@\ZMQ?43K1VL;2^"[@P>=6XOJ)UH[6-I?!=P8/.K<7U$ZT=K M&TO@NX,'G5N+ZB=:.UC:7P7<&%>>[Z4RM9,>\34SAECT=E1N^[GEX9HI)W*9 M1]"=C4+4`));;)G>(P1Q=2C$@2QB&:THL@,$(&`BP'!@Y"]O'TV.\K)P/__2 M]_'`\R5RCDEA\>?6)PD8C\JA2!:T.C(7[X0X#@.`X#@.`X#@ M.`X#@.!I#_Y#BU8T]UW;#ZU*U+8]Q^QJ*>F%Y;SS4;JR/*&V8J)$[-#@F&6K M;7-((6J+')/#73EX(XOMIM9*9+'8Q(]GMBGJ/2-]:&%^9G&[[ M.5-[LS.[@G;W1L7IC)1DM0B7H5`RC2Q8R$8!YQGY,\CJ_JZ0Z'1.O8LP0>"Q MMDB$.BK6D9(W&(XVI&=B8VA`4$E&W-;8A*)2(TBN#&0_]>%B9 MB;AJE:?^-]W9;*ZMCPAB]Q!6M+@C6^CE9.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.` MX#@.`X#@.`X#@.`X#@.`X#@.!0/27^*7>2_[_%_]'6G7)MJ?U^E_.5DX'__4 M]_'`,9.5*2PYR'&0)U*,2YC?D)*]"8H0K2B%S2_[_`!?_`$=:=\JH*R8YK*ZUZPWH\M*%!7S_:8U((3'UY[XUAZ3;>T^_5A>L2KK6]YORN97;XY:3*]I;RL)? ML"UWS"(1&9)/[(NV6:[LSVS3J$O%81WZ.;4L:5-.(\F4H$(FS`BBA1;CCPV. MZTZUI:@U(JC6BQ5+38`XI737&9XK)3*"&"22`_(G64GMR4W!"LEC/D*P_*,! MF`&A38+P/&!=..5)G-J7:]ZKZ\N6X/>"LJZIXJI:HW+=;B6-"8G59(;"G37Z M.N+@!-C"K`L!5+C!&BZI>&_-EGEG*ER>YQK!ZEX;\V6 M>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK M!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6> M6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK! MZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6 M<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!Z MEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6< M%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZE MX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<% MR>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX M;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R M>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX; M\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R> MYQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\ MV6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>Y MQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V M6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQK!ZEX;\V6>6<%R>YQ MK!ZEX;\V6>6<%RKSW?43CD'F/>)Q2)-"1ACK/ONYDMC2A",*1$4=J%J`K-`2 M$8QCP$:E0,>>G.?E%GDA>WCZ;'>5DX'_UO?QP'`&X+Y-9'?NI6N[/;T\HV$V\V;(RZ9SFM7 M)B8)>X.-102+J8E#D,D?6=_(:DQXYHN?U``)L>,E1O(##0D^$)/+'$RSO3"X M+4MS1>@[BD")#/K7E511YW7&G*"8.WV"[DEY;RY9D\MN<4+`GFZ1(%W#XNF, M2!PKQ@@/@<@X)YF%8X:+?.L=C]K;-:M+X;,([>;Y3KJR'>]9$8_XB"`5*R0A MP*\&IKQP7*?#.*,S/6.3I,AZO0'!@=^_T_8;VS8;[).5*C9Z M>=^_T_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIYW[_3]AO;-AOLDX*C:/(M M9/>*,4UL^3+](HL[MV;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/._ M?Z?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/._?Z M?L-[9L-]DG!4;1Y%K)[Q1BFMGR9?I%%G=KG#M&7!B8CMSHOX")IV.(M4>7(T MF#JO/3X`ZN*`Q:/P)9(>N=GK8$+I%F+C&4A^GG?O]/V&]LV&^R3E2HV>GG?O M]/V&]LV&^R3@J-GIYW[_`$_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIYW[_ M`$_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIYW[_`$_8;VS8;[)."HV>GG?O M]/V&]LV&^R3@J-GIYW[_`$_8;VS8;[)."HVCV%V3WBD:DEN/3GI%%GU%85A- MLOCK6?N=%_!0QF1536,!/C2+QBKU).$RJ00=<\9\`!.5X9V,Z2\F>$-,&-I" M]/._?Z?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/ M._?Z?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/._ M?Z?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1M'L+LGO M%(U)+<>G/2*+/J*PK";9?'6L_=^_T_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIY MW[_3]AO;-AOLDX*C9Z>=^_T_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIYW[ M_3]AO;-AOLDX*C9Z>=^_T_8;VS8;[)."HV>GG?O]/V&]LV&^R3@J-GIYW[_3 M]AO;-AOLDX*C:/879/>*1J26X].>D46?45A6$VR^.M9^YT7\%#&9%5-8P$^- M(O&*O4DX3*I!!USQGP`$Y7AG8SI+R9X0TP8VD+T\[]_I^PWMFPWV2<%1L]/. M_?Z?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/._? MZ?L-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&ST\[]_I^PWMFPWV2<%1L]/._?Z? ML-[9L-]DG!4;/3SOW^G[#>V;#?9)P5&T>PNR>\4C4DMQZ<](HL^HK"L)ME\= M:S]SHOX*&,R*J:Q@)\:1>,5>I)PF52"#KGC/@`)RO#.QG27DSPAI@QM(7IYW M[_3]AO;-AOLDX*C9Z>=^_P!/V&]LV&^R3@J-GIYW[_3]AO;-AOLDX*C9Z>=^ M_P!/V&]LV&^R3@J-OWT9@UZQ=?MU,;XJUJJ5ZO':53;\9C#38C+91)49.H.A MJS#DQ^96]J+\+],5BK%U3DRH.`6`(ABQC(YPJ#* MN\DU[BD`JBQ3&>X9(TVKKNT[7!;(/5SW-'ZO-?W1J8G<5CV<@C@W`B--+>0_ M``:44_3I6]HR@DGIA` M;#510'$:,0PXR*EL*X0X#@.`X#@1[:UJP&D:\E-JVC(T42@<,;P.4A?U^#AD M(R3E:9O1E`)3EG*52UQ65W@E&UQ.,5TG9[3L^6K&>'/,<::;@:BR%,HJC&.R9@-&07"7^QE*I,4G2JR0C0&K$P7'Q/Q@KKB MI7\X0X#@.`X#@1A,)8`Y$+&.#G"K=A=XSKY6T:@LJ>6ZV7ELF5!M^T3L&&5 MA()BHK&@UZ5$KS9EH>;X5J:-L*$"HW!^"3%B@.$2HP)8BB!F<+4NRM'?^E*N MGRVLC(_;5A30E#&%K4QU-`%-@.,FR^Q.16`]IF)L9U^741M>0!G0/+Z8K(2) MB4TD9BDIJM8M\5+%2R1@WIUIE]AZ\5A"YZ"82K9^!K+0JTAA0J#2#*^30M;. MDTID8EOB2F/(W5I0&%)B3BO'!+`#*&2#)9N2Q4Y6]X0X#@.`X#@1?,)8,9$ M+&."(O"KM@=XOKY6\:@TL>6^V'9GEU$,VSKZ;#ZR?I>.J*$>TZ<]/9EK?0&% MI4=8R,F'A,+3#7K,X0+#`$C(3&FA+4N39_>%415]E.52'M5I3V=HD3&N1,E5 M0118*Q_*<(8Y6/(<,J%C7&N1OH]@`&EW?!GD)R2DTG9P)1JU"O))0J75IN\N MU9=)%%VN./,ZE42DBNC6I5;\=KJ3KJ=AT@V3;&%YI.-3JD.%XTHE`0\%2O[PAP'`2194D?E>R4>CLHHR'RJ8&)B/H:26*S3%F,3$93C`D&\(RUHTPSP!R*E? M?A#@.`X#@.!%5VW76^O%82VX+:D1,7@D+;#G-Y=#"3E1PL`#G"9O;D28!BEP M=G-3D)"5.6'(SSS`@#\N>#E5V=]X]KQ7C)#I$](K724-$-GI,LB=9/TN* MJ*AYL,PIDLBVA1W#@&-,@C$*_P`(%/E[(D=?MUJ3-P:2(^X'+#4-<0"2QYQ>##BB,9#* M6@E#XZI5Y)+%2SAZW:UU:I5JM#D,U#*7K'/D0D MUB1^B+,F//36DR>/("<*7!M4I",G#"$8@%8--QULX#G., M?],\#2-/-0MV3JH*FV"KMOV:D6O2ZX;5B48:(C((=+9 MNR4'9LIDM`(&I@R(#4A.81/ISH=A?UDY`4YL;N+F?-I40:G;00.5U7M%"X52 M[]?[;8NT[[8M/.EDO,<@">#7C'*_@56QV)60DK!W-&OIRO-?X`T&#\WD(%J1 M.X`392EFA+,)<9CP@2NN[(V9JBOY!K6U/50RRIK[E.GEC7=:ZN0R!DET"E-" MD5J7;S)`Z_\`,IR23!FGA%/M9,:4JW9M-:A+E!BLHS)81"+<<^7H!Y6#@.`X M#@.!'MN1=RF]4V="V828+Q+Z]FD7:A+31D(PN3_&W)J0B5G%E'F$IL*E8?"" M"`>0@ZZJU;7=VU;=.MDUD^SQYAL)4P[8--6D:J]NCU@(*^D:PUPIJO==*^8S M`C:$Q3BC3+O`B2]))?!<3B>$FU%I9/*E;N[0CP'Z-OZ;4&-V2WVN\DG*VX#T M_3JF'B(J5L*:LMV,#9S)P\FC)(.RE$F;NI\F1!ZG*DS=MF?"'`D4E=UQ;>N->ZJ577-UU>GVW'K65:YUK8U>5)?>M^LK!K@S5HVH]CGVGV$B4E8U8VG@, MOJ;9BN(O2\KOI`\[EK+0K>7V%(8C#C$FRR^K2ZQ"PSMB@$C4+P4G"]?(3 M!M*7#DTICS2AD'%E%C%QF/"#VSNYMG6N-ZATF[BJ*81W5"5:JR"J-CDMF6+# MI95S#4[=6*R[8P;1#=%5$%M9QG$BA#XGCKD[K\&-S;)@8,\$>A\*:6XS+?5R ML'`[2?I]1S20U$!01PE0SHW(]4K,=`K"#"TA,:B8WEG:;5#; M&MY;7FS=<1VEY;L.Z)=Q&VY(!+;">8_!R46R,JKZ45?B-3=+64D6.9='LU)Q M&+GA$THS75E2C\&85@L!(Q<<>$6P'NBK"II_TQD<$V-D3ZYTO/->E-J`D#%7 MXV]%":+UDM>GR6ZK5CA`W.5)6-PE5@N!I+$J7X2$`E;LOZ^7$"JE%45:[!3GIB;+^>I9+'JL&R MTSO`U8P0-T94"!E='^.$I?&CI&HP:;A1T]'5_9ST<+%9/0-OW^H%#>QE#?:W MP7&CT#;]_J!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7 M&CT#;]_J!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&C MT#;]_J!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT# M;]_J!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;] M_J!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J M!0WL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0 MWL90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL M90WVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90 MWVM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WV MM\%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\ M%QH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%Q MH]`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH] M`V_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V M_?Z@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V_? MZ@4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V_?Z@ M4-[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V_?Z@4- M[&4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V_?Z@4-[& M4-]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QH]`V_?Z@4-[&4- M]K?!<:/0-OW^H%#>QE#?:WP7&CT#;]_J!0WL90WVM\%QI&$L.KT"BXF\-I7*R<#__UO?QP'`,U[]>U-?B?"/KSA:G35KWI/? M$1+02`U9+ZI8ZQV2<)_+WF-NS(TV\V(#(TC;&4#H0ZG#C;;+3S`*SQ>!Q@PL MD&,X^06<_)R3*]>MJX]V'W^B;?&^Y=4-I5)76N_7M37XGPC MZ\Y6:G3O8YW906F)&H4F$-S8Z*EAH$Y! M8ACR$&<``'.<]&,=/"4U,POO;53YKEOG:C_5B)NLO4NWY?5U>5^A<'!0CN## MQ8KW35`.:90,L3D2.Q;>C3FQJP$%CP0YHZU@ MHF*ND&1ZF3[J[I):-80"-R1#,,`46-9ZYKY3I:>T._.K]6WA8]_TC0$U8('KA8MSQB>4=*INDBC# M/Z^1M:S-265'YX$$F4)),F7GG-D@:1Y+-^CSBU"%*(98LBHGB?*,F_O/Y[6, MZCK9L'C5*:P=\H&]+Z?G#5"VI18,ZJR.T77R>QW-3/X9(H^A+*;)8A&-J;#0 MK"/"O.`$8Z^1='%E?;.3MQ]UZKAU.;'[&TI0D957&Y?%X',IZZ7?KTS M7F_1^)5S*)JYO;*CA%@DMDJE+4>:-=X3>.VK;19?W>L::+92%NSG4;#>LO<=C69#@ MIQ-5-".!*FOQ8Z3I24&3QIS#<`"GP(>18QC@F*OERM+^]"E>]GH+C='U]"'. M5>9$9LSJ\S>X)G]#&&E)-:ZZ5/,+;!P2^ZJ=)*"SS'!82NC=A"<)V1$XRK1^#$W M";)5B"&HTXQ9":-Q5DEXS^U@(A$7$RJ2Y][;/GA1LH9"8+3T?B]7[6TKKO5E MC6S-'J.P&41>QYG9=N!9'6XG* MWE/7,ZF<0*?C'%$UIK#\03-K M,+(G)6(@LHX&?"9Y+7UKEDTGWWV`HEZL:GMAZUJ0Z[(JMU5EL&?JL?9<.L+, MIG8K:J"ZR2%\PUR8@4IADVK-ZE!@U#>>J6IU@S4IA1O@1#X*CPM;MC>-SUA* M-:*VHB-5A()]L3:LMKU(JMMWE;/$&!'#J2LZYE[BH40YM=WHQ2J1UN8D)"%. M,'A5`U?[/ZKTO-Q0F9/4GK&1UEM:J M>10BTX&XNS'')0A<4Y$;=$:II0GGDF@R&+4Y3K-M%9 MSS4+-%+DH2684PZ"N3PX>;%M4NLV*-UV26E''']EV-):9JQ/;6[$@`(*)R0D M=8?@UA0<+)ZU6DXS/=C:B1+;VL"AH%K*BHV@K;G5%HTFP=H/M>V-L/9]2*%: M&RF&M7TDH$`KXD+^TN#.R'/(G'+@K0&J#P)$O2(`J,7+$[R[R.T6:Z"ZBK`6 MJ51N1.O%7WM'D6X=J'PM;?CM9P9$J)K&CGZ+.X82N6Q0N.X1.;P%P=B0N"\K M)*0U*48HRL]?^6VJM9(_S*N8!+Y7$E,`E$JA45DDD@BUS;WM9"G]\8D#F\1) M6\M)AK4[J8VXJC$9BI*(2=0,G(R\Y`+&>5EJ"V`[U^74-*6LE52J:7PY#NA= M6OL^41Q:[*Y1'Z:H^G(U<G3J>5]M%656I$#0P M1F3U]=5&O#\.O9E]+*G5!)(.\Q"<*E$SBDRB!Z!,HP;X58W.:%>$99A)I)I/ M*DUXE;;A#@.`X#@.`X#@.`X#@.`X%`]VOXI=VU_O\0?T=;B\FFH_;Z7\Y63@ M?__7]_'`"T`MFJ*UM`$?$N$PAL2"Q>:A9!.F$F',30&2M;GAM$XX;R M/#Y)ZGAO`%]?IZ@>@(R]R[3K\IVM'X$U;_\`=7A;G;67WF?6.\@?9!$Z+CH%$K;W%G`W)F97F(*H8IR2B4A\.'PQIP.MGY`XS\O) M,+U[4KWW;'_'QCVE=YRNT[NL6I]I8H_U.^P!OK^548A$WL\A=9A!)$DF).); M()BV^.M[;%5:(/42EG]1P'T&A#UP#4L][CANX]R[3K\IVM'X$U;_`/=7E9N= MLLA6M>N=:OZ>65U0-*0"4I"529))855<%BK^E3K21)EI"=Y8F)`XD$JTX\EF MA"9@)@,Y"+&<9Z.$MK#3=T04"RJ3GRFXPY00.7;$2NT(FDBQZ9KMM1-;]OC8 MC6SQXSZ>$)M4:]SZ^%ZL0AA4X=CTY0@82X!@/)37MB8=9%>Z!5X MW@1P32E'MFTJV=I=N+M!![DCVRNSE?L_GGKA9%!06OJ`AMC1:G$[[9Z9J+?; MGM..RNR7QSL25M8&D"1C;AFDHV-(/-A["0@"5XD(P9F!<9FLKFQ37E9&]O;DV>'*4 MRM!:E*4S4J>'@:C25;,HJJ36@_J'LYYRN,)6DO0+#`4`@**4>TQT*V6U+C]'UWB8:*RV#5&4WLRR7D:C3YGOY^CA:A3EU.3V=[Q"IG02 MY:A6FDEKALIQ``YQ@:

;_L]:\DM^,7$"K)B5KW"*WJI_21?+R]UK;M9[$L>P<(MA&I-=$Z5: MF0.;"!O/;LDARH3''8$;U!Y!D1-(?1%:KTY990WKQ6%'VN;157*T]I.,CRK6A*6HC`&9-ZQA@C.L%1[,OFFD.U4\ MA,0;%5AZ2P"857L?2VQ=;+*?U3L>#0E6]UH;%NJJ&1O&F M&WL+7[%5_K=L]`*WHG9RRY_;#PZR.N)8\7]1$IN56-RMX5)2Z/3^-Q@_Z9?E M"MV9%+FA"I87%P&,.5&"2\B%QBXRPZP.YZJ>ZT.TCK>,SE=AVA=3Z1]UB6Q<#: MFUKEJJL#'5,G/;U9B(2[P8S3L%].:EQ/A:NQM=T=C;(T+>KLN9E3/3-9[!P) M1#7=@*=OIY9=CM1CDB>DZU2?E*W>;1=0'%C`).:-1](8R$9?@A8,%XF%)EW= MM3B*2R8W/2-Q1.#WF@W&M+:>GE+Y7BMYK!!&+>I2L:9GE'61$FV3,R]YC\F: MZ["HR[M:IO7MR@1!J8'7)'@Z+?BL.LG_`'>NPEW$6_:MP7O51NS4X3:Y1JLS MXI5LH)HFH:^UUV2A>RJ*,>:SA8.)].7"P)C$^L].!KTW#Z@B"DY9($^,C%QQ M6$DSS7'?:QWBE+"D5[ZA)[2U\MAXL6NU++K=6T"8Y+T'%*`CZN*EQIUK+W?,_=9$ZV];EV1N9W[.MG]:+W ML"116MW"%5ZD@NKYBT,`IN`0Y?.9>]-#W0X3HX.[@J/6N9QIH,XP$/(M M^*P@:U.YM361J35E%I+E)BENU1:5PRQNN)JB2OQ.25M=>Q,JO.8T]*8QB1%& M.494&.[4,`AJAB)>F%,L)"6$9A65'MF<82%9?=YWFYEWY55=63KBOUVV%N*; M7OE%?=!+K=LR@+)MH*W-J/E/"53%!`GE2M=7=S=6(YU;RC69:[J2AY5IL8+& M+C&,N"=W?6RL5JJ$4G%;5UMNJJD.M5%T<_UWMM2$CLR&PJ7TW6#?6#A9%.,C M3-VQ*UM=AH412]S87$)V<."4)H%^,'&!`H]H_E<+5"HKAUX1Q?7ES>D4NU]I M'6C7ZO:ZGKDW(FZ:3&RHX5,V"R52Y.EE;XH1,"1A9(\B5C0E#2\S*!*F]TGM2.4(M!SC19"=6VJT3-A-D(S#4I>,RE] MMPNO"*6W8"^V-:UB;'5P*T),SUO"(!7L,A%@^[96\+B\Z!(Y\]FP1^LH;Q,; M:L=A6*T&'\Y0CRT@+2%EE'IRC"CJEQI??A#@.`X#@.`X#@.`X#@.`X%`]VOX MI=VU_O\`$']'6XO)IJ/V^E_.5DX'_]#W\C.,XX.&;\!P*8I.\(U`6VSBE4]O8%-AV.=3 MI"PR!V:GK=9;9"W#8;5S?=*B%E4VXV(%VSXE]"D/QCEE<$2;!.3PB+PM?6>4 MP7QL?26LD5;YK><_;(!'7=YQ'FA4L1/+LM=GG#6YOAR%J9(ZVO#XXC1,;*L7 M*1$IA@2HDIIYP@%%C'@1$SPD`,\AQD##9Z>0MRROS(CB>$2M`:)P:%4.$S>< M)!4U=8?-1[;:T7U+Y5`J:NRO['F$ M+3J5LA88L^D.*Q,V(GH^-K'E#D&`D/C"E?TXD9B]"-2C`IR$O)N!#!@0F)CF M%B>$.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X%`] MVOXI=VU_O\0?T=;B\FFH_;Z7\Y63@?_1]_'`,P9>32B1`$S&FK#OH&CO#H%3L^D6K-Z;16B"['LFLVW6BD]6JS ML%O@L%?HHJ13MX=;%C%3R"X&9N/0HU`$R[Z3(7%.;H3A.<`!/[$EKK7E7K_C MQ[C^4N/\5_X`Q2:,0F*Q MV93APLN5LK&W-TAL%U9(]&G*9.Z5.`I;(ES!$T#7&6=2Z'AR:-.A3$)2LBZI M8`AQC'*R\VQ&+&C$I0P6HX5M.VV&Y;H)Y+..[SOW7`W8O49"-YV,\\)G=M:; M7O\`1D=8JWAI+6YK9VS/":4J5"-\,++`CR+.#,1O_;A9_OH(G/K,/HFODJVV MJ[KQ)&[XGS7=-+TK=-RRA'?*.%HZUKZFY**ATCM.()7%OP6T92E>5A23!JXA M/XN0>0((S`I.LU6<04\)-1/*-M#M';))JSN]; M2V.NRSY,Y:X:_5VY5CKQ(ZR@59(::G,FH%LKAX9YD)!%T5AR1\K^+O*UF*3N MZDD].K"(]2`2D/R"9YI">]!MC0/8G8ZQ*+?-ZHOM/(JOUWCNN\8J^FO/?6^[ MGB$N\R'*,*4`0`SD?-XI-VBK:^R:Q>[:A3=1]L5E(='-)K+J#9Y\GE53 M6L8ZUV$[L5%P1+7<=DCRP-L6MTZ5S*`NTG"N95CFV81IP*_&,GJ\AP)\YYEO MTY6#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!0/= MK^*7=M?[_$']'6XO)IJ/V^E_.5DX'__2]_'`>6?,XC9%7PABHVQ;"CD]4N)$GL^+KX( MFA]3E(LI<)E4U22*6,TH6$N?AQ>!PT('$>/!"Z^`?L]()=9\SCELUS7;31MB MS.)S5,YGR*XF!?!"('61J`E6:E2R]$]2QLF:HYV&G`61EK;%X,".#X3(,8%D M(:3_`/D(;R[3ZB:^Q)GUR8II!"+(D[2RRG9AH*83VR*)U**6*LUU'CS'$Y^C MT]?L,!:D+EEO\7*;L&@3*`+!A$3);Z1$SE0O_CE=X?NE?EQV1K_=LBLC86KT M$*\[RK1F;F&2OM0R`A4(EN12&9/R\$@>&">$EGIDZ4PQQ5$KDQ9A`"DWCI@4 M+WB(BX>J0BSYF=>2VJ#*-L5/!TL0!)";]-7P3-9KG<1B0&86F;BY8.P`R``5 M`Q9,,9P(N@D70?TY#@5J%=&V*SP=AB">2-E^KU\$'6'-$)JUO+=$L)>PM$=>#&UX2&JR M%`5(RPCC?PM/WSMD7`EC%05+KVS7+.+&/37!>DYKZG9U-*I6+:1J^NG*(.DT M?[$KJ2QZ=A)KJV+2B3T@CS2!P/DZ]`!$,C(,]`DG7YX6YJ6\F&Z.[C46S75C MRFQD)&O=C,#=\' MVFC-547,=C8V3KMINZ'1]#<<%KUDKAS<91MB2H<4358KR@0*5TZ*;RPJ3FXO MPF0LQ6%.5EM7VR:6-A=9M M-J>6[$ZW6&_1BWMAI*BA\AO+;6W8&77#9*'>J8!,;`AHKEGC[%+9V.E+2C4N M2I8H;$K,V*T?A22`$$\2=:S,\+9:G[0+MG]TJ4LMF?GE/"K1[JR/V6Z0$#HY M`CC!9P]B<1V9D*(^-2)M+E,4>D:YD/4Y+$H#A*,KPF08^4DQ5Q\OTV/U-J9Z MWJU@9E+UL`B9+]0[42VU&./[<;7Q9D?7R',%>O$9.:F>,W4T-D*0M#A(%8RT M3$4VHLA-Z@B1%@+"$1.)4S<[\VD@VJ7>_1:!T[:=@PB`VGOM&HSL`9L3'$3I M33#&ZK+2MP65OFLJ-M)1BL$1`'1/E`,1YQHL^+"RIR+.6UQ?7*\6U)ORYBGI%?3.K95+9`E9IZ28%XB3]/I+$6YD^ET MYY2X`G8023<'F@Z21S.&.6*]T]W8*3:5^JR[K*?3&?6!ILR,Z=V%-+3O`MOL M=SGCI7-8SF'S>S9=+Y2PE6[9#^ECRN/E+1BU8:L&C8:R MV+NX]T]:'BW-@;.L^E[2TFFP5O( MZQN[:Z1;&KIA.H_-X1&FNV*PE;==][(JN>X&0\X1+S"9*D7+PN*7`6_J$"5! M)XCCEMGT'IAQBLE331]U@O\`I=8=624":;V?OI8VR\-A MLS&XK2RLJRUQC:48E++&2687X40!5F?MM8X0X#@.`X#@.`X#@.`X#@.`X#@. M`X#@.`X#@.`X#@.!0/=K^*7=M?[_`!!_1UN+R::C]OI?SE9.!__4]_'`%P7-[20I@1M1[ZX%^&"0L?G M,(1NCXH1E'C+3B5G'93DY\&7U`8P'A9F9YE.W"'`I0G[NG3%+:/IA3TDW%S# M$]!:H$.)=86:Y*L\MSR]@L9/38I<*GT\Z`]Y\=P[%L05^%F,'^%\+C`\%N>$ MFWOJ;K[LN?%UMTUX3*W6%DOJ.,OJ&1R^%R1J:Y22D32AA+DL$D$9?E$9DR=` M0!Q:SE)C>N"4#!Y)F`XZ!$S'#MJRUGHJF:SDM-5;7#-!ZIEBV4KG:OV%0ZIH MJ2.;)<))0E86@3@8EB;2[`R,8D+5A$B+/--.+*`<<:,8F9G,I(@4&BE806%U MI`VO(G'(-#(^F.5J4[%%(DSHV".LY"A>H5KCR6QH;R2`C.---$$&,C& M(6F-5&-Y!3" MIGSP,L1))9AF5HO"B'@)>`!5=Z[N'3)^:X&S*Z=&C05E'Y!%8."/6-;$44,< M=E,J63=_:,+HO.V=>XHG*5KS5H@JS3^J:+'4ZH0A#@MREVG]6*(H9W42"KH0 M:QOZJ'-E?'/SK+)M-'O,*9Y7+IRVQHMVG,DDC@0UII9/'9=X,LP/7.5YZV1! M+*"6+F4*/G=GZ22!V(?%E*B0NB44O\44QJR;>3EZLN6MZ$B)3UD3(F MAXGDC7.@D10`)"E2D>2BP8Z,8%SM9=NI"KVI=43HDBX2.ODSP@AC$2W3EZX4F5!;KK0 MN!-X8/L4[6.^W1'_`*0?,IYVZVXSX8+&6+U&73*YO')VC'@#0HC4H"@_*3@L M7R\+?#L)[0=.6C41U#6'7S!,*B/8V>."A#X2>L;2VN.A1A8,)5`S\.:-P8QM MY!J-:2>!:F/)`:6:$T.!X%S$WY0=">[TT[KYO^CXW3*,0QV17UMKGJ2S&Q)Q M+GN>U.J$NK-UDLVFTND,PE#?!%P\GM;8XKE34C.SD9:8(OEX+G:1K6U.UYN^ M3F3*TZS:Y;)SXC'X&H=U#G(6Y0JB,4M&+W3&F-6!E>&TA6D9+1AK<\)LF@&8 M4H)$#`O`GGEFBYAV5M:RT;>JU4XVM`DTN6+JPGM,+C#WJ2M85M7V>H8%<[AR MPEC>6PA4V2!9%FXX8C`B.*.1EC)&6(/3P7,,.IC2O6_7R4YF=2PE^CDA^A%4 M=PI7VG;DP1`9UAJ(X](4R3:=R-C*%DQO)ZIH4V#BPAZH!A"(6,BY6HX0X#@. M`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!0/=K^*7=M?[_`!!_1UN+R::C M]OI?SE9.!__5]_'`E_O(_R-:T=ON5_!'QDKKL]+_>1_D:UH[?E_O(_P`C6M';[E?P1\9*Z[/2_P!Y'^1K6CM]ROX(^,E==GI? M[R/\C6M';[E?P1\9*Z[/2_WD?Y&M:.WW*_@CXR5UV>E_O(_R-:T=ON5_!'QD MKKL]+_>1_D:UH[?1_D:UH[?E_O(_R-:T=ON5_!'QDKKL]+_>1_D:UH[?E_O(_R- M:T=ON5_!'QDKKL]+_>1_D:UH[?E_O(_P`C6M';[E?P1\9*Z[/2_P!Y'^1K6CM]ROX(^,E==GI?[R/\C6M' M;[E?P1\9*Z[/2_WD?Y&M:.WW*_@CXR5UV>E_O(_R-:T=ON5_!'QDKKL]+_>1 M_D:UH[?1_D:UH[?E_O(_R-:T=ON5_!'QDKKL]+_>1_D:UH[?E_O(_R-:T=ON5_! M'QDKKL]+_>1_D:UH[?E_O( M_P`C6M';[E?P1\9*Z[/2_P!Y'^1K6CM]ROX(^,E==HXDT7WCOZW]3G&TM=*) MIR`T-L-F[Y')(IM3(;>D#FF2T?=E5IH\VQ)9K55J;!JEPM4E2)2-TZ"BT@@^ M"'DS`@#$7EM#Y63@?__6]^9)Y*@&3"#BCP!-/($,DP!@`G)CC$RDG(@9%C!J M=04(L8?\0##D.>C.,XX'&;G1M=TYBMI<4+FE*7.C6:I;E:=:G*)J MB%7B;BEZOC*!7X`8_%UJ?KA\(4/H&#IQTXQT\#F\#B(%Z%T1IW%L6I'%O6%! M/2+D"DE6C5$C_P#"G'`_7@<'(B5*4XM0 MG.#@60Y$4<2(99@<"#G'3C.?EQP.1P..0K2JLGX2J4ZG*50-(JP0<6=E,J+" M`9B8_!8A>!4%@,#D0!=`L8%C.!^BA2G1D&JE9Y*5,0#)AZA0:`@@DL M/RB,-.-$$LL` M2:#!A1Q)I>1`,*,`+`@B#G.,XSTXX'Z\#C@5I3%)Z(M2G,6)2DYZE(`XL2E, M2KR>%*<>0$6322E(DIF"Q"QC`\EBZ.GJYZ`Y'`*I5!Y9ZCPI^.H'J!SUA_)CY>!W/`YY4+;,#6*X=F2XS#+&KPQ<]-D"M5SCB$D[J-[HY.2^`+6Q"O/`%,E\)&I MYAV6R14(1556Z>YB7PB98[FR@4?=Y$&DR'#NGWF3AF0G,NCRFP&3D=]ENI=: M!'E-@#M]$XR`O/BGCX>"/_*6==@M:?G3`_!!;:90QR`-8BAH3<_1OTMD`D&,+LJL\?\`)/$_XTL!)I#?DFW] MMRBH#:4LH>$6AM9AGF,ZJRM:@!.7*-0_NV*!L5G#B93BKYDG5K!3E.)$)T7D MKEH&[K-Q!I)9*7"4F*B40TSM_P!X=*46LT#.72":3G9>CM;]H&67^C&$M#-% MH=6M7RQ;M;53NJ*B25K12.T[*A441)A*4YJI"&S%(D!Z$+>C+(968ZY5?KW? M'==_JBTT*88!9QMPSN(177]12U,2:P'+6N%UY8R52Y3 MJ.M09H)B+:TRP;@B78R*B^,KIH[3EM-]W'W3R9=:4FUNJ6455K-$-C M;[8V"/K7JHH.BU&<7YD*6KIK%9E&H"CF=K,#%'5;XXM9Q3<%QR7UTYQQ9Y;3 M/,]E>R=C][I94`*)50L$E**16$WK:_V M=T];U#AJEJ[!F%LC MZY%KB;'TQ1#VL?7`"!:YJ''Q=(Z*,96IRQ=(#V7@%=5=%H:8_)0Y[PMV%KM> M8HU/6)[6V)+I79M_O=ZV;".[VE30J3'1^RC["DCRR2AS$@7Y^B2$"=42G0DD MX(?\K&?^O^N6PZ7+9CKQL7WIDJ@\DL"4SZQ:,T:8:6/GTD<)*C9KGO.U-O:[ MK2&0P;E@*9CK^,V+.6PX#0D_RD*8XXSHR(T0Q-L\QU:QI'3BNK-J&?7'7MRB M&+IAU]-[$BOEB>;.5[B5EJE#]1B8H\0AYJA?`0D.%(LC8B+6M#REDI\;?W\] M&F1(3'<9V"#7BY7"[FH1ZV])\HK6'TS$J:8M1*%C5E.5#3J?SV*67LH"32Q2 MXV#8*^:02N#&6]G&-%JLR1F6)7>2M!9R,IX<,*1!("A.S`8K;.W3125ASJ`W M#*:O8];:*A-MQZHH33U--4*LBQ;&W]W8ALH)F:0=6&OYS$LK.IFU,J0,RQK- M&>,:6W[VO:"Y->Y#4P:XN)VK%E/@%H2=4QQI3"&&9SN>,KK"" M8,DAIEK4K94#NES;"3G$HVM4S]#7N0?2!1Q*X0"/\I*=8N\*K*;ZF586?8\0 MGVZ5S:YU!)=@-N97.+250&G5;[!;,1L=..E!5`:4ZTR\-L:9)NSS!^=4Z):% MP62%9&T[6C5`&-2%66OBW1M.VFS5HQUW:]EKUL2A=@WNNZW:8[I-':&CC]'K M?JRH4B/(.%1XX7.[K M"XMB7;76>0VWO&<7C4M-4PJJ?7[Z`CS-!&ZI%=#L2RE)!$YD2WI93.W"RUJ, M\B5*7)U$!F?TIR`E&W%%`&K0G:(\<*GP#;':V91QGCU7;96%8LIL6O=.CKUF MKW35:%*-/-DKIW;UUIV=U(Q1@56-#6S^-U99&`B+E+LJ@#5X4B M+4>86U[SJP[BU[;:@D]2/BYWL&N=4=WWIDL>00&`3::BFD(JFM#8W(3UBN$' M-K<\/SH6,]>E;DB%N=3<^#,2")+**+2G6IY0C9M[;`4Q=\DU]MS/"H M'4+BB),1A$B:<[;2N_-F*ZB%O2K6EACX=\;Z?$U/5G2CDHE-@U(S:=M=>LC MC,YI3+JHD:$IUL5SRI.W2XQZ$4H9`&D^1':\M&B#M8M7A= M6HB.H5^81)+=;4"5&^>'"XN*XSQ$M:,.#BP"O/A4%ON633+9"M+#B&QDCVO? M,U[HF5.)=.:JJ]<.J[/<[UFCU8U=-"-GJF,L\:<(DZ&EKR4YZ,R0QD:[P(EV M,8+`46L<+%$;';OU_65`O4]VCMA_C^R^IFJNP-^VNOJBF4#MJL@L*YZMCMP2 M>L6F,U(C8VAL9*ZL(:57].-K^%H$D,>LE%`*.`62HO$+*5YMK=;MW;G>*W-7 MNP[S>LMH:>;(QS7"\5D"K@#VZQ2!0.(/%=.)D?CL#9H1-51"MU-,PX&LQA+U MU\*,%Y(-*+`\)4>T7"%[%V(W5IO=9DUX6[&/KZ;$;%U1C%=-D]1P)E<=I(+9 MBZ-..P<^45=!]9GQ[F:)M<90]L257&Y)&&Z!$1A,H&LL.OIB)E;^TK].7"/TU==I"KJ#-*>P7 MFX=JD+>Q7HTJA53+6J/M]4:8M2>0KSVUD4,[>YR["E:W+RVWQ7C)77"O$VWY MV\C=31>09VE&HBZ&6;$"K>41=W@RJP+T;HNDI=?5N8O8LPTZCM$[..<7?I%) MF@<2828.IF2420U(Z'G)%0@%J+X2U'9ULP39-\U]`=E[VKOSOOG>BUYFC#7] M*AF[`*OM?*)L.H&=.5(ZCD>(@W.6M($E2.^Q4^>&.<1[N[;2LVX)JR4W6YM),&R%4[:RF[TC#.F_7R306LX1Y[ MTW$&A(M?8R_B8?I@8,G!.5%J"A43X?9>S^_LNJ.V[4*V3FC,GUQT;]XF!((- M7-9N;)L)-&_:#;.'1!\L!ZF6OL9DKRSR>G:C8TKHC8&^/-SR<>!Z:P(TZ@D) MK)777E=VF)7=53:H=Z;)*QD4TM^^*XV,W2D%<1F6,,;=7='(T2,I5[U>[K`02K9"H9+>DLIZ->[W3P]=JA8H;%'9CVJ?+#G4Q8KX( M=7AZ@DDE3R[0&/-;<1]',3FT&,"94!X4Y-)-%U!$8X[&2O5*0K7].8_@<4[J]0T MU4=@U2YJSE`Q_KZ4>W&NZQE.M.U=33V])'0K$=1MQJ=?*BAE8UTA8]JIC,]N M]M(E;\>=D8ZU7>A%8^V M9K9;>&^8P"(]XT-79^S5>3K=],L:MQ?X1'5)3S)YP M^L$R(?#0)TF3,DHR"5&$[VE=&RE%W6\T%<&Z%KQ779CLVF%UE[@+X'2C?.X4 MGG>OEORX4'3O9-.JZPB,"F=R0!N+(7KHZK4-V%(6G*S_`+TC.!B M-8%Z801KN^8F0]]=X44V5LP1^&12;68MLW<^Z&^QYKABLQ@Z]&) M:9$9XPK:Y"D-5F-A@Q8\*68C.'JWALSC%@QY'*X:[IWV/."AT2HW1*!060>H M9790+I!C&1%YSCIQT9S7-H7HO45_EEL;8WPOJG11[8X M[NIM%($LBM/3\Z<[4DJXM*USFQ.L*O1PL-(U,^6QW(3J&4P4=5X1>#SU?""R M$08W?$7*LS%NUMK7PU)/!G$@%13,9!N]+F6!1E#".\"MVX6 M&=S&JF^4VU(X-2U%1F`V,KJ.TI98%1$[&&T;.(K&U;W*&5E$5$2Z^>I2Q+B` MLXEAXW;JI7\E9_JM[W75C3Z^9_;EJSJ0+E=@3S1+N]D4QFR>/)60X=G,4AW= MCD]4%LBV/-K.B?F&6)3L*T(VTDA.J#U!I0`S@KB$[5%1"I\EW/=4V1'*QC;U#&R#I6]QRQND M9:@S-2J"D+.(2B3%J+01;G>.[CQJFV5>TWF]!FD5J>Y[+J^1)O,%MC^Q"&)W MA)HK`CQ*'C5DY]V1DK+$(BT,.CL"CJIL/(?QN1*9>0>C6OK#>7K'.KKL! M_P!U;6VKJVCK&LY_$T<94:MP2#UAU8!,GP!D,E*^2R)F&P%JP*Q%&G*A1N8B/"6- MA+WOR&L=KTM=&X5MU[6L2B>[L62QQIK0/NJ#JQ1NTFG%4RHT:M+*K)>L*EQP#W)S0)A-AAV24J7Q(33 MO8COOL@]/^M\BL[:63U+K#L.6M)CHV/+<1&36@MJ"$M8H)$(5&<87`W)2Z4@W\=''>2&U-*J]SHE M'T$1!:M>([`/S(S;PL7#LEKM$)@?GXF:&-!X>IEF`!SP$0!%YQG`8M3&O#I1U4V8I1XF-Y(IQ:,N).BEAQ5;K[:]H7--6 M"IFMICKRTQQ[BKK%U01N*O(Q#R>$U43T:.K;/F4.V5L)TV/"7,$NQ M&N*^EX:NAFDT;3;55W6I4S;98UUTH>Z_4;4: M`\E1K#B,6SF[EEU]A-%MK)BDB;%!>\ALR'6C6;!4UEN=I->N<`U.D](L[S:< MIUCB,-FS4*C3#K0L^XV>YM;6_8W-KCGG#AX\!X!04!,*AN/H:2VI+*8WLL^Z[, MNN=H"[BW.K>%0""1N"1Z1UW5-%6O=D)B"&D2(Y$XX^OEER.*)4P4[D\.*\:Y M4B;<@R48%2H6&9K%-6VN5?U/-<=XY7^MTS3EZZO>H]9N\9E^J#I/JV`QRB&" MNG!D/NQ:J$ZD.VUG6%.68LQ0J`QIW=A]=/A,44@?7I*F,+&8$[!AV.@&< M8%G%9GR__]#W\<"-*F_]UG7^&G\2[I_A-_[K?QBG?_\`E?\`XE_;3_\`W'Z4 MX$E\!P'`J_P`E MDZ_B7_[_`-#_`,"_YA?XY5Y_+M_\G\ M8_YF?X@NG\V7_P"8K_[:_P#1/$N2%[/\`[4_]"\3Y(:[G\'6O^+G_`.=S[`?_`+OT'R>6 2X_J],7*P -----END PRIVACY-ENHANCED MESSAGE-----